<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD001187.pub3" GROUP_ID="AIRWAYS" ID="066399072809304071" MERGED_FROM="" MODIFIED="2011-08-16 15:24:16 +0200" MODIFIED_BY="Emma Welsh" NOTES="&lt;p&gt;Emma edits 29/07/2011&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;Lee 2003 has been withdrawn http://www.ncbi.nlm.nih.gov/pubmed/17046767&lt;/p&gt;&lt;p&gt;Are group comparitive trials parallel trials?&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;CJc Edit of update Dec 14&lt;br&gt;Thanks very much for updating this review. I am puzzled by the Dietermann results; could you clarify how you derived the SDs. I am not able to tell whether the figure quoted for baseline CI relects half the confidence interval or the whole CI?? The data entered shows significant differences that are not reported in the paper. This is a rather minor point, but now is the time to try to get it right! You comment on the SD in the paper as possibly being too low. If the figure given is only half the CI then you would need to double the SD in each arm. What do you think?&lt;br&gt;Otherwise this all looks fine.&lt;br&gt;Chris.&lt;/p&gt;&lt;p&gt;=========================&lt;/p&gt;&lt;p&gt;1. Cannot remove one of my contact details, with rev ID 1111. Please remove it!&lt;br&gt;2. Unclear whether Lee 2003 should be contacted or not, many questionmarks???&lt;/p&gt;&lt;p&gt;Old title: House dust mite control measures for asthma&lt;/p&gt;&lt;p&gt;Edit by CJC 1st July&lt;br&gt;What's new. It would be a great help to list the new included studies (and name those that contribute new data to the meta-analysis) and comment on the impact of the new data on the conclusions and results. This section should enable the reader to assess whether they need to read the whole review again or not!&lt;br&gt;Cross-over studies are most appropriately entered into RevMAn using Generic Inverse Variance. This requires the results for paired t-tests in the papers and I know that older papers may not include this. I would like something to be included about the feasibility (or not for this review) please. I note that the new studies are all parallel anyway.&lt;br&gt;Many thanks for updating this. Could you fine tune as above please.&lt;br&gt;Chris.&lt;br&gt;Old title: #House dust mite control measures for asthma UPDATE (WITH CHRIS 010704)&lt;br&gt;________________________________________________________________________________________________&lt;br&gt;Abstract:&lt;br&gt;previously: Forty-nine trials (2,733 patients) were included.&lt;br&gt;now: Forty-nine trials (2,733 patients) were included; the number of patients has more than doubled since the last version of this review. FINE&lt;/p&gt;&lt;p&gt;Description of studies, first para:&lt;br&gt;Names of the 21 new trials added as requested.&lt;br&gt;previously: The most frequently reported and useful outcome was PEFR in the morning (19 trials, 1339 patients).&lt;br&gt;now: The most frequently reported and useful outcome was PEFR in the morning (1339 patients); in the previous version of this review (G&amp;#248;tzsche 2001) only 565 patients contributed to this outcome.&lt;/p&gt;&lt;p&gt;Discussion, first sentence:&lt;br&gt;previously: We were unable to demonstrate any clinical benefit to mite sensitive asthmatics of measures designed to reduce mite exposure.&lt;br&gt;now: We were unable to demonstrate any clinical benefit to mite sensitive asthmatics of measures designed to reduce mite exposure. This finding has been considerably strengthened in the present version of our review as the number of patients in the trials has more than doubled since the last update (G&amp;#248;tzsche 2001).&lt;/p&gt;&lt;p&gt;Crossover trials:&lt;br&gt;Under Statistical methods, I have changed the 2nd sentence to:&lt;br&gt;Since the results from cross-over trials were usually reported by the authors in summary form, as if they had come from a group comparative trial, we analysed these data accordingly, assuming that no important carry-over effects had occurred. We decided not to enter paired data from cross-over trials using the generic inverse variance method, since rather few data were reported in this format and since it would require that all other data should also be so analysed in order to present summary estimates for each outcome.&lt;/p&gt;&lt;p&gt;I hope these changes are OK with you. Most crossover trials are very small and it would be more difficult for clinicians to read and understand the graphs if they were all changed into generic inverse variance ones (and most crossover data would still have to be treated as if the came from parallel groups&lt;br&gt;_______________________________________________________________________________________________&lt;br&gt;CJC second look 15 July 2004&lt;br&gt;Thanks for adding the extra information. I have pasted the list of new studies into the what's new section of the review. As well as the new sentences about the results.&lt;br&gt;Many thanks for updating the review.&lt;br&gt;I have run spell check.&lt;br&gt;This is ready for copy edit and submission.&lt;/p&gt;&lt;p&gt;Old title: ##House dust mite control measures for asthma UPDATE (WITH COPYEDITOR; READY FOR SUBMISSION 160704)&lt;/p&gt;" NOTES_MODIFIED="2011-08-16 10:37:13 +0100" NOTES_MODIFIED_BY="Emma Welsh" REVIEW_NO="MITE-AST" REVMAN_SUB_VERSION="5.1.2" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="9.0">
<COVER_SHEET MODIFIED="2011-08-16 15:24:16 +0200" MODIFIED_BY="Emma Welsh">
<TITLE>House dust mite control measures for asthma</TITLE>
<CONTACT MODIFIED="2011-08-16 15:24:16 +0200" MODIFIED_BY="Emma Welsh"><PERSON ID="6571" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Peter</FIRST_NAME><MIDDLE_INITIALS>C</MIDDLE_INITIALS><LAST_NAME>Gøtzsche</LAST_NAME><POSITION>Director</POSITION><EMAIL_1>pcg@cochrane.dk</EMAIL_1><ADDRESS><DEPARTMENT>The Nordic Cochrane Centre</DEPARTMENT><ORGANISATION>Rigshospitalet</ORGANISATION><ADDRESS_1>Blegdamsvej 9, 3343</ADDRESS_1><CITY>Copenhagen</CITY><ZIP>DK-2100</ZIP><COUNTRY CODE="DK">Denmark</COUNTRY><PHONE_1>+45 3545 7112</PHONE_1><FAX_1>+45 3545 7007</FAX_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2011-08-16 15:24:16 +0200" MODIFIED_BY="Emma Welsh"><PERSON ID="6571" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Peter</FIRST_NAME><MIDDLE_INITIALS>C</MIDDLE_INITIALS><LAST_NAME>Gøtzsche</LAST_NAME><POSITION>Director</POSITION><EMAIL_1>pcg@cochrane.dk</EMAIL_1><ADDRESS><DEPARTMENT>The Nordic Cochrane Centre</DEPARTMENT><ORGANISATION>Rigshospitalet</ORGANISATION><ADDRESS_1>Blegdamsvej 9, 3343</ADDRESS_1><CITY>Copenhagen</CITY><ZIP>DK-2100</ZIP><COUNTRY CODE="DK">Denmark</COUNTRY><PHONE_1>+45 3545 7112</PHONE_1><FAX_1>+45 3545 7007</FAX_1></ADDRESS></PERSON><PERSON ID="12436" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Helle Krogh</FIRST_NAME><LAST_NAME>Johansen</LAST_NAME><POSITION>Senior Researcher</POSITION><EMAIL_1>hkj@cochrane.dk</EMAIL_1><ADDRESS><DEPARTMENT>The Nordic Cochrane Centre</DEPARTMENT><ORGANISATION>Rigshospitalet</ORGANISATION><ADDRESS_1>Blegdamsvej 9, 3343</ADDRESS_1><CITY>Copenhagen</CITY><ZIP>DK 2100</ZIP><COUNTRY CODE="DK">Denmark</COUNTRY><PHONE_1>+45 35 45 7112</PHONE_1><FAX_1>+45 35 45 70 07</FAX_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2011-07-29 10:15:13 +0100" MODIFIED_BY="Emma J Welsh" NOTES="&lt;p&gt;Minor update: 19/12/07&lt;/p&gt;&lt;p&gt;New studies found and included or excluded: 31/05/07&lt;/p&gt;&lt;p&gt;Reformatted: 28/07/99&lt;/p&gt;" NOTES_MODIFIED="2011-07-29 10:15:13 +0100" NOTES_MODIFIED_BY="Emma J Welsh">
<UP_TO_DATE>
<DATE DAY="12" MONTH="7" YEAR="2011"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="12" MONTH="7" YEAR="2011"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="29" MONTH="7" YEAR="2013"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="1" YEAR="1996"/>
<REVIEW_PUBLISHED ISSUE="3" YEAR="1998"/>
<LAST_CITATION_ISSUE ISSUE="2" YEAR="2008"/>
</DATES>
<WHATS_NEW MODIFIED="2011-08-15 09:29:14 +0100" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2011-08-15 09:29:14 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="12" MONTH="7" YEAR="2011"/>
<DESCRIPTION>
<P>One new trial added (<LINK REF="STD-Wright-2009" TYPE="STUDY">Wright 2009</LINK>). No changes to conclusions made. Minor copy edits made.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2011-08-10 11:43:40 +0100" MODIFIED_BY="Emma J Welsh">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2009-10-08 08:59:45 +0100" MODIFIED_BY="Toby J Lasserson">
<DATE DAY="28" MONTH="7" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS" MODIFIED="2011-08-10 11:43:40 +0100" MODIFIED_BY="Emma J Welsh">
<DATE DAY="19" MONTH="12" YEAR="2007"/>
<DESCRIPTION>
<P>Five new included studies added (<LINK REF="STD-de-Vries-2007" TYPE="STUDY">de Vries 2007</LINK>; <LINK REF="STD-Dharmage-2006" TYPE="STUDY">Dharmage 2006</LINK>; <LINK REF="STD-Fang-2001" TYPE="STUDY">Fang 2001</LINK>; <LINK REF="STD-Ghazala-2004" TYPE="STUDY">Ghazala 2004</LINK>; <LINK REF="STD-van-den-Bemt-2004" TYPE="STUDY">van den Bemt 2004</LINK>), one new excluded study added (<LINK REF="STD-Shedd-2007" TYPE="STUDY">Shedd 2007</LINK>). The conclusions of the review have not altered substantially.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES>
<SOURCE>
<NAME>The Nordic Cochrane Centre</NAME>
<COUNTRY CODE="DK">Denmark</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>Rigshospitalet</NAME>
<COUNTRY CODE="DK">Denmark</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES>
<SOURCE>
<NAME>The Swedish Heart Lung Foundation (grant 54506)</NAME>
<COUNTRY CODE="SE">Sweden</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>Nordic Council of Ministers</NAME>
<COUNTRY CODE="DK">Denmark</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>Sygekassernes Helsefond</NAME>
<COUNTRY CODE="DK">Denmark</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2011-08-15 09:29:58 +0100" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2011-08-10 13:52:33 +0100" MODIFIED_BY="Emma J Welsh">
<TITLE MODIFIED="2011-08-10 13:52:33 +0100" MODIFIED_BY="Emma J Welsh">Does controlling exposure to house dust mites improve asthma?</TITLE>
<SUMMARY_BODY MODIFIED="2011-08-10 13:52:33 +0100" MODIFIED_BY="Emma J Welsh">
<P>Asthma is a chronic inflammatory disease of the airways. The prevalence of asthma has increased and it is now the commonest chronic disease among children. Asthma is triggered by allergens (substances that cause an allergic reaction) and house dust presents a problem in some people with asthma. The major allergen in house dust comes from mites and it is hypothesised that controlling exposure to house dust mites will reduce asthma symptoms in people who are sensitive to house dust mites. </P>
<P>We included 55 randomised trials on 3121 people with asthma. There are both chemical (10 trials) and physical methods such as mattress encasings (37 trials) of reducing mite allergen levels and we included both types in this review. There were also eight trials that used both physical and chemical methods. Many trials were of poor quality and would therefore be expected to exaggerate the reported effect, but we did not find an effect of the interventions. There was no difference in peak flow (a measure of lung function), asthma symptoms and medication scores, or the number of patients reporting an improvement in their asthma symptoms.</P>
<P>While reducing exposure to house dust mites is recommended in guidelines, we did not find an effect of control measures to reduce the exposure to mites or their products. . </P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2011-08-15 09:29:58 +0100" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND>
<P>The major allergen in house dust comes from mites. Chemical, physical and combined methods of reducing mite allergen levels are intended to reduce asthma symptoms in people who are sensitive to house dust mites.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES>
<P>To assess the effects of reducing exposure to house dust mite antigens in the homes of people with mite-sensitive asthma.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2011-08-15 09:29:58 +0100" MODIFIED_BY="[Empty name]">
<P>We searched PubMed and the Cochrane Airways Group Register (last search July 2011). No restrictions were placed on language of publication.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2011-07-29 14:56:40 +0100" MODIFIED_BY="Emma J Welsh">
<P>We included randomised trials of mite control measures versus placebo or no treatment in people with asthma known to be sensitive to house dust mites.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2011-07-29 14:56:57 +0100" MODIFIED_BY="Emma J Welsh">
<P>Two authors applied the trial inclusion criteria and evaluated the data. We contacted trial authors to clarify information.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2011-08-10 11:43:54 +0100" MODIFIED_BY="Emma J Welsh">
<P>We included 55 trials (3121 patients). Thirty-seven trials assessed physical methods, including 26 trials employing mattress encasings. Ten trials involved chemical methods and eight trials involved a combination of chemical and physical methods. Despite the fact that many trials were of poor quality and would be expected to exaggerate the reported effect, we did not find an effect of the interventions. For the most frequently reported outcome, peak flow in the morning (1665 patients), the standardised mean difference (SMD) was 0.01 (95% confidence interval (CI) -0.08 to 0.11). There were no statistically significant differences either in number of patients improved (risk ratio 1.01, 95% CI 0.80 to 1.27), asthma symptom scores (SMD -0.06, 95% CI -0.16 to 0.05), or in medication usage (SMD -0.05, 95% CI -0.17 to 0.07).</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS>
<P>Chemical and physical methods aimed at reducing exposure to house dust mite allergens cannot be recommended. It is doubtful whether further studies, similar to the ones in our review, are worthwhile. If other types of studies are considered, they should be methodologically rigorous and use other methods than those used so far, with careful monitoring of mite exposure and relevant clinical outcomes. </P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2011-08-10 13:27:52 +0100" MODIFIED_BY="Emma J Welsh">
<BACKGROUND MODIFIED="2011-08-10 13:27:52 +0100" MODIFIED_BY="Emma J Welsh">
<P>Asthma is a chronic inflammatory disorder of the airways. The prevalence of asthma has increased and it is now the commonest chronic disease among children. The treatment of asthma is both pharmacological, including immunotherapy (<LINK REF="REF-Vervloet-1990" TYPE="REFERENCE">Vervloet 1990</LINK>; <LINK REF="REF-Abramson-1995" TYPE="REFERENCE">Abramson 1995</LINK>), and non-pharmacological. Non-pharmacological treatment often involves environmental procedures such as elimination of allergens in the patient's surroundings (<LINK REF="REF-Colloff-1992" TYPE="REFERENCE">Colloff 1992</LINK>).</P>
<P>Exposure to different allergens can trigger asthma attacks in sensitised individuals. House dust is a mixture containing many different allergens, but the major allergen is derived from mites, especially the species <I>Dermatophagoides pteronyssinus</I> and <I>Dermatophagoides farinae</I>. A common site for house dust mites is the bed, where pillows, quilts and mattresses often serve as reservoirs for the allergen. Carpets and upholstered furniture may also contain high mite levels (<LINK REF="REF-Platts_x002d_Mills-1989" TYPE="REFERENCE">Platts-Mills 1989</LINK>; <LINK REF="REF-Tovey-1992" TYPE="REFERENCE">Tovey 1992</LINK>). It appears very reasonable, and is usually recommended, that environmental control of allergens, although difficult, should be an integral part of the overall management of sensitised patients. However, some of the evidence behind these recommendations is derived from observational studies, including some in which patients were moved to high altitudes or hospitals, whereupon their symptoms improved (<LINK REF="REF-Custovic-1998" TYPE="REFERENCE">Custovic 1998</LINK>). These measures are not feasible for most patients, and it is not clear whether the allergen levels that can be obtained in the patients' homes are large enough to lead to improvements in the asthma.</P>
<P>Different methods for reducing mite exposure have been tried, for example chemical methods, physical methods and combinations of these (<LINK REF="REF-Platts_x002d_Mills-1989" TYPE="REFERENCE">Platts-Mills 1989</LINK>). We published a systematic review of these methods in 1998 (<LINK REF="REF-G_x00f8_tzsche-1998" TYPE="REFERENCE">Gøtzsche 1998</LINK>; <LINK REF="REF-Hammarquist-1998" TYPE="REFERENCE">Hammarquist 1998</LINK>) and the current review is the most recent update.</P>
</BACKGROUND>
<OBJECTIVES>
<P>To study whether patients with asthma who are sensitised to house dust mites benefit from measures designed to reduce their exposure to mite antigen in the home. </P>
</OBJECTIVES>
<METHODS MODIFIED="2011-08-10 11:45:00 +0100" MODIFIED_BY="Emma J Welsh">
<SELECTION_CRITERIA MODIFIED="2011-08-10 11:44:24 +0100" MODIFIED_BY="Emma J Welsh">
<CRIT_STUDIES MODIFIED="2011-07-29 15:01:38 +0100" MODIFIED_BY="Emma J Welsh">
<P>We included randomised trials. Since some mite control measures are impossible to blind, we accepted non-blinded trials.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2011-08-10 11:44:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>We included participants with physician-diagnosed bronchial asthma. We included participants who had their mite sensitisation assessed by either skin testing, bronchial provocation tests or serum assays for specific IgE antibodies.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2011-08-10 11:44:15 +0100" MODIFIED_BY="Emma J Welsh">
<SUBSECTION>
<HEADING LEVEL="4">Intervention</HEADING>
<P>a) Chemical (acaricides).<BR/>b) Physical (for example mattress covers, vacuum-cleaning, heating, ventilation, freezing, washing, air-filtration and ionisers).<BR/>c) Combinations of these.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Control</HEADING>
<P>Placebo or no treatment.</P>
</SUBSECTION>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2011-08-10 11:44:24 +0100" MODIFIED_BY="Emma J Welsh">
<UL>
<LI>Subjective well-being</LI>
<LI>Asthma symptom scores</LI>
<LI>Medication usage</LI>
<LI>Days of sick-leave from school or work</LI>
<LI>Number of unscheduled visits to a physician or a hospital</LI>
<LI>FEV1 (forced expiratory volume in one second)</LI>
<LI>PEFR (peak expiratory flow rate)</LI>
<LI>PC20 (provocative concentration that causes a 20% fall in FEV1)</LI>
</UL>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2011-08-10 11:44:33 +0100" MODIFIED_BY="Emma J Welsh">
<P>We identified trials from the Cochrane Airways Group Specialised Register of trials (CAGR), which is derived from systematic searches of bibliographic databases including the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, CINAHL, AMED and PsycINFO, and handsearching of respiratory journals and meeting abstracts (please see <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK> for further details). We searched all records in the CAGR coded as 'asthma' with the terms: mite* or dust* or "house dust" or house-dust or acari*. We searched the CAGR in June 2011.</P>
<P>We also searched PubMed from 1966 onwards with the terms mite* AND asthma*, combined with one or more of the following: random* OR control* OR blind* (last search July 2011).</P>
<P>There was no language restriction.</P>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2011-08-10 11:45:00 +0100" MODIFIED_BY="Emma J Welsh">
<STUDY_SELECTION MODIFIED="2011-07-29 15:25:56 +0100" MODIFIED_BY="Emma J Welsh">
<P>The authors independently selected the trials for inclusion. We resolved ambiguities by discussion. When necessary we contacted the trial authors for clarification</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2011-07-29 15:25:56 +0100" MODIFIED_BY="Emma J Welsh">
<P>When it was not stated at what time of the day the peak flow had been recorded, we assumed it was in the morning. We resolved ambiguities by discussion. When necessary we contacted the trial authors for clarification.</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2011-08-10 11:44:37 +0100" MODIFIED_BY="Emma J Welsh">
<P>Assessment of the risk of bias and extraction of data was primarily done by one author (PCG) and checked by another (HKJ for the current version of the review). All assessments were open. We judged the adequacy of the allocation concealment according to the guidelines laid out in the<I> Cochrane Handbook of Systematic Reviews of Interventions</I> (<LINK REF="REF-Higgins-2008" TYPE="REFERENCE">Higgins 2008</LINK>).</P>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2011-08-10 11:44:52 +0100" MODIFIED_BY="Emma J Welsh">
<P>When continuous data presented on different scales, for example peak expiratory flow rate (PEFR) and forced expiratory volume in one second (FEV1), could be given either as absolute values or as percent of predicted values, we used the standardised mean difference. With this method, the difference in effect between two treatments is divided by the standard deviation of the measurements. By that transformation, the effect measures become dimensionless and outcomes from trials which have used different scales may therefore often be combined. Data on well-being and asthma symptom scores were reported in a number of different ways, but as these two outcome measures were closely related or even equivalent, we summarised categorical data in the well-being category (number of patients who improved) and continuous data (which mostly concerned asthma symptoms) in the asthma symptoms score category. The authors had usually analysed the provocative concentration that causes a 20% fall in FEV1 (PC20) after logarithmic transformation, since the data were highly skewed. We analysed the data accordingly and when the authors had converted their means and standard deviations from the logarithmic scale to the arithmetic scale, we converted them back again (<LINK REF="REF-Bland-1996" TYPE="REFERENCE">Bland 1996</LINK>). We excluded PC20 data that had not been analysed after logarithmic transformation.</P>
</EFFECT_MEASURES>
<UNIT_OF_ANALYSIS MODIFIED="2011-08-10 11:44:56 +0100" MODIFIED_BY="Emma J Welsh">
<P>Since the results from cross-over trials were usually reported by the authors in summary form, as if they had come from a group comparative trial, we analysed these data accordingly, assuming that no important carry-over effects had occurred. We decided not to enter paired data from cross-over trials using the generic inverse variance method, since rather few data were reported in this format and since it would require that all other data should also be so analysed in order to present summary estimates for each outcome. Paired data were only available for some of the cross-over trials and not for all the recorded variables.</P>
<P>When several options were available for medication, we used bronchodilators. When data were recorded at several points in time, we used the longest observation period during which the patients were still on randomised treatment, unless performance bias occurred, for example by a planned reduction in dose of inhaled steroids.</P>
<P>We did not adjust for baseline differences, since inequalities occurring despite the randomisation would be expected to equal each other out in a large sample of trials. Furthermore, baseline recordings were not always available. If we had made adjustments when possible, we would have risked biasing the review, since investigators are inclined to show baseline differences and adjust for them when this procedure favours the experimental treatment (<LINK REF="REF-G_x00f8_tzsche-2006" TYPE="REFERENCE">Gøtzsche 2006</LINK>). It has also been shown that bias occurring during data analysis is very common and almost without exception favours the new treatment over the control treatment (<LINK REF="REF-G_x00f8_tzsche-1990" TYPE="REFERENCE">Gøtzsche 1990</LINK>).</P>
<P>To avoid double-counting of the control group when there was more than one active group in a trial, we pooled the active groups when feasible. This was not possible for one very small trial in which a chemical method was used in one group and a combination of methods in another group (<LINK REF="STD-Ehnert-1992" TYPE="STUDY">Ehnert 1992</LINK>). For this trial, we split the seven patients in the control group into four patients for one comparison and three for the other.</P>
</UNIT_OF_ANALYSIS>
<HETEROGENEITY_ASSESSMENT MODIFIED="2011-08-10 11:44:59 +0100" MODIFIED_BY="Emma J Welsh">
<P>We tested heterogeneity with the Chi<SUP>2</SUP> test and assessed its magnitude with the I<SUP>2</SUP> statistic (that gives the amount of between-trial variation in relation to the total variation). When we encountered heterogeneity (P &lt; 0.10), we explored the reasons.</P>
</HETEROGENEITY_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2011-08-10 11:45:00 +0100" MODIFIED_BY="Emma J Welsh">
<P>We calculated 95% confidence intervals (CI) with a fixed-effect model.</P>
</DATA_SYNTHESIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2011-08-10 11:57:20 +0100" MODIFIED_BY="Emma J Welsh">
<STUDY_DESCRIPTION MODIFIED="2011-08-10 11:45:08 +0100" MODIFIED_BY="Emma J Welsh">
<P>We included 55 trials involving 3121 patients. This represents an addition of one trial since the last update of our review (<LINK REF="REF-G_x00f8_tzsche-2008" TYPE="REFERENCE">Gøtzsche 2008</LINK>). The potential for outcome reporting bias, i.e. the omission or incomplete reporting of outcomes that were not statistically significant (<LINK REF="REF-Chan-2004" TYPE="REFERENCE">Chan 2004</LINK>), was very large. Eleven trials did not contain any usable data for meta-analysis (<LINK REF="STD-Korsgaard-1983" TYPE="STUDY">Korsgaard 1983</LINK>; <LINK REF="STD-Charpin-1990" TYPE="STUDY">Charpin 1990</LINK>; <LINK REF="STD-Sooltangos-1992" TYPE="STUDY">Sooltangos 1992</LINK>; <LINK REF="STD-Howarth-1992" TYPE="STUDY">Howarth 1992</LINK>; <LINK REF="STD-Manjra-1994" TYPE="STUDY">Manjra 1994</LINK>; <LINK REF="STD-Jooma-1995" TYPE="STUDY">Jooma 1995</LINK>; <LINK REF="STD-van-der-Heide-1997B" TYPE="STUDY">van der Heide 1997B</LINK>; <LINK REF="STD-Frederick-1997" TYPE="STUDY">Frederick 1997</LINK>; <LINK REF="STD-Shapiro-1999" TYPE="STUDY">Shapiro 1999</LINK>; <LINK REF="STD-van-der-Heide-1999" TYPE="STUDY">van der Heide 1999</LINK>; <LINK REF="STD-Ghazala-2004" TYPE="STUDY">Ghazala 2004</LINK>). In the remaining trials, many outcomes were reported in a way that did not allow us to use them in a meta-analysis and it was often unclear how many patients contributed values to the various analyses (see <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> table). The most frequently reported outcome was PEFR in the morning (1665 patients in our meta-analysis). Length of the intervention and follow-up varied from two weeks to two years.</P>
<P>All trials but six had used skin prick testing for diagnosis of mite sensitivity. Extracts used were <I>Dermatophagoides pteronyssinus</I> and/or <I>Dermatophagoides farinae</I> apart from two trials where subjects were tested with unspecified 'house dust extract' (<LINK REF="STD-Zwemer-1973" TYPE="STUDY">Zwemer 1973</LINK>; <LINK REF="STD-Maesen-1977" TYPE="STUDY">Maesen 1977</LINK>). In three trials, sensitivity was established by specific serum IgE (<LINK REF="STD-van-der-Heide-1999" TYPE="STUDY">van der Heide 1999</LINK>; <LINK REF="STD-Luczynska-2003" TYPE="STUDY">Luczynska 2003</LINK>; <LINK REF="STD-Woodcock-2003" TYPE="STUDY">Woodcock 2003</LINK>), in two trials by either skin prick testing or IgE (<LINK REF="STD-Thiam-1999" TYPE="STUDY">Thiam 1999</LINK>; <LINK REF="STD-Rijssenbeek-2002" TYPE="STUDY">Rijssenbeek 2002</LINK>), and in one trial published only as an abstract the means of diagnosis was not given (<LINK REF="STD-Howarth-1992" TYPE="STUDY">Howarth 1992</LINK>).</P>
<P>Thirty-seven trials used physical methods to reduce exposure to mites, 10 used chemical methods and eight used a combination of chemical and physical methods (see <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> table). Twenty-six of the trials used mattress encasings (<LINK REF="STD-Burr-1976" TYPE="STUDY">Burr 1976</LINK>; <LINK REF="STD-Burr-1980B" TYPE="STUDY">Burr 1980B</LINK>; <LINK REF="STD-Walshaw-1986" TYPE="STUDY">Walshaw 1986</LINK>; <LINK REF="STD-Gillies-1987" TYPE="STUDY">Gillies 1987</LINK>; <LINK REF="STD-Howarth-1992" TYPE="STUDY">Howarth 1992</LINK>; <LINK REF="STD-Ehnert-1992" TYPE="STUDY">Ehnert 1992</LINK>; <LINK REF="STD-Marks-1994" TYPE="STUDY">Marks 1994</LINK>; <LINK REF="STD-Jooma-1995" TYPE="STUDY">Jooma 1995</LINK>; <LINK REF="STD-Carswell-1996" TYPE="STUDY">Carswell 1996</LINK>; <LINK REF="STD-Chen-1996" TYPE="STUDY">Chen 1996</LINK>; <LINK REF="STD-Cinti-1996" TYPE="STUDY">Cinti 1996</LINK>; <LINK REF="STD-van-der-Heide-1997B" TYPE="STUDY">van der Heide 1997B</LINK>; <LINK REF="STD-Frederick-1997" TYPE="STUDY">Frederick 1997</LINK>; <LINK REF="STD-Shapiro-1999" TYPE="STUDY">Shapiro 1999</LINK>; <LINK REF="STD-Thiam-1999" TYPE="STUDY">Thiam 1999</LINK>; <LINK REF="STD-Cloosterman-1999" TYPE="STUDY">Cloosterman 1999</LINK>; <LINK REF="STD-Sheikh-2002" TYPE="STUDY">Sheikh 2002</LINK>; <LINK REF="STD-Rijssenbeek-2002" TYPE="STUDY">Rijssenbeek 2002</LINK>; <LINK REF="STD-Halken-2003" TYPE="STUDY">Halken 2003</LINK>; <LINK REF="STD-Luczynska-2003" TYPE="STUDY">Luczynska 2003</LINK>; <LINK REF="STD-Lee-2003" TYPE="STUDY">Lee 2003</LINK>; <LINK REF="STD-Woodcock-2003" TYPE="STUDY">Woodcock 2003</LINK>; <LINK REF="STD-Ghazala-2004" TYPE="STUDY">Ghazala 2004</LINK>; <LINK REF="STD-van-den-Bemt-2004" TYPE="STUDY">van den Bemt 2004</LINK>; <LINK REF="STD-Dharmage-2006" TYPE="STUDY">Dharmage 2006</LINK>; <LINK REF="STD-de-Vries-2007" TYPE="STUDY">de Vries 2007</LINK>). Mite reduction occurred in 17 trials, according to the authors' own judgements (<LINK REF="STD-Walshaw-1986" TYPE="STUDY">Walshaw 1986</LINK>; <LINK REF="STD-Dorward-1988" TYPE="STUDY">Dorward 1988</LINK>; <LINK REF="STD-Charpin-1990" TYPE="STUDY">Charpin 1990</LINK>; <LINK REF="STD-Huss-1992" TYPE="STUDY">Huss 1992</LINK>; <LINK REF="STD-Warner-1993" TYPE="STUDY">Warner 1993</LINK>; <LINK REF="STD-Carswell-1996" TYPE="STUDY">Carswell 1996</LINK>; <LINK REF="STD-Frederick-1997" TYPE="STUDY">Frederick 1997</LINK>; <LINK REF="STD-Shapiro-1999" TYPE="STUDY">Shapiro 1999</LINK>; <LINK REF="STD-Cloosterman-1999" TYPE="STUDY">Cloosterman 1999</LINK>; <LINK REF="STD-Htut-2001" TYPE="STUDY">Htut 2001</LINK>; <LINK REF="STD-Fang-2001" TYPE="STUDY">Fang 2001</LINK>; <LINK REF="STD-Rijssenbeek-2002" TYPE="STUDY">Rijssenbeek 2002</LINK>; <LINK REF="STD-Halken-2003" TYPE="STUDY">Halken 2003</LINK>; <LINK REF="STD-Woodcock-2003" TYPE="STUDY">Woodcock 2003</LINK>; <LINK REF="STD-van-den-Bemt-2004" TYPE="STUDY">van den Bemt 2004</LINK>; <LINK REF="STD-Dharmage-2006" TYPE="STUDY">Dharmage 2006</LINK>; <LINK REF="STD-de-Vries-2007" TYPE="STUDY">de Vries 2007</LINK>), mite reduction was unsuccessful in 25 and was not measured or reported in the remaining 13 trials.</P>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2011-08-10 11:57:20 +0100" MODIFIED_BY="Emma J Welsh">
<P>The randomisation method was rarely described and even using rather broad criteria only eight trials reported adequate concealment of allocation: sealed, opaque envelopes (<LINK REF="STD-Cinti-1996" TYPE="STUDY">Cinti 1996</LINK>; <LINK REF="STD-Shapiro-1999" TYPE="STUDY">Shapiro 1999</LINK>), computer program (<LINK REF="STD-Halken-2003" TYPE="STUDY">Halken 2003</LINK>; <LINK REF="STD-Wright-2009" TYPE="STUDY">Wright 2009</LINK>), sealed envelopes with consecutive numbers (<LINK REF="STD-Kroidl-1998" TYPE="STUDY">Kroidl 1998</LINK>), centralised, using numbers generated from a random numbers table (<LINK REF="STD-Sheikh-2002" TYPE="STUDY">Sheikh 2002</LINK>), computer using minimisation (<LINK REF="STD-van-der-Heide-1997B" TYPE="STUDY">van der Heide 1997B</LINK>; <LINK REF="STD-van-der-Heide-1999" TYPE="STUDY">van der Heide 1999</LINK>) and co-ordination centre, using minimisation (<LINK REF="STD-Woodcock-2003" TYPE="STUDY">Woodcock 2003</LINK>). All eight trials with adequate concealment of allocation were also reported to have been blinded, although in at least one trial, the attempted blinding was not perfect (<LINK REF="REF-G_x00f8_tzsche-2003" TYPE="REFERENCE">Gøtzsche 2003</LINK>; <LINK REF="STD-Halken-2003" TYPE="STUDY">Halken 2003</LINK>) and in another the intervention frequency differed between the groups (<LINK REF="STD-Shapiro-1999" TYPE="STUDY">Shapiro 1999</LINK>). One trial maintained the blinding during data analysis (<LINK REF="STD-Sheikh-2002" TYPE="STUDY">Sheikh 2002</LINK>). A summary of our risk of bias judgements can be found in <LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>.</P>
<P>Twelve trials had a cross-over design (<LINK REF="STD-Zwemer-1973" TYPE="STUDY">Zwemer 1973</LINK>; <LINK REF="STD-Burr-1976" TYPE="STUDY">Burr 1976</LINK>; <LINK REF="STD-Maesen-1977" TYPE="STUDY">Maesen 1977</LINK>; <LINK REF="STD-Burr-1980B" TYPE="STUDY">Burr 1980B</LINK>; <LINK REF="STD-Mitchell-1980" TYPE="STUDY">Mitchell 1980</LINK>; <LINK REF="STD-Verrall-1988" TYPE="STUDY">Verrall 1988</LINK>; <LINK REF="STD-Antonicelli-1991" TYPE="STUDY">Antonicelli 1991</LINK>; <LINK REF="STD-Warner-1993" TYPE="STUDY">Warner 1993</LINK>; <LINK REF="STD-Warburton-1994" TYPE="STUDY">Warburton 1994</LINK>; <LINK REF="STD-Matthys-1996" TYPE="STUDY">Matthys 1996</LINK>; <LINK REF="STD-Frederick-1997" TYPE="STUDY">Frederick 1997</LINK>; <LINK REF="STD-van-der-Heide-1999" TYPE="STUDY">van der Heide 1999</LINK>). The remaining were group comparative trials.</P>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2011-08-10 11:45:40 +0100" MODIFIED_BY="Emma J Welsh">
<P>We did not find an effect of control measures to reduce the exposure to mites or their products in the 55 trials we reviewed.</P>
<P>The total number of patients who improved after the experimental interventions was very similar to the corresponding number in the control groups, risk ratio 1.01 (95% confidence interval (CI) 0.80 to 1.27; <LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>) (data available for seven trials in 143 participants).</P>
<P>Asthma symptom scores were very heterogeneous (P = 0.0002 for test of heterogeneity, I<SUP>2</SUP> = 61%) (20 trials on 1485 people). The heterogeneity was caused by two small trials of poor quality that were the only ones that reported a significantly positive effect (<LINK REF="STD-Zwemer-1973" TYPE="STUDY">Zwemer 1973</LINK>; <LINK REF="STD-Thiam-1999" TYPE="STUDY">Thiam 1999</LINK>). The standardised mean difference (SMD) for all trials was -0.06 (95% CI -0.16 to 0.05; <LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>). After exclusion of the two trials of poor quality, the SMD was -0.02 (95% CI -0.12 to 0.08).</P>
<P>Medication usage was very similar in the experimental and control groups (11 trials in 1115 participants). The SMD was -0.05 (95% CI -0.17 to 0.07; <LINK REF="CMP-001.03" TYPE="ANALYSIS">Analysis 1.3</LINK>). Data for chemical methods were given in only one trial (<LINK REF="STD-Dietemann-1993" TYPE="STUDY">Dietemann 1993</LINK>) in which medication usage was significantly larger in the experimental group than in the control group (0.89, 95% CI 0.02 to 1.75). This finding is of doubtful value, however, since the standard deviation was unusually low and may have been erroneous. If this trial is excluded, the SMD is -0.07 (95% CI -0.19 to 0.05).</P>
<P>For FEV1, the SMD was 0.13 (95% CI -0.02 to 0.28; <LINK REF="CMP-001.04" TYPE="ANALYSIS">Analysis 1.4</LINK>) (15 trials in 675 participants). In one trial, unusually large variations in FEV1 from visit to visit were reported which indicates that the data may not have been reliable (<LINK REF="STD-Thiam-1999" TYPE="STUDY">Thiam 1999</LINK>). If this trial is excluded, the SMD is 0.11 (95% CI -0.05 to 0.26).</P>
<P>For peak flow in the morning, the standardised mean difference was 0.01 (95% CI -0.08 to 0.11; <LINK REF="CMP-001.05" TYPE="ANALYSIS">Analysis 1.5</LINK>) (24 trials in 1665 participants). For peak flow in the evening, the SMD was 0.06 (95% CI -0.13 to 0.24; <LINK REF="CMP-001.06" TYPE="ANALYSIS">Analysis 1.6</LINK>) (13 trials).</P>
<P>For PC20 the SMD was 0.05 (95% CI -0.13 to 0.22; <LINK REF="CMP-001.07" TYPE="ANALYSIS">Analysis 1.7</LINK>) (13 trials in 493 participants).</P>
<P>Only two trials reported on unscheduled visits to a physician or hospital, or on missed work or school days. In the largest trial included in our review, 38 patients required a hospital visit or a course of oral steroids in the intervention group and 27 in the control group; number of days of work missed was 0.10 versus 0.23 (95% CI for difference -0.28 to 0.01) (<LINK REF="STD-Woodcock-2003" TYPE="STUDY">Woodcock 2003</LINK>). A small cross-over trial of poor quality reported that none of 12 participants missed school during the treatment period, as opposed to three during the control period; however, there was no mention of reasons for missing school or data on another six randomised patients (<LINK REF="STD-Zwemer-1973" TYPE="STUDY">Zwemer 1973</LINK>).</P>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2011-08-10 11:46:08 +0100" MODIFIED_BY="Emma J Welsh">
<SUMMARY_OF_RESULTS MODIFIED="2011-08-10 11:45:51 +0100" MODIFIED_BY="Emma J Welsh">
<P>We were unable to demonstrate any clinical benefit to mite-sensitive patients with asthma of measures designed to reduce mite exposure. It is not likely that we missed a clinically relevant effect, since the total number of patients in the trials was quite large. The most commonly used outcome, morning peak flow, is related to the severity of the asthma and peak flow measurements did not suggest any worthwhile effect. This can be seen more clearly if the difference in morning peak flow is translated into the most commonly used unit, L/min. With a standard deviation of 100 L/min (in accordance with the meta-analysis graph) and a control group peak flow of 300 L/min, the experimental group peak flow would be 301 L/min, with a 95% confidence interval that ranges from 292 to 311 (L/min). A similarly narrow confidence interval around no effect was seen for asthma symptoms.</P>
<P>When there is no indication of an effect of an intervention, subgroup analyses should not be performed, since they would be expected to be seriously misleading. We discuss below, however, strengths and limitations of the trials.</P>
<P>Adherence to the applied measures was rarely evaluated, but successful mite reduction was obtained in several trials, including the biggest one (<LINK REF="STD-Woodcock-2003" TYPE="STUDY">Woodcock 2003</LINK>) that contributed 628 patients of a total of 1665 to the measurements of morning peak flow. It should be noted, however, that mite reduction was determined in different ways in the various studies. Some recorded mite counts and some measured antigen levels, using dust samples from different sources, and the reductions reported do not necessarily correspond to a similar reduction in the patients' exposure. For example, removing mites from the surface of mattresses and pillows does not affect the mite content of blankets or duvets, and merely killing the mites does not necessarily reduce airborne mite antigen, if nothing is done to remove the faecal particles that contain it. A potential reservoir for mites is the scalp and it has been suggested that neglect of this source may explain the failure of many trials of mite eradication (<LINK REF="REF-Naspitz-1997" TYPE="REFERENCE">Naspitz 1997</LINK>). In a previous version of our review, we were asked to do a subgroup analysis according to whether or not mite reduction was achieved (<LINK REF="REF-G_x00f8_tzsche-2001" TYPE="REFERENCE">Gøtzsche 2001</LINK>). We did not find any difference.</P>
<P>It seems unlikely that the initial mite levels were already too low for any reduction to be effective. It has been shown that quite low allergen concentrations can affect bronchial responsiveness (<LINK REF="REF-Ihre-1988" TYPE="REFERENCE">Ihre 1988</LINK>; <LINK REF="REF-Ihre-1993" TYPE="REFERENCE">Ihre 1993</LINK>) and the concentrations were such as would usually be considered to represent a risk to mite-sensitive asthmatics. Allergen levels varied between the studies and there was a wide range of concentrations in each study, so that some participants' exposure may have been very low, but this was uncommon.</P>
<P>Potential sources of bias should be considered. The randomisation methods were rarely described. It is likely that some studies were not truly randomised, or that the allocation was not adequately concealed, which are defects that would be expected to lead to bias in favour of a treatment effect. Most trials were very small and our sample of trials may therefore have been influenced by publication bias, which also tends to exaggerate the effect of treatment. The reporting of the data was often poor, for example many trials only reported that there were no significant differences between the intervention and the control groups. This lack of proper reporting would also be expected to lead to bias in favour of a treatment effect. In a comparison of 102 trial protocols with subsequent publications, it was shown that the chance that an outcome was fully reported was twice as high if the result was statistically significant (<LINK REF="REF-Chan-2004" TYPE="REFERENCE">Chan 2004</LINK>). It should also be noted that on a few occasions it was necessary to correct the originally reported data, for example in one trial we could not confirm a reported significant effect on mite allergen level (<LINK REF="STD-Geller_x002d_Bernst-1995" TYPE="STUDY">Geller-Bernst 1995</LINK>).</P>
<P>Physical interventions may need to be applied repeatedly before the reduction in allergen levels is sufficient to be effective. However, the lack of effect was also apparent in the subgroup of trials with long treatment duration or follow-up. Furthermore, if the interventions were effective, one would expect to see at least some effect also in short-term trials as mite allergen causes a Type 1 hypersensitivity reaction.</P>
<P>The house dust mite is the allergen to which asthmatics are most frequently sensitive, and the acute effects of exposure on the symptoms of asthma are well established. The explanation that we find most plausible for the lack of effect of the interventions is therefore that the methods we have reviewed do not adequately reduce mite antigen levels as it seems inherently implausible to suggest that complete removal of a major provoking agent would be ineffective. It is important to remember, however, that mite-sensitive asthmatic patients are usually sensitive to other allergens, so that successful elimination of only one allergen may have limited benefit, whatever its success. We excluded a large trial of multiple interventions in 937 patients with multiple allergies that is interesting in this respect (<LINK REF="STD-Morgan-2004" TYPE="STUDY">Morgan 2004</LINK>). This trial reported positive effects on clinically relevant outcomes, such as number of days with symptoms, night awakenings and missed school days. However, the study was not blinded and the positive results for these subjective outcomes were obtained through telephone interviews. Furthermore, the intervention group received more home visits than the control group, results for objective outcomes such as forced expiratory volume in one second (FEV1) and peak expiratory flow rate (PEFR) were very similar for the two groups, and the allergen levels decreased by less than 50%, compared with the control group, which is far too little to be expected to have any effect. A meta-analysis that compared multifaceted with mono-faceted interventions for preventing the development of asthma in newborns suggested that multifaceted interventions might be more effective, but as the comparisons were indirect, the authors also recommended comparing these modalities directly in randomised trials (<LINK REF="REF-van-Schayck-2007" TYPE="REFERENCE">van Schayck 2007</LINK>).</P>
<P>We conclude that the trials of current chemical and physical methods aimed at reducing exposure to house dust mite allergens failed to find an effect. Reviews and guidelines should reflect the facts.</P>
</SUMMARY_OF_RESULTS>
<POTENTIAL_BIASES MODIFIED="2011-08-10 11:46:02 +0100" MODIFIED_BY="Emma J Welsh">
<P>We tried carefully to avoid bias during data extraction, for example by making blinded decisions when several options were available. On a few occasions, however, we could not select the data in a neutral fashion but had to choose data which favoured the hypothesis that interventions were effective, for example in the trials by Carswell and Reiser (see table <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>). For the biggest trial (<LINK REF="STD-Woodcock-2003" TYPE="STUDY">Woodcock 2003</LINK>), we selected data after six rather than 12 months, in accordance with the authors' power calculation, since this part investigated the effects of allergen reduction on asthma symptoms and was not biased by the planned reduction of steroids (there was also significant allergen reduction after six months, but not after 12 months). Further, there was no indication that we had excluded trials with positive results (see table <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK>). We therefore believe that we have not favoured the null hypothesis of no treatment effect in our meta-analysis; if anything, we have favoured the alternative hypothesis.</P>
</POTENTIAL_BIASES>
<AGREEMENT MODIFIED="2011-08-10 11:46:08 +0100" MODIFIED_BY="Emma J Welsh">
<P>Reviews and guidelines do not reflect the fact that measures designed to reduce the patients' exposure to mite antigen in the home are ineffective. In fact, they usually recommend several measures as being effective, and provide a highly selected and biased sample of references in support of such claims. The most quoted trial in 70 reviews had only seven patients per group, its claimed significant result was probably erroneous, and it did not report a clinical outcome (<LINK REF="REF-Schmidt-2005" TYPE="REFERENCE">Schmidt 2005</LINK>). Furthermore, recommendations were often based on non-randomised studies and the most quoted non-randomised study had included only 10 patients per group but claimed very positive results (<LINK REF="REF-Schmidt-2005" TYPE="REFERENCE">Schmidt 2005</LINK>).</P>
<P>The 2007 extensive US guidelines for asthma control (<LINK REF="REF-US-Guidelines-2007" TYPE="REFERENCE">US Guidelines 2007</LINK>) were also misleading. On page 171 the expert panel recommends various interventions, including encasing the mattress in an allergen-impermeable cover. The panel quotes 10 papers in support of this, but one is an editorial, one is a review, one is a before-after study, one is about rhinitis, one was excluded from our review as only some of the patients were allergic to mites and no outcome data were provided for this group, and one is not relevant as it involved multiple interventions and allergens (<LINK REF="REF-G_x00f8_tzsche-2008a" TYPE="REFERENCE">Gøtzsche 2008a</LINK>). What remains are only five trials and these did not show an effect of mattress encasings.</P>
<P>In 2008, guidelines endorsed by the American Academy of Allergy, Asthma, and Immunology and the European Academy of Allergology and Clinical Immunology (<LINK REF="REF-US_x002f_Europe-Guidelines-2008" TYPE="REFERENCE">US/Europe Guidelines 2008</LINK>) were described as being evidence-based and one of the authors was quoted as saying: "We tried very hard to make these recommendations evidence-based and tried to avoid expert opinion as the basis for recommendations" (<LINK REF="REF-Mitka-2008" TYPE="REFERENCE">Mitka 2008</LINK>). However, the guidelines recommend several interventions against house dust mites, none of which are evidence-based, and all three references offered in their support are irrelevant. These guidelines were published in <I>Allergy</I>, which made the editor-in-chief ask us to co-publish our Cochrane Review in his journal to bring more rigour to the field, which we did (<LINK REF="REF-G_x00f8_tzsche-2008b" TYPE="REFERENCE">Gøtzsche 2008b</LINK>).</P>
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS>
<IMPLICATIONS_PRACTICE>
<P>Chemical and physical methods aimed at reducing exposure to house dust mite allergens cannot be recommended. </P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH>
<P>It is doubtful whether further studies, similar to the ones in our meta-analysis, are worthwhile. In particular, it should be noted that several of the trials had used very extensive mite eradication and avoidance schemes, involving many different measures applied simultaneously. If other types of studies are considered, we suggest that they should be methodologically rigorous and use other methods than those used so far, with careful monitoring of mite exposure and relevant clinical outcomes. </P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS>
<P>We would like to thank Leonardo Antonicelli, Cristina Cinti, S Cloosterman, Susanne Halken, Tim Higenbottam, OF Jooma, Rolf Kroidl, Christina Luczynska, Heinrich Matthys, Lucia Rijssenbeek-Nouwens, Gail Shapiro, Onno van Schayck and Lisette van den Bemt for providing additional information on their trials. We thank Cecilia Hammarquist, Michael Burr and Lasse Schmidt who were authors on previous versions of this review, and Xiaohui Chen Nielsen for translation of a paper in Chinese.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST>
<P>None.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2011-08-10 11:46:09 +0100" MODIFIED_BY="Emma J Welsh">
<P>PCG and HKJ selected the trials for inclusion in the update of the review. Trials were reviewed by the authors, outcome data were extracted primarily by PCG (but checked by HKJ). Guarantors: both authors for the text, PCG for the statistical calculations.</P>
<P>(Cecilia Hammarquist and Michael Burr selected trials for inclusion for the first version of the review, Lasse Schmidt for the third version. The first manuscript was drafted by CH for <I>The Cochrane Library</I> and by PCG for the <I>British Medical Journal</I>).</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF/>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<STUDIES MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<INCLUDED_STUDIES MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<STUDY DATA_SOURCE="MIX" ID="STD-Antonicelli-1991" NAME="Antonicelli 1991" YEAR="1991">
<REFERENCE NOTES="&lt;p&gt;Antonicelli L, Bilo MB, Pucci S, Schou C, Bonifazi F. Efficacy of an air-cleaning device equipped with a high efficiency particulate air filter in house dust mite respiratory allergy. Allergy 1991; 46: 594-600.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Antonicelli L, Bilo MB, Pucci S, Schou C, Bonifazi F</AU>
<TI>Efficacy of an air-cleaning device equipped with a high efficiency particulate air filter in house dust mite respiratory allergy</TI>
<SO>Allergy</SO>
<YR>1991</YR>
<VL>46</VL>
<PG>594-600</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bahir-1997" MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" NAME="Bahir 1997" YEAR="1997">
<REFERENCE MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" NOTES="&lt;p&gt;Bahir A, Goldberg A, Mekori YA, Confino Cohen R, Morag H, Rosen Y et al. Continuous avoidance measures with or without acaricide in dust mite-allergic asthmatic children. Ann Allergy Asthma Immunol 1997; 78(5):506-12.&lt;/p&gt;" NOTES_MODIFIED="2011-08-10 12:11:04 +0100" NOTES_MODIFIED_BY="Emma J Welsh" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Bahir A, Goldberg A, Mekori YA, Confino Cohen R, Morag H, Rosen Y, et al</AU>
<TI>Continuous avoidance measures with or without acaricide in dust mite-allergic asthmatic children</TI>
<SO>Annals of Allergy Asthma &amp; Immunology</SO>
<YR>1997</YR>
<VL>78</VL>
<NO>5</NO>
<PG>506-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Burr-1976" NAME="Burr 1976" YEAR="1976">
<REFERENCE NOTES="&lt;p&gt;Burr ML, St Leger AS, Neale E. Anti-mite measurements in mite-sensitive adult asthma. A controlled trial. Lancet 1976; 1: 333-5.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Burr ML, St Leger AS, Neale E</AU>
<TI>Anti-mite measurements in mite-sensitive adult asthma. A controlled trial</TI>
<SO>Lancet</SO>
<YR>1976</YR>
<VL>1</VL>
<PG>333-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Burr-1980A" NAME="Burr 1980A" YEAR="1980">
<REFERENCE NOTES="&lt;p&gt;Burr ML, Dean BV, Merrett TG, Neale E, St Leger AS, Verrier-Jones ER. Effects of anti-mite measures on children with mite-sensitive asthma: a controlled trial. Thorax 1980; 35: 506-512.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Burr ML, Dean BV, Merrett TG, Neale E, St Leger AS, Verrier-Jones ER</AU>
<TI>Effects of anti-mite measures on children with mite-sensitive asthma: a controlled trial</TI>
<SO>Thorax</SO>
<YR>1980</YR>
<VL>35</VL>
<PG>506-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Burr-1980B" NAME="Burr 1980B" YEAR="1980">
<REFERENCE NOTES="&lt;p&gt;Burr ML Neale E, Dean BV, Verrier-Jones ER. Effect of a change to mite-free bedding on children with mite-sensitive asthma: a controlled trial. Thorax 1980; 35: 513-514.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Burr ML, Neale E, Dean BV, Verrier-Jones ER</AU>
<TI>Effect of a change to mite-free bedding on children with mite-sensitive asthma: a controlled trial</TI>
<SO>Thorax</SO>
<YR>1980</YR>
<VL>35</VL>
<PG>513-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Carswell-1996" MODIFIED="2011-08-10 12:02:47 +0100" MODIFIED_BY="Emma J Welsh" NAME="Carswell 1996" YEAR="1996">
<REFERENCE MODIFIED="2011-08-10 12:02:47 +0100" MODIFIED_BY="Emma J Welsh" NOTES="&lt;p&gt;Carswell F, Birmingham K, Oliver J, Crewes A, Weeks J. The respiratory effects of reduction of mite allergen in the bedrooms of asthmatic children - a double-blind controlled trial. Clin Exp Allergy 1996; 26: 386-396.&lt;/p&gt;" NOTES_MODIFIED="2011-08-10 12:02:47 +0100" NOTES_MODIFIED_BY="Emma J Welsh" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Carswell F, Birmingham K, Oliver J, Crewes A, Weeks J</AU>
<TI>The respiratory effects of reduction of mite allergen in the bedrooms of asthmatic children - a double-blind controlled trial</TI>
<SO>Clinical &amp; Experimental Allergy</SO>
<YR>1996</YR>
<VL>26</VL>
<PG>386-96</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Carswell F, Razif A, Oliver J, Crewes A, Birmingham K, Weeks J</AU>
<TI>The effect of allergen avoidance on mattress Der pI content and bronchial reactivity in mite sensitive asthmatic children</TI>
<SO>Annals of Allergy</SO>
<YR>1994</YR>
<VL>72</VL>
<PG>74 (abstract 88)</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;Carswell F. Reduced mite allergen exposure in the child's bedroom improves the respiratory health of sensitive asthmatics. Allergy 1996; 51 Suppl 31:38.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Carswell F, Weeks J, Birmingham K</AU>
<TI>Reduced mite allergen exposure in the child's bedroom improves the respiratory health of sensitive asthmatics</TI>
<SO>Allergy</SO>
<YR>1996</YR>
<VL>51</VL>
<NO>Suppl 31</NO>
<PG>38</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;Carswell F, Weeks J, and Oliver J. Mite-sensitive asthmatic children's response to mite allergen removal over a 6-month period: changes in respiratory indices [abstract]. European Respiratory Journal. Supplement. 1995; 8 Suppl 19:572S.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Carswell F, Weeks J, Oliver J</AU>
<TI>Mite-sensitive asthmatic children's response to mite allergen removal over a 6-month period: changes in respiratory indices [abstract]</TI>
<SO>European Respiratory Journal</SO>
<YR>1995</YR>
<VL>8</VL>
<NO>Suppl 19</NO>
<PG>572S, abstract P2801</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chang-1996" NAME="Chang 1996" YEAR="1996">
<REFERENCE NOTES="&lt;p&gt;Chang JH, Becker A, Ferguson A, Manfreda J, Simons E, Chan H et al. Effect of application of benzyl benzoate on house dust mite allergen levels. Ann Allergy Asthma Immunol 1996; 77(3):187-90.&lt;/p&gt;" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Chang JH, Becker A, Ferguson A, Manfreda J, Simons E, Chan H, et al</AU>
<TI>Effect of application of benzyl benzoate on house dust mite allergen levels</TI>
<SO>Annals of Allergy, Asthma and Immunology</SO>
<YR>1996</YR>
<VL>77</VL>
<NO>3</NO>
<PG>187-90</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Charpin-1990" MODIFIED="2008-07-28 11:15:26 +0100" MODIFIED_BY="Toby J Lasserson" NAME="Charpin 1990" YEAR="1990">
<REFERENCE MODIFIED="2008-07-28 11:15:26 +0100" MODIFIED_BY="Toby J Lasserson" NOTES="&lt;p&gt;Charpin D, Birnbaum J, Haddi E, N'Guyen A, Fondarai J, Vervloet D. Evaluation de l' efficacite d' un acaricide, Acardust, dans le traitement de l' allergie aux acariens. Rev Fr Allergol 1990;30: 149-155.&lt;/p&gt;" NOTES_MODIFIED="2008-07-28 11:15:26 +0100" NOTES_MODIFIED_BY="Toby J Lasserson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Charpin D, Birnbaum J, Haddi E, N'Guyen A, Fondarai J, Vervloet D</AU>
<TI>Assessment of the effectiveness of an acaricide, Acardust, in the treatment of acarian allergy</TI>
<TO>Evaluation de l' efficacité d' un acaricide, Acardust, dans le traitement de l' allergie aux acariens</TO>
<SO>Revue Française d'Allergologie</SO>
<YR>1990</YR>
<VL>30</VL>
<PG>149-55</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chen-1996" NAME="Chen 1996" YEAR="1996">
<REFERENCE NOTES="&lt;p&gt;Chen CC, . = Hsieh KH. Effects of Microstop-treated anti-mite bedding on children with mite-sensitive asthma. Chung-Hua Min Kuo Hsiao Erh Ko i Hsueh Hui Tsa Chih 1996; 37:420-7.&lt;/p&gt;" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Chen CC, Hsieh K-H</AU>
<TI>Effects of Microstop-treated anti-mite bedding on children with mite-sensitive asthma</TI>
<SO>Acta Paediatrica Sinica</SO>
<YR>1996</YR>
<VL>37</VL>
<PG>420-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Cinti-1996" NAME="Cinti 1996" YEAR="1996">
<REFERENCE NOTES="&lt;p&gt;Cinti C, Canessa PA, Lavecchia MA, Capecchi V. The efficacy of 'mite-proof' mattress-covers and pillow-covers in the control of asthma in patients allergic to mites. &amp;lt;ORIGINAL&amp;gt; EFFICACIA DI UN COPRIMATERASSO E COPRICUSCINO 'ANTIACARO' NEL CONTROLLO DELL'ASMA DEI PAZIENTI ALLERGICI AL DERMATOPHAGOIDES. Lotta Contro La Tuberculosi e Le Malattie Polmonari Sociali 1996; 66:131-8.&lt;/p&gt;" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Cinti C, Canessa PA, Lavecchia MA, Capecchi V</AU>
<TI>The efficacy of 'mite-proof' mattress-covers and pillow-covers in the control of asthma in patients allergic to mites</TI>
<TO>Efficacia di un coprimaterasso e copricuscino 'antiacaro' nel controllo dell'asma dei pazienti allergici al dermatophagoides</TO>
<SO>Lotta Contro La Tuberculosi e Le Malattie Polmonari Sociali</SO>
<YR>1996</YR>
<VL>66</VL>
<PG>131-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Cloosterman-1999" NAME="Cloosterman 1999" YEAR="1999">
<REFERENCE NOTES="&lt;p&gt;Cloosterman SG, Schermer TR, Bijl Hofland ID, Van Der Heide S, Brunekreef B, Van Den Elshout FJ et al. Effects of house dust mite avoidance measures on Der p 1 concentrations and clinical condition of mild adult house dust mite-allergic asthmatic patients, using no inhaled steroids. Clin Exp Allergy 1999; 29(10):1336-46.&lt;/p&gt;" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Cloosterman SG, Schermer TR, Bijl Hofland ID, Van Der Heide S, Brunekreef B, Van Den Elshout FJ, et al</AU>
<TI>Effects of house dust mite avoidance measures on Der p 1 concentrations and clinical condition of mild adult house dust mite-allergic asthmatic patients, using no inhaled steroids</TI>
<SO>Clinical &amp; Experimental Allergy</SO>
<YR>1999</YR>
<VL>29</VL>
<NO>10</NO>
<PG>1336-46</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;Cloosterman SG, Schermer TR, Hofland ID et al. Contribution of separate house dust mite avoidance measures in improving the clinical condition of asthmatic patients [abstract]. European Respiratory Journal. Supplement. 1996; 9 Suppl 23:394s.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cloosterman SG, Schermer TR, Hofland ID, et al</AU>
<TI>Contribution of separate house dust mite avoidance measures in improving the clinical condition of asthmatic patients [abstract]</TI>
<SO>European Respiratory Journal</SO>
<YR>1996</YR>
<VL>9</VL>
<NO>Suppl 23</NO>
<PG>394s</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-de-Vries-2007" MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" NAME="de Vries 2007" YEAR="2007">
<REFERENCE NOTES="&lt;p&gt;de Vries MP, van den Bemt L, Aretz K, Thoonen BP, Muris JW, Kester AD, et al. House dust mite allergen avoidance and self-management in allergic patients with asthma: randomised controlled trial. Br J Gen Pract 2007; 57(536):184-90.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>de Vries MP, van den Bemt L, Aretz K, Thoonen BP, Muris JW, Kester AD, et al</AU>
<TI>House dust mite allergen avoidance and self-management in allergic patients with asthma: randomised controlled trial</TI>
<SO>British Journal of General Practice</SO>
<YR>2007</YR>
<VL>57</VL>
<NO>536</NO>
<PG>184-90</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>van den Bemt L, de Vries MP, Cloosterman S, Thoonen B, Muris JW, Goossens M, et al</AU>
<TI>Influence of house dust mite impermeable covers on health-related quality of life of adult patients with asthma: results of a randomized clinical trial</TI>
<SO>Journal of Asthma</SO>
<YR>2007</YR>
<VL>44</VL>
<PG>843-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dharmage-2006" NAME="Dharmage 2006" YEAR="2006">
<REFERENCE NOTES="&lt;p&gt;Dharmage S, Walters EH, Thien F, Bailey M, Raven J, Wharton C, et al. Encasement of bedding does not improve asthma in atopic adult asthmatics. Int Arch Allergy Immunol 2006; 139(2):132-8.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dharmage S, Walters EH, Thien F, Bailey M, Raven J, Wharton C, et al</AU>
<TI>Encasement of bedding does not improve asthma in atopic adult asthmatics</TI>
<SO>International Archives of Allergy and Immunology</SO>
<YR>2006</YR>
<VL>139</VL>
<NO>2</NO>
<PG>132-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dietemann-1993" MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" NAME="Dietemann 1993" YEAR="1993">
<REFERENCE MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" NOTES="&lt;p&gt;Dietemann A, Bessot JC, Hoyet C, Ott M, Verot A, Pauli G. A double-blind, placebo controlled trial of solidified benzyl benzoate applied in dwellings of asthmatic patients sensitive to mites: Clinical efficacy and effect on mite allergens. J Allergy Clin Immunol 1993; 91: 738-746.&lt;/p&gt;" NOTES_MODIFIED="2011-08-10 12:11:04 +0100" NOTES_MODIFIED_BY="Emma J Welsh" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Dietemann A, Bessot JC, Hoyet C, Ott M, Verot A, Pauli G</AU>
<TI>A double-blind, placebo controlled trial of solidified benzyl benzoate applied in dwellings of asthmatic patients sensitive to mites: clinical efficacy and effect on mite allergens</TI>
<SO>Journal of Allergy and Clinical Immunology</SO>
<YR>1993</YR>
<VL>91</VL>
<PG>738-46</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;Dietemann A, Bessot JC, Hoyet C, and Pauli G. A double blind placebo controlled study of the acaricidal agent acarosan r: clinical efficacy in mite asthma. Allergy 1992; 47 Suppl 12:251.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dietemann A, Bessot JC, Hoyet C, Pauli G</AU>
<TI>A double blind placebo controlled study of the acaricidal agent Acarosan R: clinical efficacy in mite asthma</TI>
<SO>Allergy</SO>
<YR>1992</YR>
<VL>47</VL>
<NO>Suppl 12</NO>
<PG>251, abstract PS13</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2008-07-28 11:17:03 +0100" MODIFIED_BY="Toby J Lasserson" NOTES="&lt;p&gt;Dietemann-Molard A, Bessot JC, Ott M et al. Etude de l'efficacite clinique et biologique d'un nouvel acaricide (Acarosan&amp;#174;) chez des patients asthmatiques sensibilises a dermatophagoides pteronyssinus (DP). Revue Des Maladies Respiratoires 1991; 8 suppl 1:R16, abstract A53.&lt;/p&gt;" NOTES_MODIFIED="2008-07-28 11:17:03 +0100" NOTES_MODIFIED_BY="Toby J Lasserson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dietemann-Molard A, Bessot JC, Ott M, et al</AU>
<TI>Study of the clinical and biological effectiveness of a new acaricide (Acarosan®) in asthmatic patents sensitized to dermatophagoides pteronyssinus (DP)</TI>
<TO>Etude de l'efficacité clinique et biologique d'un nouvel acaricide (Acarosan®) chez des patients asthmatiques sensibilises à dermatophagoides pteronyssinus (DP)</TO>
<SO>Revue Des Maladies Respiratoires</SO>
<YR>1991</YR>
<VL>8</VL>
<NO>Suppl 1</NO>
<PG>R16, abstract A53</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dorward-1988" NAME="Dorward 1988" YEAR="1988">
<REFERENCE NOTES="&lt;p&gt;Dorward A J, Colloff MJ, MacKay NS, McSharry C, Thomson NC. Effect of house dust mite avoidance measures on adult atopic asthma. Thorax 1988;43: 98-102.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dorward A J, Colloff MJ, MacKay NS, McSharry C, Thomson NC</AU>
<TI>Effect of house dust mite avoidance measures on adult atopic asthma</TI>
<SO>Thorax</SO>
<YR>1988</YR>
<VL>43</VL>
<PG>98-102</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ehnert-1992" NAME="Ehnert 1992" YEAR="1992">
<REFERENCE NOTES="&lt;p&gt;Ehnert B, Lau-Schadendorf S, Weber A, Buettner P, Schou C, Wahn U. Reducing domestic exposure to dust mite allergen reduces bronchial hyperreactivity in sensitive children with asthma. J Allergy Clin Immunol 1992; 90:135-8.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ehnert B, Lau-Schadendorf S, Weber A, Buettner P, Schou C, Wahn U</AU>
<TI>Reducing domestic exposure to dust mite allergen reduces bronchial hyperreactivity in sensitive children with asthma</TI>
<SO>Journal of Allergy &amp; Clinical Immunology</SO>
<YR>1992</YR>
<VL>90</VL>
<PG>135-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fang-2001" NAME="Fang 2001" YEAR="2001">
<REFERENCE NOTES="&lt;p&gt;Fang Z, Cai Y, Wang L. [The efficacy of controlling of house dusts in attacks of mite sensitive asthmatics]. Zhonghua Jie He He Hu Xi Za Zhi 2001; 24(11):685-9.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fang Z, Cai Y, Wang L</AU>
<TI>[The efficacy of controlling of house dusts in attacks of mite sensitive asthmatics]</TI>
<SO>Zhonghua Jie He He Hu Xi Za Zhi</SO>
<YR>2001</YR>
<VL>24</VL>
<NO>11</NO>
<PG>685-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Frederick-1997" NAME="Frederick 1997" YEAR="1997">
<REFERENCE NOTES="&lt;p&gt;Frederick JM, Warner JO, Jessop WJ, Enander I, Warner JA. Effect of a bed covering system in children with asthma and house dust mite hypersensitivity. Eur Respir J 1997; 10(2):361-6.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Frederick JM, Warner JO, Jessop WJ, Enander I, Warner JA</AU>
<TI>Effect of a bed covering system in children with asthma and house dust mite hypersensitivity</TI>
<SO>European Respiratory Journal</SO>
<YR>1997</YR>
<VL>10</VL>
<NO>2</NO>
<PG>361-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Geller_x002d_Bernst-1995" MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" NAME="Geller-Bernst 1995" YEAR="1995">
<REFERENCE MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" NOTES="&lt;p&gt;Geller-Bernstein C, Pibourdin JM, Dornelas A, Fondarai J. Efficacy of the acaricide : Acardust for the prevention of asthma and rhinitis due to dust mite allergy, in children. Allergie et immunologie 1995; 27: 147-154.&lt;/p&gt;" NOTES_MODIFIED="2011-08-10 12:11:04 +0100" NOTES_MODIFIED_BY="Emma J Welsh" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Geller-Bernstein C, Pibourdin JM, Dornelas A, Fondarai J</AU>
<TI>Efficacy of the acaricide: Acardust for the prevention of asthma and rhinitis due to dust mite allergy, in children</TI>
<SO>Allergie et Immunologie</SO>
<YR>1995</YR>
<VL>27</VL>
<PG>147-54</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ghazala-2004" NAME="Ghazala 2004" YEAR="2004">
<REFERENCE NOTES="&lt;p&gt;Ghazala L , Schmid F , Helbling A , Pichler W J , Pichler C E . Efficacy of house dust mite- and allergen-impermeable encasings in patients with house dust mite allergy. Allergologie 2004; 27(1):26-34.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ghazala L, Schmid F , Helbling A , Pichler WJ , Pichler C E</AU>
<TI>Efficacy of house dust mite- and allergen-impermeable encasings in patients with house dust mite allergy</TI>
<SO>Allergologie</SO>
<YR>2004</YR>
<VL>27</VL>
<NO>1</NO>
<PG>26-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gillies-1987" NAME="Gillies 1987" YEAR="1987">
<REFERENCE NOTES="&lt;p&gt;Gillies DRN, Littlewood JM, Sarsfield JK. Controlled trial of house dust mite avoidance in children with mild to moderate asthma. Clin Allergy 1987; 17: 105-111.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gillies DRN, Littlewood JM, Sarsfield JK</AU>
<TI>Controlled trial of house dust mite avoidance in children with mild to moderate asthma</TI>
<SO>Clinical Allergy &amp; Immunology</SO>
<YR>1987</YR>
<VL>17</VL>
<PG>105-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Halken-2003" MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" NAME="Halken 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Halken S, Høst A</AU>
<TI>Are encasings effective in asthma caused by house dust mite allergens (reply)?</TI>
<SO>Journal of Allergy &amp; Clinical Immunology</SO>
<YR>2003</YR>
<VL>112</VL>
<PG>220-1</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" NOTES="&lt;p&gt;Halken S, Host A, Niklassen U, et al. Effect of mattress and pillow encasings on children with asthma and house dust mite allergy. J Allergy Clin Immunol 2003; 111(1):169-76.&lt;/p&gt;" NOTES_MODIFIED="2011-08-10 12:11:04 +0100" NOTES_MODIFIED_BY="Emma J Welsh" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Halken S, Host A, Niklassen U, Hansen LG, Nielsen F, Pedersen S, et al</AU>
<TI>Effect of mattress and pillow encasings on children with asthma and house dust mite allergy</TI>
<SO>Journal of Allergy &amp; Clinical Immunology</SO>
<YR>2003</YR>
<VL>111</VL>
<NO>1</NO>
<PG>169-76</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Halken S, Niklassen U, Hansen LG, et al</AU>
<TI>Encasing of mattresses in children with asthma and house dust mite allergy [abstract]</TI>
<SO>Journal of Allergy &amp; Clinical Immunology</SO>
<YR>1997</YR>
<VL>99</VL>
<PG>S320</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Howarth-1992" NAME="Howarth 1992" YEAR="1992">
<REFERENCE NOTES="&lt;p&gt;Howarth P, Lunn A, Tomkin S. Bedding barrier intervention in house dust mite respiratory allergy. Clin Exp All 1992;22:140.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Howarth P, Lunn A, Tomkin S</AU>
<TI>Bedding barrier intervention in house dust mite respiratory allergy</TI>
<SO>Clinical &amp; Experimental Allergy</SO>
<YR>1992</YR>
<VL>22</VL>
<PG>140</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Htut-2001" MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" NAME="Htut 2001" YEAR="2001">
<REFERENCE MODIFIED="2011-07-20 14:18:47 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Htut T, Higenbottam TW, Gill G, Darwin R, Anderson PB, and Syed N. Mite eradication trial: a double blind randomised study. European Respiratory Society; 1999 Oct 9-13; Madrid, Spain 1999; [P2253].&lt;/p&gt;" NOTES_MODIFIED="2011-07-20 14:18:47 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Htut T, Higenbottam TW, Gill G, Darwin R, Anderson PB, Syed N</AU>
<TI>Mite eradication trial: a double blind randomised study</TI>
<SO>European Respiratory Society; Oct 9-13, 1999; Madrid</SO>
<YR>1999</YR>
<PG>334s, abstract P2253</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Htut T, Higenbottam TW, Gill G, Darwin R, Anderson PB, Syed N</AU>
<TI>Six month's report on mite-allergen eradication trial [abstract]</TI>
<SO>European Respiratory Journal</SO>
<YR>1998</YR>
<VL>12</VL>
<NO>Suppl 28</NO>
<PG>69s, abstract P0512</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2011-07-28 09:18:42 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Htut T, Higenbottam TW, Gill GW, Darwin R, Anderson PB, Syed N. Eradication of house dust mite from homes of atopic asthmatic subjects: a double-blind trial. J Allergy Clin Immunol 2001; 107(1):55-60.&lt;/p&gt;" NOTES_MODIFIED="2011-07-28 09:18:42 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Htut T, Higenbottam TW, Gill GW, Darwin R, Anderson PB, Syed N</AU>
<TI>Eradication of house dust mite from homes of atopic asthmatic subjects: a double-blind trial</TI>
<SO>Journal of Allergy &amp; Clinical Immunology</SO>
<YR>2001</YR>
<VL>107</VL>
<NO>1</NO>
<PG>55-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Htut T, Higenbottam TW, Gill GW, Darwin R, Anderson PB, Syed N</AU>
<TI>Impact of mite eradication in homes on bronchial hyperresponsiveness of adult asthmatics</TI>
<SO>Thorax</SO>
<YR>1999</YR>
<VL>54</VL>
<NO>Suppl 3</NO>
<PG>A28 (abstract P40)</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Huss-1992" NAME="Huss 1992" YEAR="1992">
<REFERENCE NOTES="&lt;p&gt;Huss K, Squire EN, Carpenter GB, Smith LJ, Huss RW, Salata K, Salerno M, Agostinelli D, ,Hershey J. Effective education of adults with asthma who are allergic to dust mites. J Allergy Clin Immunol 1992;89:836-43.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Huss K, Squire EN, Carpenter GB, Smith LJ, Huss RW, Salata K, et al</AU>
<TI>Effective education of adults with asthma who are allergic to dust mites</TI>
<SO>Journal of Allergy &amp; Clinical Immunology</SO>
<YR>1992</YR>
<VL>89</VL>
<PG>836-43</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jooma-1995" NAME="Jooma 1995" YEAR="1995">
<REFERENCE NOTES="&lt;p&gt;Jooma OF, Weinberg EG, Berman D, Manjra AI, Potter PC. Accumulation of house-dust mite (Der-p-1) levels on mattress covers. S Afr Med J 1995; 85(10):1002-5.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jooma OF, Weinberg EG, Berman D, Manjra AI, Potter PC</AU>
<TI>Accumulation of house-dust mite (Der-p-1) levels on mattress covers</TI>
<SO>South African Medical Journal</SO>
<YR>1995</YR>
<VL>85</VL>
<NO>10</NO>
<PG>1002-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Korsgaard-1983" NAME="Korsgaard 1983" YEAR="1983">
<REFERENCE NOTES="&lt;p&gt;Korsgaard J. Preventive measures in mite asthma. A controlled trial. Allergy 1983; 38: 93-102.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Korsgaard J</AU>
<TI>Preventive measures in mite asthma. A controlled trial</TI>
<SO>Allergy</SO>
<YR>1983</YR>
<VL>38</VL>
<PG>93-102</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Kroidl-1998" NAME="Kroidl 1998" YEAR="1998">
<REFERENCE NOTES="&lt;p&gt;Kroidl RF, Gobel D, Balzer D, Trendelenburg F, Schwichtenberg U. Clinical effects of benzyl benzoate in the prevention of house-dust-mite allergy. Results of a prospective, double-blind, multicenter study. Allergy 1998; 53(4):435-40.&lt;/p&gt;" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Kroidl RF, Gobel D, Balzer D, Trendelenburg F, Schwichtenberg U</AU>
<TI>Clinical effects of benzyl benzoate in the prevention of house-dust-mite allergy. Results of a prospective, double-blind, multicenter study</TI>
<SO>Allergy</SO>
<YR>1998</YR>
<VL>53</VL>
<NO>4</NO>
<PG>435-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lee-2003" MODIFIED="2011-08-10 12:05:37 +0100" MODIFIED_BY="Emma J Welsh" NAME="Lee 2003" YEAR="2003">
<REFERENCE MODIFIED="2011-08-10 12:05:37 +0100" MODIFIED_BY="Emma J Welsh" NOTES="&lt;p&gt;Lee IS, Moon JS, Yoo YS. Effectiveness of bedding control instruction for patients with respiratory allergies: A randomized controlled trial. Int J Nurs Stud 2006.&lt;/p&gt;" NOTES_MODIFIED="2011-08-10 12:05:37 +0100" NOTES_MODIFIED_BY="Emma J Welsh" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lee IS, Moon JS, Yoo YS</AU>
<TI>[WITHDRAWN]Effectiveness of bedding control instruction for patients with respiratory allergies: a randomized controlled trial</TI>
<SO>International Journal of Nursing Studies</SO>
<YR>2006</YR>
<PG>doi:10.1016/j.ijnurstu.2006.08.009</PG>
<IDENTIFIERS MODIFIED="2011-08-10 12:05:14 +0100" MODIFIED_BY="Emma J Welsh">
<IDENTIFIER MODIFIED="2011-08-10 12:05:14 +0100" MODIFIED_BY="Emma J Welsh" TYPE="DOI" VALUE="doi:10.1016/j.ijnurstu.2006.08.009"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2011-08-10 12:05:18 +0100" MODIFIED_BY="Emma J Welsh" NOTES="&lt;p&gt;Lee IS. Effect of bedding control on amount of house dust mite allergens, asthma symptoms, and peak expiratory flow rate. Yonsei Med J 2003; 44(2):313-22.&lt;/p&gt;" NOTES_MODIFIED="2011-08-10 12:05:18 +0100" NOTES_MODIFIED_BY="Emma J Welsh" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Lee IS</AU>
<TI>Effect of bedding control on amount of house dust mite allergens, asthma symptoms, and peak expiratory flow rate</TI>
<SO>Yonsei Medical Journal</SO>
<YR>2003</YR>
<VL>44</VL>
<NO>2</NO>
<PG>313-22</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Luczynska-2003" NAME="Luczynska 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Luczynska C, Tredwell E, Smeeton N, Burney P</AU>
<TI>A randomized controlled trial of mite allergen-impermeable bed covers in adult mite-sensitized asthmatics</TI>
<SO>Clinical &amp; Experimental Allergy</SO>
<YR>2003</YR>
<VL>33</VL>
<PG>1648-53</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Maesen-1977" MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" NAME="Maesen 1977" YEAR="1977">
<REFERENCE MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" NOTES="&lt;p&gt;Maesen FPV, Sluysmans FG, Brombacher PJ, Smeets JJ. Ervaringen met het gebruik van luchtfiltratieapparatuur in de woonruimten van voor huisstof overgevoelige atopische patienten. Acta Tuberc Pneumol Belg 1977; 68: 133-147.&lt;/p&gt;" NOTES_MODIFIED="2011-08-10 12:11:04 +0100" NOTES_MODIFIED_BY="Emma J Welsh" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Maesen FPV, Sluysmans FG, Brombacher PJ, Smeets JJ</AU>
<TI>Ervaringen met het gebruik van luchtfiltratieapparatuur in de woonruimten van voor huisstof overgevoelige atopische patienten</TI>
<SO>Acta Tuberculosea et Pneumologica Belgica</SO>
<YR>1977</YR>
<VL>68</VL>
<PG>133-47</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Manjra-1994" NAME="Manjra 1994" YEAR="1994">
<REFERENCE NOTES="&lt;p&gt;Manjra A, Berman D, Toerien A, Weinberg EG, Potter PC. The effects of a single treatment of an acaricide, Acarosan, and a detergent, Metsan, on Der p 1 allergen levels in the carpets and mattresses of asthmatic children. S Afr Med J 1994; 84: 278-280.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Manjra A, Berman D, Toerien A, Weinberg EG, Potter PC</AU>
<TI>The effects of a single treatment of an acaricide, Acarosan, and a detergent, Metsan, on Der p 1 allergen levels in the carpets and mattresses of asthmatic children</TI>
<SO>South African Medical Journal</SO>
<YR>1994</YR>
<VL>84</VL>
<PG>278-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Marks-1994" MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" NAME="Marks 1994" YEAR="1994">
<REFERENCE MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" NOTES="&lt;p&gt;Marks GB, Tovey ER, Green W, Shearer M, Salome CM, Woolcock AJ. House dust mite allergen avoidance: A randomized controlled trial of surface chemical treatment and encasement of bedding. Clin Exp Allergy 1994; 24: 1078-1083.&lt;/p&gt;" NOTES_MODIFIED="2011-08-10 12:11:04 +0100" NOTES_MODIFIED_BY="Emma J Welsh" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Marks GB, Tovey ER, Green W, Shearer M, Salome CM, Woolcock AJ</AU>
<TI>House dust mite allergen avoidance: a randomized controlled trial of surface chemical treatment and encasement of bedding</TI>
<SO>Clinical &amp; Experimental Allergy</SO>
<YR>1994</YR>
<VL>24</VL>
<PG>1078-83</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Marks GB, Tovey ER, Green W, Shearer M, Salome CM, Woolcock AJ</AU>
<TI>The effect of changes in house dust mite allergen exposure on the severity of asthma</TI>
<SO>Clinical &amp; Experimental Allergy</SO>
<YR>1995</YR>
<VL>25</VL>
<PG>114-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Matthys-1996" NAME="Matthys 1996" YEAR="1996">
<REFERENCE NOTES="&lt;p&gt;Matthys H, Hupert A, and Busch B. Dry air in bedrooms of patients with house dust mite-induced asthma. European Respiratory Journal. Supplement. 1996; 9 Suppl 23:350s-1s.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Matthys H, Hupert A, Busch B</AU>
<TI>Dry air in bedrooms of patients with house dust mite-induced asthma</TI>
<SO>European Respiratory Journal</SO>
<YR>1996</YR>
<VL>9</VL>
<NO>Suppl 23</NO>
<PG>350s, abstract P2175</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mitchell-1980" NAME="Mitchell 1980" YEAR="1980">
<REFERENCE NOTES="&lt;p&gt;Mitchell EA, Elliott RB. Controlled trial of an electrostatic precipitator in childhood asthma. Lancet 1980; 2: 559-61.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mitchell EA, Elliott RB</AU>
<TI>Controlled trial of an electrostatic precipitator in childhood asthma</TI>
<SO>Lancet</SO>
<YR>1980</YR>
<VL>2</VL>
<PG>559-61</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Popplewell-2000" MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" NAME="Popplewell 2000" YEAR="2000">
<REFERENCE MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" NOTES="&lt;p&gt;Popplewell EJ, Innes VA, Lloyd-Hughes S, et al. The effect of high-efficiency and standard vacuum-cleaners on mite, cat and dog allergen levels and clinical progress. Pediatr Allergy Immunol 2000; 11(3):142-8.&lt;/p&gt;" NOTES_MODIFIED="2011-08-10 12:11:04 +0100" NOTES_MODIFIED_BY="Emma J Welsh" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Popplewell EJ, Innes VA, Lloyd-Hughes S, Jenkins EL, Khdir K, Bryant TN, et al</AU>
<TI>The effect of high-efficiency and standard vacuum-cleaners on mite, cat and dog allergen levels and clinical progress</TI>
<SO>Pediatric Allergy &amp; Immunology</SO>
<YR>2000</YR>
<VL>11</VL>
<NO>3</NO>
<PG>142-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Reiser-1990" NAME="Reiser 1990" YEAR="1990">
<REFERENCE NOTES="&lt;p&gt;Reiser J, Ingram D, Mitchell EB, Warner JO. House dust mite allergen levels and an anti-mite mattress spray (natamycin) in the treatment of childhood asthma. Clin Exp Allergy 1990; 20: 561-567.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Reiser J, Ingram D, Mitchell EB, Warner JO</AU>
<TI>House dust mite allergen levels and an anti-mite mattress spray (natamycin) in the treatment of childhood asthma</TI>
<SO>Clinical &amp; Experimental Allergy</SO>
<YR>1990</YR>
<VL>20</VL>
<PG>561-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Rijssenbeek-2002" NAME="Rijssenbeek 2002" YEAR="2002">
<REFERENCE NOTES="&lt;p&gt;Rijssenbeek-Nouwens LH, Oosting AJ, De Monchy JG, Bregman I, Postma DS, De Bruin-Weller MS. The effect of anti-allergic mattress encasings on house dust mite-induced early- and late-airway reactions in asthmatic patients. A double-blind, placebo-controlled study. Clinical &amp;amp; Experimental Allergy 2002; 32:117-25.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rijssenbeek-Nouwens LH, Oosting AJ, De Monchy JG, Bregman I, Postma DS, De Bruin-Weller MS</AU>
<TI>The effect of anti-allergic mattress encasings on house dust mite-induced early- and late-airway reactions in asthmatic patients. A double-blind, placebo-controlled study</TI>
<SO>Clinical &amp; Experimental Allergy</SO>
<YR>2002</YR>
<VL>32</VL>
<PG>117-25</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;Rijssenbeek-Nouwens LH, Oosting AJ, de Bruin-Weller MS, Bregman I, de Monchy JG, Postma DS. Clinical evaluation of the effect of anti-allergic mattress covers in patients with moderate to severe asthma and house dust mite allergy: a randomised double blind placebo controlled study. Thorax 2002; 57(9):784-90.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rijssenbeek-Nouwens LH, Oosting AJ, de Bruin-Weller MS, Bregman I, de Monchy JG, Postma DS</AU>
<TI>Clinical evaluation of the effect of anti-allergic mattress covers in patients with moderate to severe asthma and house dust mite allergy: a randomised double blind placebo controlled study</TI>
<SO>Thorax</SO>
<YR>2002</YR>
<VL>57</VL>
<NO>9</NO>
<PG>784-90</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sette-1994" MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" NAME="Sette 1994" YEAR="1994">
<REFERENCE MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" NOTES="&lt;p&gt;Sette L, Comis A, Marcucci F, Sensi L, Piacentini GL, Boner AL. Benzyl-bensoate foam: Effects on mite allergens in mattress, serum and nasal secretory IgE to Dermatophagoides pteronyssinus, and bronchial hyperreactivity in children with allergic asthma. Pediatric Pulmonology 1994; 18:218-227.&lt;/p&gt;" NOTES_MODIFIED="2011-08-10 12:11:04 +0100" NOTES_MODIFIED_BY="Emma J Welsh" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sette L, Comis A, Marcucci F, Sensi L, Piacentini GL, Boner AL</AU>
<TI>Benzyl-bensoate foam: effects on mite allergens in mattress, serum and nasal secretory IgE to Dermatophagoides pteronyssinus, and bronchial hyperreactivity in children with allergic asthma</TI>
<SO>Pediatric Pulmonology</SO>
<YR>1994</YR>
<VL>18</VL>
<PG>218-27</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Shapiro-1999" NAME="Shapiro 1999" YEAR="1999">
<REFERENCE NOTES="&lt;p&gt;Shapiro GG, Wighton TG, Chinn T, Zuckrman J, Eliassen AH, Picciano JF et al. House dust mite avoidance for children with asthma in homes of low-income families. J Allergy Clin Immunol 1999; 103(6):1069-74.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shapiro GG, Wighton TG, Chinn T, Zuckrman J, Eliassen AH, Picciano JF, et al</AU>
<TI>House dust mite avoidance for children with asthma in homes of low-income families</TI>
<SO>Journal of Allergy &amp; Clinical Immunology</SO>
<YR>1999</YR>
<VL>103</VL>
<NO>6</NO>
<PG>1069-74</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sheikh-2002" NAME="Sheikh 2002" YEAR="2002">
<REFERENCE NOTES="&lt;p&gt;Sheikh A, Hurwitz B, Sibbald B, Barnes G, Howe M, Durham S. House dust mite barrier bedding for childhood asthma: randomised placebo controlled trial in primary care. BMC Fam Pract 2002; 3(1):12.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sheikh A, Hurwitz B, Sibbald B, Barnes G, Howe M, Durham S</AU>
<TI>House dust mite barrier bedding for childhood asthma: randomised placebo controlled trial in primary care</TI>
<SO>BMC Family Practice</SO>
<YR>2002</YR>
<VL>3</VL>
<NO>1</NO>
<PG>12</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sooltangos-1992" NAME="Sooltangos 1992" YEAR="1992">
<REFERENCE NOTES="&lt;p&gt;Sooltangos S, Khodaboccus F, Baligadoo S, Leynadier F, Fadel R. Effect of house dust mites (HDM) avoidance measures on symptoms of asthmatic patients in Island of Mauritius. J All Clin Immunol 1992; 89: 259.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sooltangos S, Khodaboccus F, Baligadoo S, Leynadier F, Fadel R</AU>
<TI>Effect of house dust mites (HDM) avoidance measures on symptoms of asthmatic patients in Island of Mauritius</TI>
<SO>Journal of Allergy &amp; Clinical Immunology</SO>
<YR>1992</YR>
<VL>89</VL>
<PG>259</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Thiam-1999" NAME="Thiam 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Thiam DG, Tim CF, Hoon LS, Lei Z, Bee-Wah L</AU>
<TI>An evaluation of mattress encasings and high efficiency particulate filters on asthma control in the tropics</TI>
<SO>Asian Pacific Journal of Allergy &amp; Immunology</SO>
<YR>1999</YR>
<VL>17</VL>
<PG>169-74</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-van-den-Bemt-2004" MODIFIED="2011-07-28 09:18:22 +0100" MODIFIED_BY="[Empty name]" NAME="van den Bemt 2004" YEAR="2004">
<REFERENCE MODIFIED="2011-07-28 09:18:22 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Van Den Bemt L, Van Knapen L, De Vries MP, Jansen M, Cloosterman S, Van Schayck CP. Clinical effectiveness of a mite allergen-impermeable bed-covering system in asthmatic mite-sensitive patients. Journal of Allergy &amp;amp; Clinical Immunology 2004; 114(4):858-62.&lt;/p&gt;" NOTES_MODIFIED="2011-07-28 09:18:22 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Van den Bemt L, Van Knapen L, De Vries MP, Jansen M, Cloosterman S, Van Schayck CP</AU>
<TI>Clinical effectiveness of a mite allergen-impermeable bed-covering system in asthmatic mite-sensitive patients</TI>
<SO>Journal of Allergy &amp; Clinical Immunology</SO>
<YR>2004</YR>
<VL>114</VL>
<NO>4</NO>
<PG>858-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>van den Bemt L, Jansen M, van Knapen L, Cloostermann S, De Vries M, van Schayck O</AU>
<TI>Effectiveness of a mite-allergen impermeable (non-polyurethane) bed covering system in asthmatic mite-sensitive patients (abstract)</TI>
<SO>European Respiratory Journal</SO>
<YR>2000</YR>
<VL>16</VL>
<PG>468S</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-van-der-Heide-1997A" NAME="van der Heide 1997A" YEAR="1997">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>van der Heide S, Kaufmann HF, Dubois AEJ, de Monchy JGR</AU>
<TI>Allergen-avoidance measures in homes of house-dust-mite-allergic asthmatic patients: effects of acaricides and mattress encasings</TI>
<SO>Allergy</SO>
<YR>1997</YR>
<VL>52</VL>
<PG>921-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-van-der-Heide-1997B" MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" NAME="van der Heide 1997B" YEAR="1997">
<REFERENCE MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" NOTES="&lt;p&gt;van der Heide S, Kauffman HF, Dubois AE, de Monchy JG. Allergen reduction measures in houses of allergic asthmatic patients: effects of air-cleaners and allergen-impermeable mattress covers [see comments]. Eur Respir J 1997; 10(6):1217-23.&lt;/p&gt;" NOTES_MODIFIED="2011-08-10 12:11:04 +0100" NOTES_MODIFIED_BY="Emma J Welsh" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>van der Heide S, Kauffman HF, Dubois AE, de Monchy JG</AU>
<TI>Allergen reduction measures in houses of allergic asthmatic patients: effects of air-cleaners and allergen-impermeable mattress covers [see comments]</TI>
<SO>European Respiratory Journal</SO>
<YR>1997</YR>
<VL>10</VL>
<NO>6</NO>
<PG>1217-23</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-van-der-Heide-1999" NAME="van der Heide 1999" YEAR="1999">
<REFERENCE NOTES="&lt;p&gt;van der Heide S, van Aalderen WM, Kauffman HF, Dubois AE, de Monchy JG. Clinical effects of air cleaners in homes of asthmatic children sensitized to pet allergens. J Allergy Clin Immunol 1999; 104(2 Pt 1):447-51.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>van der Heide S, van Aalderen WM, Kauffman HF, Dubois AE, de Monchy JG</AU>
<TI>Clinical effects of air cleaners in homes of asthmatic children sensitized to pet allergens</TI>
<SO>Journal of Allergy &amp; Clinical Immunology</SO>
<YR>1999</YR>
<VL>104</VL>
<NO>2 Pt 1</NO>
<PG>447-51</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Verrall-1988" MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" NAME="Verrall 1988" YEAR="1988">
<REFERENCE MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" NOTES="&lt;p&gt;Verrall B, Muir DCF, Wilson WM, Milner R, Johnston M, Dolovitch J. Laminar flow air cleaner bed attachment : a controlled trial. Ann Allergy 1988; 61:117-122.&lt;/p&gt;" NOTES_MODIFIED="2011-08-10 12:11:04 +0100" NOTES_MODIFIED_BY="Emma J Welsh" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Verrall B, Muir DC, Wilson WM, Milner R, Johnston M, Dolovitch J</AU>
<TI>Laminar flow air cleaner bed attachment: a controlled trial</TI>
<SO>Annals of Allergy</SO>
<YR>1988</YR>
<VL>61</VL>
<PG>117-22</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Walshaw-1986" NAME="Walshaw 1986" YEAR="1986">
<REFERENCE NOTES="&lt;p&gt;Walshaw MJ, Evans CC. Allergen avoidance in house dust mite sensitive adult asthma. Quart J Med 1986; 58: 199-215.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Walshaw MJ, Evans CC</AU>
<TI>Allergen avoidance in house dust mite sensitive adult asthma</TI>
<SO>Quarterly Journal of Medicine</SO>
<YR>1986</YR>
<VL>58</VL>
<PG>199-215</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Warburton-1994" NAME="Warburton 1994" YEAR="1994">
<REFERENCE NOTES="&lt;p&gt;Warburton CJ, Niven RMcL, Pickering CAC, Fletcher AM, Hepworth J, Francis HC. Domiciliary air filtration units, symptoms and lung function in atopic asthmatics. Respir Med 1994; 88:771-776.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Warburton CJ, Niven RMcL, Pickering CA, Fletcher AM, Hepworth J, Francis HC</AU>
<TI>Domiciliary air filtration units, symptoms and lung function in atopic asthmatics</TI>
<SO>Respiratory Medicine</SO>
<YR>1994</YR>
<VL>88</VL>
<PG>771-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Warner-1993" NAME="Warner 1993" YEAR="1993">
<REFERENCE NOTES="&lt;p&gt;Warner JA, Marchant JL, Warner JO. Double blind trial of ionisers in children with asthma sensitive to the house dust mite. Thorax 1993; 48: 330-333.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Warner JA, Marchant JL, Warner JO</AU>
<TI>Double blind trial of ionisers in children with asthma sensitive to the house dust mite</TI>
<SO>Thorax</SO>
<YR>1993</YR>
<VL>48</VL>
<PG>330-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Warner-2000" MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" NAME="Warner 2000" YEAR="2000">
<REFERENCE MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Warner JA, Frederick JM, Bryant TN, Weich C, Raw GJ, Hunter C, et al</AU>
<TI>Mechanical ventilation and high-efficiency vacuum cleaning: a combined strategy of mite and mite allergen reduction in the control of mite-sensitive asthma</TI>
<SO>Journal of Allergy &amp; Clinical Immunology</SO>
<YR>2000</YR>
<VL>105</VL>
<NO>1 Pt 1</NO>
<PG>75-82</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Woodcock-2003" MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" NAME="Woodcock 2003" YEAR="2003">
<REFERENCE NOTES="&lt;p&gt;Custovic A, Forster L Matthews E Martin J Letley L Vickers M Britton J Strachan D Howarth P Altmann Frost C Woodcock A and MRC GP research framework. The effect of mite allergen control by the use of allergen-impermeable covers in adult asthma: the SMAC trial. Thorax 2002; 57:iii45.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Custovic A, Forster L, Matthews E, Martin J, Letley L, Vickers M, et al</AU>
<TI>The effect of mite allergen control by the use of allergen-impermeable covers in adult asthma: the SMAC trial</TI>
<SO>Thorax</SO>
<YR>2002</YR>
<VL>57</VL>
<PG>iii45</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" NOTES="&lt;p&gt;Woodcock A, Forster L, Matthews E, et al. Control of exposure to mite allergen and allergen-impermeable bed covers for adults with asthma. N Engl J Med 2003; 349(3):225-36.&lt;/p&gt;" NOTES_MODIFIED="2011-08-10 12:11:04 +0100" NOTES_MODIFIED_BY="Emma J Welsh" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Woodcock A, Forster L, Matthews E, Martin J, Letley L, Vickers M, et al</AU>
<TI>Control of exposure to mite allergen and allergen-impermeable bed covers for adults with asthma</TI>
<SO>New England Journal of Medicine</SO>
<YR>2003</YR>
<VL>349</VL>
<NO>3</NO>
<PG>225-36</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wright-2009" MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" NAME="Wright 2009" YEAR="2009">
<REFERENCE MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Wright GR, Chaudhuri R, Howieson S, McSharry C, McMahon AD, Thompson J, et al</AU>
<TI>Effect of improved ventilation in homes of adults with house dust mite sensitive asthma [Abstract]</TI>
<SO>American Thoracic Society International Conference, May 16-21</SO>
<YR>2008</YR>
<PG>A615[#A45]</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2011-07-28 09:17:59 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Wright GR, Howieson S, McSharry C, McMahon AD, Chaudhuri R, Thompson J, et al</AU>
<TI>Effect of improved home ventilation on asthma control and house dust mite allergen levels</TI>
<SO>Allergy</SO>
<YR>2009</YR>
<VL>64</VL>
<PG>1671-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2011-07-12 12:18:01 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Wright GR, Howieson S, McSharry C, McMahon AD, Chaudhuri R, Thompson J, et al</AU>
<TI>The effect of mechanical heat recovery ventilation on the control of asthma: a randomised controlled trial [Abstract]</TI>
<SO>Thorax</SO>
<YR>2007</YR>
<VL>62(Suppl iii)</VL>
<PG>A5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zwemer-1973" NAME="Zwemer 1973" YEAR="1973">
<REFERENCE NOTES="&lt;p&gt;Zwemer RJ, Karibo J. Use of laminar control device as adjunct to standard environmental control measures in symptomatic asthmatic children. Ann Allergy 1973; 31: 284-290.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zwemer RJ, Karibo J</AU>
<TI>Use of laminar control device as adjunct to standard environmental control measures in symptomatic asthmatic children</TI>
<SO>Annals of Allergy</SO>
<YR>1973</YR>
<VL>31</VL>
<PG>284-90</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<STUDY DATA_SOURCE="PUB" ID="STD-Bowler-1985" NAME="Bowler 1985" YEAR="1985">
<REFERENCE NOTES="&lt;p&gt;Bowler SD, Mitchell CA, Miles J. House dust control and asthma: a placebo-control trial of cleaning air filtration. Ann Allergy 1985; 55:498-500.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bowler SD, Mitchell CA, Miles J</AU>
<TI>House dust control and asthma: a placebo-control trial of cleaning air filtration</TI>
<SO>Annals of Allergy</SO>
<YR>1985</YR>
<VL>55</VL>
<PG>498-500</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Brown-1991" NAME="Brown 1991" YEAR="1991">
<REFERENCE NOTES="&lt;p&gt;Brown HM, Merrett TG. Effectiveness of an acaricide in management of house dust mite allergy. Ann Allergy 1991; 67: 25-31&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Brown HM, Merrett TG</AU>
<TI>Effectiveness of an acaricide in management of house dust mite allergy</TI>
<SO>Annals of Allergy</SO>
<YR>1991</YR>
<VL>67</VL>
<PG>25-31</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Burr-1988" NAME="Burr 1988" YEAR="1988">
<REFERENCE NOTES="&lt;p&gt;Burr ML, Dean BV, Butland BK, Neale E. Prevention of mite infestation of bedding by means of an impregnated sheet. A randomized controlled trial. Allergy 1988; 43: 299-302&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Burr ML, Dean BV, Butland BK, Neale E</AU>
<TI>Prevention of mite infestation of bedding by means of an impregnated sheet. A randomized controlled trial</TI>
<SO>Allergy</SO>
<YR>1988</YR>
<VL>43</VL>
<PG>299-302</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Carswell-1999" NAME="Carswell 1999" YEAR="1999">
<REFERENCE NOTES="&lt;p&gt;Carswell F, Oliver J, Weeks J. Do mite avoidance measures affect mite and cat airborne allergens? Clin Exp Allergy 1999; 29(2):193-200.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Carswell F, Oliver J, Weeks J</AU>
<TI>Do mite avoidance measures affect mite and cat airborne allergens?</TI>
<SO>Clinical and Experimental Allergy</SO>
<YR>1999</YR>
<VL>29</VL>
<NO>2</NO>
<PG>193-200</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Carter-2001" NAME="Carter 2001" YEAR="2001">
<REFERENCE NOTES="&lt;p&gt;Carter MC, Perzanowski MS, Raymond A, Platts-Mills TA. Home intervention in the treatment of asthma among inner-city children. J Allergy Clin Immunol 2001; 108(5):732-7.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Carter MC, Perzanowski MS, Raymond A, Platts-Mills TA</AU>
<TI>Home intervention in the treatment of asthma among inner-city children</TI>
<SO>Journal of Allergy &amp; Clinical Immunology</SO>
<YR>2001</YR>
<VL>108</VL>
<NO>5</NO>
<PG>732-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chew-1996" NAME="Chew 1996" YEAR="1996">
<REFERENCE NOTES="&lt;p&gt;Chew FT, Goh DY, Lee BW. Effects of an acaricide on mite allergen levels in the homes of asthmatic children. Acta Paediatr Jpn 1996; 38(5):483-8.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chew FT, Goh DY, Lee BW</AU>
<TI>Effects of an acaricide on mite allergen levels in the homes of asthmatic children</TI>
<SO>Acta Paediatrica Japonica</SO>
<YR>1996</YR>
<VL>38</VL>
<NO>5</NO>
<PG>483-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cloosterman-1997" NAME="Cloosterman 1997" YEAR="1997">
<REFERENCE NOTES="&lt;p&gt;Cloosterman SG, Hofland ID, Lukassen HG, Wieringa MH, Folgering HTh, van der Heide S et al. House dust mite avoidance measures improve peak flow and symptoms in patients with allergy but without asthma: a possible delay in the manifestation of clinical asthma? [see comments]. J Allergy Clin Immunol 1997; 100(3):313-9.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cloosterman SG, Hofland ID, Lukassen HG, Wieringa MH, Folgering HTh, van der Heide S, et al</AU>
<TI>House dust mite avoidance measures improve peak flow and symptoms in patients with allergy but without asthma: a possible delay in the manifestation of clinical asthma? [see comments]</TI>
<SO>Journal of Allergy &amp; Clinical Immunology</SO>
<YR>1997</YR>
<VL>100</VL>
<NO>3</NO>
<PG>313-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-de-Blay-2003" MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" NAME="de Blay 2003" YEAR="2003">
<REFERENCE MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" NOTES="&lt;p&gt;De Blay F, Fourgaut G Lieutier-Colas F Ott M Touron D Rolland C Pauli G Francoise-Bernard M. Mite allergen reduction: Role of an indoor technician in patients compliance and allergen exposure. Journal of Allergy and Clinical Immunology 2001; 107:S218.&lt;/p&gt;" NOTES_MODIFIED="2011-08-10 12:11:04 +0100" NOTES_MODIFIED_BY="Emma J Welsh" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>De Blay F, Fourgaut G, Lieutier-Colas F, Ott M, Touron D, Rolland C, et al</AU>
<TI>Mite allergen reduction: role of an indoor technician in patients compliance and allergen exposure</TI>
<SO>Journal of Allergy and Clinical Immunology</SO>
<YR>2001</YR>
<VL>107</VL>
<PG>S218, abstract 720</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" NOTES="&lt;p&gt;de Blay F, Fourgaut G, Hedelin G, et al. Medical Indoor Environment Counselor (MIEC): role in compliance with advice on mite allergen avoidance and on mite allergen exposure. Allergy 2003; 58(1):27-33.&lt;/p&gt;" NOTES_MODIFIED="2011-08-10 12:11:04 +0100" NOTES_MODIFIED_BY="Emma J Welsh" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>de Blay F, Fourgaut G, Hedelin G, Vervloet D, Michel FB, Godard P, et al</AU>
<TI>Medical Indoor Environment Counselor (MIEC): role in compliance with advice on mite allergen avoidance and on mite allergen exposure</TI>
<SO>Allergy</SO>
<YR>2003</YR>
<VL>58</VL>
<NO>1</NO>
<PG>27-33</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Elixmann-1988" NAME="Elixmann 1988" YEAR="1988">
<REFERENCE NOTES="&lt;p&gt;Elixmann JH, Bischoff E, Jorde W, Linskens HF. Einmalige Acarosan-applikation zur sanierung von wohntextilien in haushalten von patienten mit milbenallergie. Allergologie 1988; 11: 274-279.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Elixmann JH, Bischoff E, Jorde W, Linskens HF</AU>
<TI>Einmalige Acarosan-applikation zur Sanierung von Wohntextilien in Haushalten von Patienten mit Milbenallergie</TI>
<SO>Allergologie</SO>
<YR>1988</YR>
<VL>11</VL>
<PG>274-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gallardo-1994" MODIFIED="2011-08-09 17:46:08 +0100" MODIFIED_BY="[Empty name]" NAME="Gallardo 1994" YEAR="1994">
<REFERENCE MODIFIED="2011-08-09 17:46:08 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gallardo JFM, Gómez JC, Gil FC, García RA, Armengol MAS, Biedma MLM</AU>
<TI>Usefulness of dehumidifying devices in reducing the concentration of mites</TI>
<TO>Utilidad de los dispositivos deshumidificadores en la reducción de la concentración ácaros</TO>
<SO>Archivos de Bronconeumologia</SO>
<YR>1994</YR>
<VL>30</VL>
<PG>287-90</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Glasgow-2011" MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" NAME="Glasgow 2011" YEAR="2011">
<REFERENCE MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Glasgow NJ, Ponsonby A-L, Kemp A, Tovey E, Van Asperen P, McKay K, et al</AU>
<TI>Feather bedding and childhood asthma associated with house dust mite sensitisation: a randomised controlled trial</TI>
<SO>Archives of Diseases in Children</SO>
<YR>2011</YR>
<VL>96</VL>
<PG>541-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Griffin-1989" NAME="Griffin 1989" YEAR="1989">
<REFERENCE NOTES="&lt;p&gt;Griffin, S. P. Woolcock AJ, Riley I, Green W, Alpers M. Allersearch DMS reduces mite numbers and causes clinical improvement in atopic asthmatic subjects in the South Fore of Papua New Guinea. 1989; 19:649.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Griffin SP, Woolcock AJ, Riley I, Green W, Alpers M</AU>
<TI>Allersearch DMS reduces mite numbers and causes clinical improvement in atopic asthmatic subjects in the South Fore of Papua New Guinea</TI>
<SO>Thoracic Society of Australia and New Zealand</SO>
<YR>1989</YR>
<VL>19</VL>
<PG>649</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hannaway-1993" NAME="Hannaway 1993" YEAR="1993">
<REFERENCE NOTES="&lt;p&gt;Hannaway PJ, Hopper DK, and Conner BL. Reduced house dust mite (HDM) levels and asthma morbidity following environmental controls with benzylbenzoate-acarosan (BB), allergen-proof encasings and aggressive cleaning measures. Ann Allergy 1993; 70:54.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hannaway PJ, Hopper DK, Conner BL</AU>
<TI>Reduced house dust mite (HDM) levels and asthma morbidity following environmental controls with benzylbenzoate-acarosan (BB), allergen-proof encasings and aggressive cleaning measures</TI>
<SO>Annals of Allergy</SO>
<YR>1993</YR>
<VL>70</VL>
<PG>54</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Harving-1994" NAME="Harving 1994" YEAR="1994">
<REFERENCE NOTES="&lt;p&gt;Harving H, Korsgaard J, Dahl R. Clinical efficacy of reduction in house-dust mite exposure in specially designed, mechanically ventilated 'healthy' homes. Allergy 1994; 49: 866-870.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Harving H, Korsgaard J, Dahl R</AU>
<TI>Clinical efficacy of reduction in house-dust mite exposure in specially designed, mechanically ventilated 'healthy' homes</TI>
<SO>Allergy</SO>
<YR>1994</YR>
<VL>49</VL>
<PG>866-70</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;Harving H, Korsgaard J, Dahl R. House-dust mite exposure reduction in specially designed, mechanically ventilated 'healthy' homes Allergy 1994; 49: 713-718.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Harving H, Korsgaard J, Dahl R</AU>
<TI>House-dust mite exposure reduction in specially designed, mechanically ventilated 'healthy' homes</TI>
<SO>Allergy</SO>
<YR>1994</YR>
<VL>49</VL>
<PG>713-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hayden-1997" NAME="Hayden 1997" YEAR="1997">
<REFERENCE NOTES="&lt;p&gt;Hayden ML, Perzanowski M, Matheson L, Scott P, Call RS, Platts Mills TA. Dust mite allergen avoidance in the treatment of hospitalized children with asthma. Ann Allergy Asthma Immunol 1997; 79(5):437-42.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hayden ML, Perzanowski M, Matheson L, Scott P, Call RS, Platts Mills TA</AU>
<TI>Dust mite allergen avoidance in the treatment of hospitalized children with asthma</TI>
<SO>Annals of Allergy Asthma &amp; Immunology</SO>
<YR>1997</YR>
<VL>79</VL>
<NO>5</NO>
<PG>437-42</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hegarty-1995" NAME="Hegarty 1995" YEAR="1995">
<REFERENCE NOTES="&lt;p&gt;Hegarty J, Rouhbakhsh S, Dahil J, Warner JO, and Warner JA. A comparison of a conventional and high efficiency vacuum cleaner in the homes of children with house dust mite sensitive asthma [abstract]. European Respiratory Journal. Supplement. 1995; 8 Suppl 19:277S.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hegarty J, Rouhbakhsh S, Dahil J, Warner JO, Warner JA</AU>
<TI>A comparison of a conventional and high efficiency vacuum cleaner in the homes of children with house dust mite sensitive asthma [abstract]</TI>
<SO>European Respiratory Journal</SO>
<YR>1995</YR>
<VL>8</VL>
<NO>Suppl 19</NO>
<PG>277S</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Huss-1991" NAME="Huss 1991" YEAR="1991">
<REFERENCE NOTES="&lt;p&gt;Huss K, Salerno M, Huss RW. Computer-assisted reinforcement of instruction: effects on adherence in adult atopic asthmatics. Res Nurs Health 1991; 14(4):259-67.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Huss K, Salerno M, Huss RW</AU>
<TI>Computer-assisted reinforcement of instruction: effects on adherence in adult atopic asthmatics</TI>
<SO>Research in Nursing &amp; Health</SO>
<YR>1991</YR>
<VL>14</VL>
<NO>4</NO>
<PG>259-67</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Huss-1994" MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" NAME="Huss 1994" YEAR="1994">
<REFERENCE MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" NOTES="&lt;p&gt;Huss RW, Huss K, Squire EN, Jr Carpenter GB, Smith LJ, Salata K, Hershey J. Mite allergen control with acaricide fails. J All Clin Immunol 1994; 94: 27-32.&lt;/p&gt;" NOTES_MODIFIED="2011-08-10 12:11:04 +0100" NOTES_MODIFIED_BY="Emma J Welsh" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Huss RW, Huss K, Squire EN Jr, Carpenter GB, Smith LJ, Salata K, et al</AU>
<TI>Mite allergen control with acaricide fails</TI>
<SO>Journal of Allergy &amp; Clinical Immunology</SO>
<YR>1994</YR>
<VL>94</VL>
<PG>27-32</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hyndman-2000" NAME="Hyndman 2000" YEAR="2000">
<REFERENCE NOTES="&lt;p&gt;Hyndman SJ, . = Vickers LM, Htut T, Maunder JW, Peock A, Higenbottam TW. A randomized trial of dehumidification in the control of house dust mite. Clinical &amp;amp; Experimental Allergy 2000; 30:1172-80.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hyndman SJ, Vickers LM, Htut T, Maunder JW, Peock A, Higenbottam TW</AU>
<TI>A randomized trial of dehumidification in the control of house dust mite</TI>
<SO>Clinical &amp; Experimental Allergy</SO>
<YR>2000</YR>
<VL>30</VL>
<PG>1172-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Joseph-2003" NAME="Joseph 2003" YEAR="2003">
<REFERENCE NOTES="&lt;p&gt;Joseph KE, Adams CD, Cottrell L, Hogan MB, Wilson NW. Providing dust mite-proof covers improves adherence to dust mite control measures in children with mite allergy and asthma. Ann Allergy Asthma Immunol 2003; 90(5):550-3.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Joseph KE, Adams CD, Cottrell L, Hogan MB, Wilson NW</AU>
<TI>Providing dust mite-proof covers improves adherence to dust mite control measures in children with mite allergy and asthma</TI>
<SO>Annals of Allergy Asthma &amp; Immunology</SO>
<YR>2003</YR>
<VL>90</VL>
<NO>5</NO>
<PG>550-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Korsgaard-1982" NAME="Korsgaard 1982" YEAR="1982">
<REFERENCE NOTES="&lt;p&gt;Korsgaard J. Preventive measures in house dust allergy Am Rev Respir Dis 1982: 125: 80-84.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Korsgaard J</AU>
<TI>Preventive measures in house dust allergy</TI>
<SO>American Review of Respiratory Disease</SO>
<YR>1982</YR>
<VL>125</VL>
<PG>80-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Krieger-2005" MODIFIED="2008-08-08 08:31:01 +0100" MODIFIED_BY="[Empty name]" NAME="Krieger 2005" YEAR="2005">
<REFERENCE MODIFIED="2008-08-08 08:30:24 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Krieger JK, Takaro TK, Allen C, Song L, Weaver M, Chai S, et al. The Seattle-King County healthy homes project: implementation of a comprehensive approach to improving indoor environmental quality for low-income children with asthma. Environ Health Perspect 2002; 110 Suppl 2:311-22.&lt;/p&gt;" NOTES_MODIFIED="2008-08-08 08:30:24 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Krieger JW, Takaro TK, Song L, Weaver M</AU>
<TI>The Seattle-King County Healthy Homes Project: a randomized, controlled trial of a community health worker intervention to decrease exposure to indoor asthma triggers</TI>
<SO>American Journal of Public Health</SO>
<YR>2005</YR>
<VL>95</VL>
<PG>652-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lau-2002" NAME="Lau 2002" YEAR="2002">
<REFERENCE NOTES="&lt;p&gt;Lau S, Wahn J, Schulz G, Sommerfeld C, Wahn U. Placebo-controlled study of the mite allergen-reducing effect of tannic acid plus benzyl benzoate on carpets in homes of children with house dust mite sensitization and asthma. Pediatr Allergy Immunol 2002; 13(1):31-6.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lau S, Wahn J, Schulz G, Sommerfeld C, Wahn U</AU>
<TI>Placebo-controlled study of the mite allergen-reducing effect of tannic acid plus benzyl benzoate on carpets in homes of children with house dust mite sensitization and asthma</TI>
<SO>Pediatric Allergy &amp; Immunology</SO>
<YR>2002</YR>
<VL>13</VL>
<NO>1</NO>
<PG>31-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lau_x002d_Schadendorf-1991" NAME="Lau-Schadendorf 1991" YEAR="1991">
<REFERENCE NOTES="&lt;p&gt;Lau-Schadendorf S, Rusche AF, Weber A-K, Buettner-Goetz P, Wahn U. Short-term effect of solidified benzyl bensoate on mite-allergen concentrations in house dust. J Allergy Clin Immunol 1991; 87: 7.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lau-Schadendorf S, Rusche AF, Weber A-K, Buettner-Goetz P, Wahn U</AU>
<TI>Short-term effect of solidified benzyl bensoate on mite-allergen concentrations in house dust</TI>
<SO>Journal of Allergy &amp; Clinical Immunology</SO>
<YR>1991</YR>
<VL>87</VL>
<PG>7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Leclercq-1985" MODIFIED="2008-07-28 11:18:17 +0100" MODIFIED_BY="Toby J Lasserson" NAME="Leclercq 1985" YEAR="1985">
<REFERENCE MODIFIED="2008-07-28 11:18:17 +0100" MODIFIED_BY="Toby J Lasserson" NOTES="&lt;p&gt;Leclercq-Foucart J, de Saint-Georges-Gridelet D, Geubelle F, Lebrun Ph. Controle de l' acarien des poussieres par utilisation d' un fongicide. Observations experimentale. Essai clinique chez l' enfant allergique au Dermatophagoides. Revue Medicale de Liege 1985: 40: 91-9.&lt;/p&gt;" NOTES_MODIFIED="2008-07-28 11:18:17 +0100" NOTES_MODIFIED_BY="Toby J Lasserson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Leclercq-Foucart J, de Saint-Georges-Gridelet D, Geubelle F, Lebrun Ph</AU>
<TI>Control of dust mite with the use of a fungicide. Clinical trial in children allergic to Dermatophagoides</TI>
<TO>Controle de l' acarien des poussieres par utilisation d' un fongicide. Observations experimentales. Essai clinique chez l' enfant allergique au Dermatophagoides</TO>
<SO>Revue Medicale de Liege</SO>
<YR>1985</YR>
<VL>40</VL>
<PG>91-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Massey-1993" MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" NAME="Massey 1993" YEAR="1993">
<REFERENCE MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" NOTES="&lt;p&gt;Massey, DG., FournierMassey, G., James, RH Minimizing acarians and house dust in the tropics Ann Allergy 1993; 71: 439-444.&lt;/p&gt;" NOTES_MODIFIED="2011-08-10 12:11:04 +0100" NOTES_MODIFIED_BY="Emma J Welsh" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Massey DG, Fournier Massey G, James RH</AU>
<TI>Minimizing acarians and house dust in the tropics</TI>
<SO>Annals of Allergy</SO>
<YR>1993</YR>
<VL>71</VL>
<PG>439-44</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Medina-1994" MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" NAME="Medina 1994" YEAR="1994">
<REFERENCE MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" NOTES="&lt;p&gt;Medina Gallardo JF, Castillo Gomez J, Capote Gil F Ayerbe Garcia R, Sanchez Armengol M A, Munoz Biedma ML. Usefulness of dehumidifiers in the reduction of acari concentrations]. [Spanish] Archivos de Bronconeumologia 1994;30:287-90.&lt;/p&gt;" NOTES_MODIFIED="2011-08-10 12:11:04 +0100" NOTES_MODIFIED_BY="Emma J Welsh" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Medina Gallardo JF, Castillo Gomez J, Capote Gil F, Ayerbe Garcia R, Sanchez Armengol MA, Munoz Biedma ML</AU>
<TI>Usefulness of dehumidifiers in the reduction of acari concentrations [Spanish]</TI>
<SO>Archivos de Bronconeumologia</SO>
<YR>1994</YR>
<VL>30</VL>
<PG>287-90</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Morgan-2004" NAME="Morgan 2004" YEAR="2004">
<REFERENCE NOTES="&lt;p&gt;Morgan WJ, Crain EF, Gruchalla RS, O'Connor GT, Kattan M, Evans R 3rd, et al. Results of a home-based environmental intervention among urban children with asthma. N Engl J Med 2004; 351(11):1068-80.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Morgan WJ, Crain EF, Gruchalla RS, O'Connor GT, Kattan M, Evans R 3rd, et al</AU>
<TI>Results of a home-based environmental intervention among urban children with asthma</TI>
<SO>New England Journal of Medicine</SO>
<YR>2004</YR>
<VL>351</VL>
<NO>11</NO>
<PG>1068-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mosbech-1988" NAME="Mosbech 1988" YEAR="1988">
<REFERENCE NOTES="&lt;p&gt;Mosbech H, Korsgaard J, Lind P. Control of house dust mites by electrical heating blankets. J Allergy Clin Immunol 1988;81:706-10.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mosbech H, Korsgaard J, Lind P</AU>
<TI>Control of house dust mites by electrical heating blankets</TI>
<SO>Journal of Allergy &amp; Clinical Immunology</SO>
<YR>1988</YR>
<VL>81</VL>
<PG>706-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Munir-1993" NAME="Munir 1993" YEAR="1993">
<REFERENCE NOTES="&lt;p&gt;Munir AK, Einarsson R, Dreborg SK. Vacuum cleaning decreases the levels of mite allergens in house dust. Pediatr Allergy Immunol 1993; 4(3):136-43.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Munir AK, Einarsson R, Dreborg SK</AU>
<TI>Vacuum cleaning decreases the levels of mite allergens in house dust</TI>
<SO>Pediatric Allergy &amp; Immunology</SO>
<YR>1993</YR>
<VL>4</VL>
<NO>3</NO>
<PG>136-43</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Murray-1983" NAME="Murray 1983" YEAR="1983">
<REFERENCE NOTES="&lt;p&gt;Murray AB, Ferguson AC. Dust-free bedrooms in the treatment of asthmatic children with house dust or house dust mite allergy: a controlled trial. Pediatrics 1983; 71: 418-22.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Murray AB, Ferguson AC</AU>
<TI>Dust-free bedrooms in the treatment of asthmatic children with house dust or house dust mite allergy: a controlled trial</TI>
<SO>Pediatrics</SO>
<YR>1983</YR>
<VL>71</VL>
<PG>418-22</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nambu-2008" MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" NAME="Nambu 2008" YEAR="2008">
<REFERENCE MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nambu M, Shirai H, Sakaguchi M, Aihara M, Takatori K</AU>
<TI>Effect of house dust mite-free pillow on clinical course of asthma and IgE level - a randomized, double-blind, controlled study</TI>
<SO>Pediatric Asthma, Allergy &amp; Immunology</SO>
<YR>2008</YR>
<VL>21</VL>
<PG>137-43</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nishioka-2006" NAME="Nishioka 2006" YEAR="2006">
<REFERENCE NOTES="&lt;p&gt;Nishioka K, Saito A, Akiyama K, Yasueda H. Effect of home environment control on children with atopic or non-atopic asthma. Allergol Int 2006; 55(2):141-8.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nishioka K, Saito A, Akiyama K, Yasueda H</AU>
<TI>Effect of home environment control on children with atopic or non-atopic asthma</TI>
<SO>Allergology International</SO>
<YR>2006</YR>
<VL>55</VL>
<NO>2</NO>
<PG>141-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Olaguibel-1994" MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" NAME="Olaguibel 1994" YEAR="1994">
<REFERENCE MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Olaguibel JM, Quirce S, Garcia Figueroa BE, Barber D, Rico P, Tabar AI</AU>
<TI>Grado de exposición alergénica a Dermatophagoides spp. y eficacia de las medidas fisicas de desalergenización, en el área de Pamplona</TI>
<SO>Revista Española de Alergología e Inmunología Clínica</SO>
<YR>1994</YR>
<VL>9</VL>
<PG>83-90</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Owen-1990" NAME="Owen 1990" YEAR="1990">
<REFERENCE NOTES="&lt;p&gt;Owen S, Morganstern M, Hepworth J, Woodcock A. Control of house dust mite antigen in bedding. Lancet 1990;335:396-7.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Owen S, Morganstern M, Hepworth J Woodcock A</AU>
<TI>Control of house dust mite antigen in bedding</TI>
<SO>Lancet</SO>
<YR>1990</YR>
<VL>335</VL>
<PG>396-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Peroni-1994" NAME="Peroni 1994" YEAR="1994">
<REFERENCE NOTES="&lt;p&gt;Peroni, DG., Boner, AL., Vallone, G., Antolini, I., Warner, JO Effective allergen avoidance at high altitude reduces allergen-induced bronchial hyperresponsiveness Am J Respir Crit Care Med 1994; 149: 1442-1446.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Peroni DG, Boner AL, Vallone G, Antolini I, Warner JO</AU>
<TI>Effective allergen avoidance at high altitude reduces allergen-induced bronchial hyperresponsiveness</TI>
<SO>American Journal of Respiratory &amp; Critical Care Medicine</SO>
<YR>1994</YR>
<VL>149</VL>
<PG>1442-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Quek-1994" NAME="Quek 1994" YEAR="1994">
<REFERENCE NOTES="&lt;p&gt;Quek SC, Chong A, Connett GJ, Lee BW. Effects of an acaricide on asthmatic children with house dust mite allergy. Acta Paediatr Jpn 1994;36:669-72.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Quek SC, Chong A, Connett GJ, Lee BW</AU>
<TI>Effects of an acaricide on asthmatic children with house dust mite allergy</TI>
<SO>Acta Paediatrica Japonica</SO>
<YR>1994</YR>
<VL>36</VL>
<PG>669-72</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rebmann-1996" MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" NAME="Rebmann 1996" YEAR="1996">
<REFERENCE MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" NOTES="&lt;p&gt;Rebmann H, Weber AK, Focke I, Rusche A, Lau S, Ehnert B et al. Does benzyl benzoate prevent colonization of new mattresses by mites? A prospective study. Allergy: European Journal of Allergy and Clinical Immunology 1996; 51:876-82.&lt;/p&gt;" NOTES_MODIFIED="2011-08-10 12:11:04 +0100" NOTES_MODIFIED_BY="Emma J Welsh" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rebmann H, Weber AK, Focke I, Rusche A, Lau S, Ehnert B, et al</AU>
<TI>Does benzyl benzoate prevent colonization of new mattresses by mites? A prospective study</TI>
<SO>Allergy: European Journal of Allergy and Clinical Immunology</SO>
<YR>1996</YR>
<VL>51</VL>
<PG>876-82</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Reisman-1990" NAME="Reisman 1990" YEAR="1990">
<REFERENCE NOTES="&lt;p&gt;Reisman RE, Mauriello PM, Davis GB, Georgitis JW, DeMasi JM. A double-blind study of the effectiveness of a high-efficiency particulate air (HEPA) filter in the treatment of patients with perennial allergic rhinitis and asthma. J Allergy Clin Immunol 1990; 85 : 1050-7.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Reisman RE, Mauriello PM, Davis GB, Georgitis JW, DeMasi JM</AU>
<TI>A double-blind study of the effectiveness of a high-efficiency particulate air (HEPA) filter in the treatment of patients with perennial allergic rhinitis and asthma</TI>
<SO>Journal of Allergy &amp; Clinical Immunology</SO>
<YR>1990</YR>
<VL>85</VL>
<PG>1050-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sarsfield-1974" NAME="Sarsfield 1974" YEAR="1974">
<REFERENCE NOTES="&lt;p&gt;Sarsfield JK, Gowland G, Toy R, Norman AL. Mite-sensitive asthma of childhood. Trial of avoidance measures. Arch Dis Child 1974;49:716-21.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sarsfield JK, Gowland G, Toy R, Norman AL</AU>
<TI>Mite-sensitive asthma of childhood. Trial of avoidance measures</TI>
<SO>Archives of Disease in Childhood</SO>
<YR>1974</YR>
<VL>49</VL>
<PG>716-21</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Scherr-1977" NAME="Scherr 1977" YEAR="1977">
<REFERENCE NOTES="&lt;p&gt;Scherr MS, Peck LW. The effects of high efficiency air filtration system on nighttime asthma attacks. The West Virginia Medical Journal 1977; 73 (7): 144-148.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Scherr MS, Peck LW</AU>
<TI>The effects of high efficiency air filtration system on nighttime asthma attacks</TI>
<SO>The West Virginia Medical Journal</SO>
<YR>1977</YR>
<VL>73</VL>
<NO>7</NO>
<PG>144-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shedd-2007" MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" NAME="Shedd 2007" YEAR="2007">
<REFERENCE MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" NOTES="&lt;p&gt;Shedd AD, Peters JI, Wood P et al. Impact of home environment characteristics on asthma quality of life and symptom scores. J Asthma 2007; 44(3):183-7.&lt;/p&gt;" NOTES_MODIFIED="2011-08-10 12:11:04 +0100" NOTES_MODIFIED_BY="Emma J Welsh" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shedd AD, Peters JI, Wood P, Inscore S, Forkner E, Smith B, et al</AU>
<TI>Impact of home environment characteristics on asthma quality of life and symptom scores</TI>
<SO>Journal of Asthma</SO>
<YR>2007</YR>
<VL>44</VL>
<NO>3</NO>
<PG>183-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sporik-1998" NAME="Sporik 1998" YEAR="1998">
<REFERENCE NOTES="&lt;p&gt;Sporik R, Hill DJ, Thompson PJ, Stewart GA, Carlin JB, Nolan TM et al. The Melbourne House Dust Mite Study: long-term efficacy of house dust mite reduction strategies. J Allergy Clin Immunol 1998; 101(4 Pt 1):451-6.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sporik R, Hill DJ, Thompson PJ, Stewart GA, Carlin JB, Nolan TM, et al</AU>
<TI>The Melbourne House Dust Mite Study: long-term efficacy of house dust mite reduction strategies</TI>
<SO>Journal of Allergy &amp; Clinical Immunology</SO>
<YR>1998</YR>
<VL>101</VL>
<NO>4 Pt 1</NO>
<PG>451-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Terreehorst-2005" NAME="Terreehorst 2005" YEAR="2005">
<REFERENCE NOTES="&lt;p&gt;Terreehorst I, Duivenvoorden HJ, Tempels-Pavlica Z, Oosting AJ, de Monchy JG, Bruijnzeel-Koomen CA, et al. The effect of encasings on quality of life in adult house dust mite allergic patients with rhinitis, asthma and/or atopic dermatitis. Allergy 2005; 60(7):888-93.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Terreehorst I, Duivenvoorden HJ, Tempels-Pavlica Z, Oosting AJ, de Monchy JG, Bruijnzeel-Koomen CA, et al</AU>
<TI>The effect of encasings on quality of life in adult house dust mite allergic patients with rhinitis, asthma and/or atopic dermatitis</TI>
<SO>Allergy</SO>
<YR>2005</YR>
<VL>60</VL>
<NO>7</NO>
<PG>888-93</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tobias-2004" NAME="Tobias 2004" YEAR="2004">
<REFERENCE NOTES="&lt;p&gt;Tobias KR, Ferriani VP, Chapman MD, Arruda LK. Exposure to indoor allergens in homes of patients with asthma and/or rhinitis in southeast Brazil: effect of mattress and pillow covers on mite allergen levels. Int Arch Allergy Immunol 2004; 133(4):365-70.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tobias KR, Ferriani VP, Chapman MD, Arruda LK</AU>
<TI>Exposure to indoor allergens in homes of patients with asthma and/or rhinitis in southeast Brazil: effect of mattress and pillow covers on mite allergen levels</TI>
<SO>International Archives of Allergy &amp; Immunology</SO>
<YR>2004</YR>
<VL>133</VL>
<NO>4</NO>
<PG>365-70</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Villaveces-1977" NAME="Villaveces 1977" YEAR="1977">
<REFERENCE NOTES="&lt;p&gt;Villaveces JW, Rosengren H, Evans J. Use of laminar air flow portable filter in asthmatic children. Ann Allergy 1977; 38: 400-404.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Villaveces JW, Rosengren H, Evans J</AU>
<TI>Use of laminar air flow portable filter in asthmatic children</TI>
<SO>Annals of Allergy</SO>
<YR>1977</YR>
<VL>38</VL>
<PG>400-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Warner-1993B" NAME="Warner 1993B" YEAR="1993">
<REFERENCE NOTES="&lt;p&gt;Warner JA, Marchant JL, Warner JO. Allergen avoidance in the homes of atopic asthmatic children: the effect of Allersearch DMS. Clin Exp Allergy 1993; 23: 279-286.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Warner JA, Marchant JL, Warner JO</AU>
<TI>Allergen avoidance in the homes of atopic asthmatic children: the effect of Allersearch DMS</TI>
<SO>Clinical &amp; Experimental Allergy</SO>
<YR>1993</YR>
<VL>23</VL>
<PG>279-86</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Weeks-1995" NAME="Weeks 1995" YEAR="1995">
<REFERENCE NOTES="&lt;p&gt;Weeks J, Oliver J, Birmingham K, Crewes A, Carswell F. A combined approach to reduce mite allergen in the bedroom. Clin Exp Allergy 1995; 25(12):1179-83.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Weeks J, Oliver J, Birmingham K, Crewes A, Carswell F</AU>
<TI>A combined approach to reduce mite allergen in the bedroom</TI>
<SO>Clinical &amp; Experimental Allergy</SO>
<YR>1995</YR>
<VL>25</VL>
<NO>12</NO>
<PG>1179-83</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Williams-2006" NAME="Williams 2006" YEAR="2006">
<REFERENCE NOTES="&lt;p&gt;Williams SG, Brown CM, Falter KH, Alverson CJ, Gotway-Crawford C, Homa D, et al. Does a multifaceted environmental intervention alter the impact of asthma on inner-city children? J Natl Med Assoc 2006; 98(2):249-60.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Williams SG, Brown CM, Falter KH, Alverson CJ, Gotway-Crawford C, Homa D, et al</AU>
<TI>Does a multifaceted environmental intervention alter the impact of asthma on inner-city children?</TI>
<SO>Journal of the National Medical Association</SO>
<YR>2006</YR>
<VL>98</VL>
<NO>2</NO>
<PG>249-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<ADDITIONAL_REFERENCES MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<REFERENCE ID="REF-Abramson-1995" MODIFIED="2008-07-28 11:05:48 +0100" MODIFIED_BY="Toby J Lasserson" NAME="Abramson 1995" NOTES="&lt;p&gt;Abramson MJ, Puy RM, Weiner JM. Is allergen immunotherapy effective in asthma? A meta-analysis of randomized controlled trials. Am J Respir Crit Care Med 1995; 151: 969-74.&lt;/p&gt;" NOTES_MODIFIED="2008-07-28 11:05:48 +0100" NOTES_MODIFIED_BY="Toby J Lasserson" TYPE="JOURNAL_ARTICLE">
<AU>Abramson MJ, Puy RM, Weiner JM</AU>
<TI>Is allergen immunotherapy effective in asthma? A meta-analysis of randomized controlled trials</TI>
<SO>American Journal of Respiratory &amp; Critical Care Medicine</SO>
<YR>1995</YR>
<VL>151</VL>
<PG>969-74</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bland-1996" MODIFIED="2008-07-28 11:05:48 +0100" MODIFIED_BY="Toby J Lasserson" NAME="Bland 1996" TYPE="JOURNAL_ARTICLE">
<AU>Bland JM, Altman DG</AU>
<TI>Measurement error proportional to the mean</TI>
<SO>BMJ</SO>
<YR>1996</YR>
<VL>313</VL>
<PG>106</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Chan-2004" MODIFIED="2011-08-09 17:51:46 +0100" MODIFIED_BY="[Empty name]" NAME="Chan 2004" TYPE="JOURNAL_ARTICLE">
<AU>Chan A-W, Hróbjartsson A, Haahr MT, Gøtzsche PC, Altman DG</AU>
<TI>Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles</TI>
<SO>JAMA</SO>
<YR>2004</YR>
<VL>291</VL>
<PG>2457-65</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Colloff-1992" MODIFIED="2008-07-28 11:05:48 +0100" MODIFIED_BY="Toby J Lasserson" NAME="Colloff 1992" NOTES="&lt;p&gt;Colloff MJ, Ayres J, Carswell F, Howarth PH, Merrett TG, Mitchell EB, Walshaw MJ, Warner JO, Warner JA, Woodcock AA. The control of allergens of dust mites and domestic pets: a position paper. Clin Exp Allergy 1992; 22(suppl 2): 1-28.&lt;/p&gt;" NOTES_MODIFIED="2008-07-28 11:05:48 +0100" NOTES_MODIFIED_BY="Toby J Lasserson" TYPE="JOURNAL_ARTICLE">
<AU>Colloff MJ, Ayres J, Carswell F, Howarth PH, Merrett TG, Mitchell EB, et al</AU>
<TI>The control of allergens of dust mites and domestic pets: a position paper</TI>
<SO>Clinical and Experimental Allergy</SO>
<YR>1992</YR>
<VL>22</VL>
<NO>Suppl 2</NO>
<PG>1-28</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Custovic-1998" MODIFIED="2008-07-28 11:05:48 +0100" MODIFIED_BY="Toby J Lasserson" NAME="Custovic 1998" TYPE="JOURNAL_ARTICLE">
<AU>Custovic A, Simpson A, Chapman MD, Woodcock A</AU>
<TI>Allergen avoidance in the treatment of asthma and atopic disorders</TI>
<SO>Thorax</SO>
<YR>1998</YR>
<VL>53</VL>
<PG>63-72</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-G_x00f8_tzsche-1990" MODIFIED="2008-07-28 11:05:48 +0100" MODIFIED_BY="Toby J Lasserson" NAME="Gøtzsche 1990" NOTES="&lt;p&gt;Gotzsche PC. Bias in double-blind trials (thesis). Dan Med Bull 1990;37:329-36.&lt;br&gt;&lt;/p&gt;" NOTES_MODIFIED="2008-07-28 11:05:48 +0100" NOTES_MODIFIED_BY="Toby J Lasserson" TYPE="JOURNAL_ARTICLE">
<AU>Gøtzsche PC</AU>
<TI>Bias in double-blind trials (thesis)</TI>
<SO>Danish Medical Bulletin</SO>
<YR>1990</YR>
<VL>37</VL>
<PG>329-36</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-G_x00f8_tzsche-2003" MODIFIED="2008-07-28 11:05:48 +0100" MODIFIED_BY="Toby J Lasserson" NAME="Gøtzsche 2003" TYPE="JOURNAL_ARTICLE">
<AU>Gøtzsche PC, Johansen HK, Burr M</AU>
<TI>Are encasings effective in asthma caused by house dust mite allergens (letter)?</TI>
<SO>Journal of Allergy &amp; Clinical Immunology</SO>
<YR>2003</YR>
<VL>112</VL>
<PG>220</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-G_x00f8_tzsche-2006" MODIFIED="2008-07-28 11:05:48 +0100" MODIFIED_BY="Toby J Lasserson" NAME="Gøtzsche 2006" TYPE="JOURNAL_ARTICLE">
<AU>Gøtzsche PC</AU>
<TI>Believability of relative risks and odds ratios in abstracts: cross-sectional study</TI>
<SO>BMJ</SO>
<YR>2006</YR>
<VL>333</VL>
<PG>231-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-G_x00f8_tzsche-2008a" MODIFIED="2011-07-12 19:10:21 +0100" MODIFIED_BY="[Empty name]" NAME="Gøtzsche 2008a" TYPE="JOURNAL_ARTICLE">
<AU>Gøtzsche PC</AU>
<TI>Asthma guidelines on house dust mites are not evidence-based</TI>
<SO>Lancet</SO>
<YR>2008</YR>
<VL>370</VL>
<PG>2100-1</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-G_x00f8_tzsche-2008b" MODIFIED="2011-07-12 19:27:02 +0100" MODIFIED_BY="[Empty name]" NAME="Gøtzsche 2008b" TYPE="JOURNAL_ARTICLE">
<AU>Gøtzsche PC, Johansen HK</AU>
<TI>House dust mite control measures for asthma: systematic review</TI>
<SO>Allergy</SO>
<YR>2008</YR>
<VL>63</VL>
<PG>646-59</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2008" MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" NAME="Higgins 2008" TYPE="BOOK">
<AU>Higgins JPT, Green S, editors</AU>
<SO>Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008]</SO>
<YR>2008 (Available from www.cochrane-handbook.org)</YR>
<PB>The Cochrane Collaboration</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ihre-1988" MODIFIED="2008-07-28 11:05:48 +0100" MODIFIED_BY="Toby J Lasserson" NAME="Ihre 1988" NOTES="&lt;p&gt;Ihre E, Axelsson IGK, Zetterstr&amp;#246;m O. Late asthmatic reactions and bronchial variability after challenge with low doses of allergen. Clin Allergy 1988; 18: 557-567.&lt;/p&gt;" NOTES_MODIFIED="2008-07-28 11:05:48 +0100" NOTES_MODIFIED_BY="Toby J Lasserson" TYPE="JOURNAL_ARTICLE">
<AU>Ihre E, Axelsson IGK, Zetterström O</AU>
<TI>Late asthmatic reactions and bronchial variability after challenge with low doses of allergen</TI>
<SO>Clinical Allergy</SO>
<YR>1988</YR>
<VL>18</VL>
<PG>557-67</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ihre-1993" MODIFIED="2008-07-28 11:05:48 +0100" MODIFIED_BY="Toby J Lasserson" NAME="Ihre 1993" NOTES="&lt;p&gt;Ihre E, Zetterstrom O. Increase in non-specific bronchial responsiveness after repeated inhalation of low doses of allergen. Clin Exp Allergy 1993; 23: 298-305.&lt;/p&gt;" NOTES_MODIFIED="2008-07-28 11:05:48 +0100" NOTES_MODIFIED_BY="Toby J Lasserson" TYPE="JOURNAL_ARTICLE">
<AU>Ihre E, Zetterstrom O</AU>
<TI>Increase in non-specific bronchial responsiveness after repeated inhalation of low doses of allergen</TI>
<SO>Clinical &amp; Experimental Allergy</SO>
<YR>1993</YR>
<VL>23</VL>
<PG>298-305</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Mitka-2008" MODIFIED="2011-07-12 19:20:32 +0100" MODIFIED_BY="[Empty name]" NAME="Mitka 2008" TYPE="JOURNAL_ARTICLE">
<AU>Mitka M</AU>
<TI>New evidence-based guidelines focus on treatment of children with asthma</TI>
<SO>JAMA</SO>
<YR>2008</YR>
<VL>299</VL>
<PG>1122-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Naspitz-1997" MODIFIED="2008-07-28 11:05:48 +0100" MODIFIED_BY="Toby J Lasserson" NAME="Naspitz 1997" NOTES="&lt;p&gt;Naspitz CK, Diniz C, Rizzo MC, Fernandez-Caldas E, Sole D. Human scalps as a reservoir of domestic mites. Lancet 1997; 349: 404.&lt;/p&gt;" NOTES_MODIFIED="2008-07-28 11:05:48 +0100" NOTES_MODIFIED_BY="Toby J Lasserson" TYPE="JOURNAL_ARTICLE">
<AU>Naspitz CK, Diniz C, Rizzo MC, Fernandez-Caldas E, Sole D</AU>
<TI>Human scalps as a reservoir of domestic mites</TI>
<SO>Lancet</SO>
<YR>1997</YR>
<VL>349</VL>
<PG>404</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Platts_x002d_Mills-1989" MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" NAME="Platts-Mills 1989" NOTES="&lt;p&gt;Dust mite allergens and asthma - A worldwide problem. Report of an international workshop. J Allergy Clin Immunol 1989; 83: 416-427.&lt;/p&gt;" NOTES_MODIFIED="2011-08-10 12:11:04 +0100" NOTES_MODIFIED_BY="Emma J Welsh" TYPE="JOURNAL_ARTICLE">
<AU>Dust mite allergens and asthma - a worldwide problem</AU>
<TI>Report of an international workshop</TI>
<SO>Journal of Allergy &amp; Clinical Immunology</SO>
<YR>1989</YR>
<VL>83</VL>
<PG>416-27</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Schmidt-2005" MODIFIED="2008-07-28 11:05:49 +0100" MODIFIED_BY="Toby J Lasserson" NAME="Schmidt 2005" NOTES="&lt;p&gt;Schmidt LM, Gotzsche PC. Of mites and men: reference bias in narrative review articles: a systematic review. J Fam Pract 2005; 54(4):334-8.&lt;/p&gt;" NOTES_MODIFIED="2008-07-28 11:05:49 +0100" NOTES_MODIFIED_BY="Toby J Lasserson" TYPE="JOURNAL_ARTICLE">
<AU>Schmidt LM, Gøtzsche PC</AU>
<TI>Of mites and men: reference bias in narrative review articles: a systematic review</TI>
<SO>Journal of Family Practice</SO>
<YR>2005</YR>
<VL>54</VL>
<NO>4</NO>
<PG>334-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Tovey-1992" MODIFIED="2008-07-28 11:05:48 +0100" MODIFIED_BY="Toby J Lasserson" NAME="Tovey 1992" NOTES="&lt;p&gt;Tovey ER. Allergen exposure and control. [Review] Experimental &amp;amp; Applied Acarology 1992; 16: 181-202.&lt;/p&gt;" NOTES_MODIFIED="2008-07-28 11:05:48 +0100" NOTES_MODIFIED_BY="Toby J Lasserson" TYPE="JOURNAL_ARTICLE">
<AU>Tovey ER</AU>
<TI>Allergen exposure and control</TI>
<SO>Experimental &amp; Applied Acarology</SO>
<YR>1992</YR>
<VL>16</VL>
<PG>181-202</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-US-Guidelines-2007" MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" NAME="US Guidelines 2007" TYPE="OTHER">
<AU>National Heart, Lung, and Blood Institute; National Asthma Education and Prevention Program</AU>
<TI>Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma</TI>
<SO>US Department of Health</SO>
<YR>2007</YR>
<PG>http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm (accessed 13 September 2007)</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-US_x002f_Europe-Guidelines-2008" MODIFIED="2011-08-09 17:53:30 +0100" MODIFIED_BY="[Empty name]" NAME="US/Europe Guidelines 2008" TYPE="JOURNAL_ARTICLE">
<AU>Bacharier LB, Boner A, Carlsen KH, Eigenmann PA, Frischer T, Götz M, et al</AU>
<TI>Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report</TI>
<SO>Allergy</SO>
<YR>2008</YR>
<VL>63</VL>
<PG>5-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-van-Schayck-2007" MODIFIED="2011-07-20 08:44:03 +0100" MODIFIED_BY="[Empty name]" NAME="van Schayck 2007" TYPE="JOURNAL_ARTICLE">
<AU>van Schayck OCP, Maas T, Kaper J, Knotterus AJA, Sheikh A</AU>
<TI>Is there any role for allergen avoidance in the primary prevention of childhood asthma?</TI>
<SO>Journal of Allergy and Clinical Immunology</SO>
<YR>2007</YR>
<VL>119</VL>
<PG>1323-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Vervloet-1990" MODIFIED="2008-07-28 11:05:48 +0100" MODIFIED_BY="Toby J Lasserson" NAME="Vervloet 1990" TYPE="JOURNAL_ARTICLE">
<AU>Vervloet D, van der Brempt X, Charpin D, Birnbaum J</AU>
<TI>Immunotherapy in allergic respiratory diseases [Review]</TI>
<SO>Lung</SO>
<YR>1990</YR>
<VL>168 Suppl</VL>
<PG>1013-24</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2011-07-29 14:54:51 +0100" MODIFIED_BY="Emma J Welsh">
<REFERENCE ID="REF-G_x00f8_tzsche-1998" MODIFIED="2008-07-28 11:05:48 +0100" MODIFIED_BY="Toby J Lasserson" NAME="Gøtzsche 1998" TYPE="JOURNAL_ARTICLE">
<AU>Gøtzsche PC, Hammarquist C, Burr M</AU>
<TI>House dust mite control measures in the management of asthma: meta-analysis</TI>
<SO>BMJ</SO>
<YR>1998</YR>
<VL>317</VL>
<PG>1105-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-G_x00f8_tzsche-2001" NAME="Gøtzsche 2001" TYPE="COCHRANE_REVIEW">
<AU>Gøtzsche PC, Johansen HK, Burr ML, Hammarquist C</AU>
<TI>House dust mite control measures for asthma</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2001</YR>
<NO>3</NO>
<PB>Update Software</PB>
<CY>Oxford</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-G_x00f8_tzsche-2004" MODIFIED="2011-07-20 14:28:34 +0100" MODIFIED_BY="[Empty name]" NAME="Gøtzsche 2004" NOTES="&lt;p&gt;Gotzsche PC, Johansen HK, Schmidt LM, Burr ML. House dust mite control measures for asthma. Cochrane Database Syst Rev 2004; (4):CD001187.&lt;/p&gt;" NOTES_MODIFIED="2011-07-20 14:28:34 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="COCHRANE_REVIEW">
<AU>Gotzsche PC, Johansen HK, Schmidt LM, Burr ML</AU>
<TI>House dust mite control measures for asthma</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2004</YR>
<NO>4</NO>
<IDENTIFIERS MODIFIED="2011-07-20 14:28:34 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-07-20 14:28:34 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD001187.pub2"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-G_x00f8_tzsche-2008" MODIFIED="2011-07-20 14:28:28 +0100" MODIFIED_BY="[Empty name]" NAME="Gøtzsche 2008" NOTES="&lt;p&gt;Gotzsche PC, Johansen HK, Schmidt LM, Burr ML. House dust mite control measures for asthma. Cochrane Database Syst Rev 2004; (4):CD001187.&lt;/p&gt;" NOTES_MODIFIED="2011-07-20 14:28:28 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="COCHRANE_REVIEW">
<AU>Gotzsche PC, Johansen HK</AU>
<TI>House dust mite control measures for asthma</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2008</YR>
<NO>2</NO>
<IDENTIFIERS MODIFIED="2011-07-20 14:28:28 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-07-20 14:28:28 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD001187.pub3"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Hammarquist-1998" MODIFIED="2011-07-29 14:54:51 +0100" MODIFIED_BY="Emma J Welsh" NAME="Hammarquist 1998" TYPE="COCHRANE_REVIEW">
<AU>Hammarquist C, Burr ML, Gøtzsche PC</AU>
<TI>House dust mites and control measures in the management of asthma</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>1998</YR>
<NO>3</NO>
<PB>Update Software</PB>
<CY>Oxford</CY>
<IDENTIFIERS/>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2011-08-15 09:45:33 +0100" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2011-08-15 09:45:33 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2011-08-10 11:46:20 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Antonicelli-1991">
<CHAR_METHODS MODIFIED="2011-08-10 11:46:13 +0100" MODIFIED_BY="Emma J Welsh">
<P>Cross-over trial<BR/>Randomisation method: not described<BR/>Not blind (apart from PD20)<BR/>Physical</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-08-10 11:46:16 +0100" MODIFIED_BY="Emma J Welsh">
<P>N = 9 (9 in analyses)<BR/>Mean age 16 years (range 10 to 28)<BR/>Skin positive to D pter and D far</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-08-10 11:46:19 +0100" MODIFIED_BY="Emma J Welsh">
<P>Test: HEPA-filter (Enviracaire) in bedroom for 8 weeks<BR/>Control: none<BR/>Each period lasted 8 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-08-10 11:46:20 +0100" MODIFIED_BY="Emma J Welsh">
<P>Daily symptom score (scale 0 to 3), medication score, FEV1, PEFR morning and evening, PD20</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>No reduction in mite allergens (ELISA). Additional data from author. For asthma symptoms, we selected daytime wheeze blindly as the most relevant variable (other variables yielded closely similar results). Medication usage: salbutamol. FEV1 and PEFR from Table 2.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-08-10 11:46:27 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Bahir-1997">
<CHAR_METHODS MODIFIED="2011-08-10 11:46:22 +0100" MODIFIED_BY="Emma J Welsh">
<P>Randomisation method: not described<BR/>Double-blind<BR/>Chemical</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-08-10 11:46:25 +0100" MODIFIED_BY="Emma J Welsh">
<P>N = 40 children (30 in analyses)<BR/>Age range 6 to 17 years<BR/>Skin positive to D pter and/or D far</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-08-10 11:46:27 +0100" MODIFIED_BY="Emma J Welsh">
<P>Test: acaricide (esdepallethin 0.9% and piperonyl butoxide 7.2%)<BR/>Control: placebo (and a third control group)<BR/>6 months</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-08-10 11:46:27 +0100" MODIFIED_BY="Emma J Welsh">
<P>Daily symptom score, use of beta-2 agonists, FEV1, morning and evening PEFR, Acarex test</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>No reduction in mite allergens (guanine determination). The authors' fig. 3 indicates SEM which must be an error, should have been SD as for other data.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-08-10 11:46:35 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Burr-1976">
<CHAR_METHODS MODIFIED="2011-08-10 11:46:29 +0100" MODIFIED_BY="Emma J Welsh">
<P>Cross-over trial<BR/>Randomisation method: not described<BR/>Not blind<BR/>Physical</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-08-10 11:46:31 +0100" MODIFIED_BY="Emma J Welsh">
<P>N = 32 (32 in analyses)<BR/>Mean age: 33 years<BR/>Positive skin tests to D pter</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-08-10 11:46:34 +0100" MODIFIED_BY="Emma J Welsh">
<P>Test: initial vacuum-cleaning of the bed and laundering; enclosure of the mattress with a plastic cover for 6 weeks<BR/>Control: no such interventions</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-08-10 11:46:34 +0100" MODIFIED_BY="Emma J Welsh">
<P>Medication used during the past 24 hours, morning PEFR</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-08-10 11:46:35 +0100" MODIFIED_BY="Emma J Welsh">
<P>No assessment of mite reduction. Data from Table II</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-08-10 11:46:42 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Burr-1980A">
<CHAR_METHODS MODIFIED="2011-08-10 11:46:36 +0100" MODIFIED_BY="Emma J Welsh">
<P>Randomisation method: not described<BR/>Blind assessment<BR/>Physical</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-08-10 11:46:38 +0100" MODIFIED_BY="Emma J Welsh">
<P>N = 55 children (53 in analyses)<BR/>Age range 5 to 14 years<BR/>Skin positive to D pter</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-08-10 11:46:41 +0100" MODIFIED_BY="Emma J Welsh">
<P>Test: visited by a nurse, extensive scheme with vacuum-cleaning, laundering, beating in open air, removal of toys, etc.<BR/>Placebo: visited by a nurse, given a placebo treatment that consisted mainly of removal of dust in the living-room<BR/>8 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-08-10 11:46:42 +0100" MODIFIED_BY="Emma J Welsh">
<P>Numbers improved, PEFR morning and evening<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>No reduction in mite counts or mite antigen. Numbers improved: much better or better from Table 3. Peak flow was measured as coefficient of variation and was therefore omitted (very similar results were obtained in test and control groups).</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-08-10 11:46:48 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Burr-1980B">
<CHAR_METHODS MODIFIED="2011-08-10 11:46:44 +0100" MODIFIED_BY="Emma J Welsh">
<P>Cross-over<BR/>Randomisation method: not described<BR/>Not blind<BR/>Physical</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-08-10 11:46:45 +0100" MODIFIED_BY="Emma J Welsh">
<P>N = 21 children from trial <LINK REF="STD-Burr-1980A" TYPE="STUDY">Burr 1980A</LINK> who still complained of symptoms</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-08-10 11:46:47 +0100" MODIFIED_BY="Emma J Welsh">
<P>Test: new sleeping bag, pillow and blanket, mattress enclosed in an impervious plastic bag, other bedding enclosed or renewed, vacuum-cleaning of carpets in the bedroom<BR/>Control: as in <LINK REF="STD-Burr-1980A" TYPE="STUDY">Burr 1980A</LINK>
<BR/>Each period lasted 1 month</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-08-10 11:46:48 +0100" MODIFIED_BY="Emma J Welsh">
<P>Mothers asked whether the patients were better during test or control period, PEFR morning and evening</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>No reduction in mite counts. Peak flow was measured as coefficient of variation and therefore omitted (very similar results were obtained in test and control period).</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-08-10 11:46:54 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Carswell-1996">
<CHAR_METHODS MODIFIED="2011-08-10 11:46:49 +0100" MODIFIED_BY="Emma J Welsh">
<P>Randomisation method: not described<BR/>Double-blind<BR/>Combination</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-08-10 11:46:51 +0100" MODIFIED_BY="Emma J Welsh">
<P>N = 70 children (49 in analyses)<BR/>Mean age 9.9 years<BR/>Positive skin test D pter</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-08-10 11:46:53 +0100" MODIFIED_BY="Emma J Welsh">
<P>Test: Acarosan powder and foam, Medivac filter vacuum cleaner, allergen exclusion covers, bed linen washed weekly at 60 degrees C<BR/>Control: chalk dust and water spray, cotton placebo covers, bed linen washed weekly at 40 degrees C<BR/>24 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-08-10 11:46:54 +0100" MODIFIED_BY="Emma J Welsh">
<P>Numbers improved (no. randomised minus no. with symptoms in Fig. 5 minus no. without symptoms at baseline), asthma symptoms, medication usage, PEFR measured in 4 different 2-week periods, FEV1 (only reported after 24 weeks), PC20</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Mite antigen level (ELISA) fell in bedding. Data reported after 2, 6 and 24 weeks. FEV was only reported after 24 weeks. We used 6 weeks data for PEFR which was only reported accurately at this time (house dust mite removal was most effective after 6 weeks and there was a significant effect in bronchial sensitivity after 6 weeks, but not after 24 weeks).</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-08-10 11:46:58 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Chang-1996">
<CHAR_METHODS MODIFIED="2011-08-10 11:46:55 +0100" MODIFIED_BY="Emma J Welsh">
<P>Randomisation method: not described<BR/>Not blind<BR/>Chemical</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-08-10 11:46:56 +0100" MODIFIED_BY="Emma J Welsh">
<P>N = 26 (11 children and 15 adults, 26 in analyses)<BR/>Positive skin test to mite allergen</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-08-10 11:46:57 +0100" MODIFIED_BY="Emma J Welsh">
<P>Test: acaricide (Acarosan) to mattresses and carpets in bedroom<BR/>Control: no acaricide<BR/>3 months</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-08-10 11:46:57 +0100" MODIFIED_BY="Emma J Welsh">
<P>Daily symptoms, medication, FEV1, morning and evening PEFR, PC20</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-08-10 11:46:58 +0100" MODIFIED_BY="Emma J Welsh">
<P>No mite antigen reduction (ELISA)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-08-10 11:47:02 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Charpin-1990">
<CHAR_METHODS MODIFIED="2011-08-10 11:46:59 +0100" MODIFIED_BY="Emma J Welsh">
<P>Randomisation method: table provided by laboratory<BR/>Double-blind<BR/>Chemical</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-08-10 11:47:01 +0100" MODIFIED_BY="Emma J Welsh">
<P>N = 42 (11 only had rhinitis)<BR/>Numbers in analyses not clear<BR/>Mean age 27 years<BR/>Positive skin prick test</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-08-10 11:47:01 +0100" MODIFIED_BY="Emma J Welsh">
<P>Test: Acardust (synthetic pyrethrinoid + piperonyl butoxide) sprayed once on bed linen and in room<BR/>Control: no acaricide<BR/>3 months</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-08-10 11:47:02 +0100" MODIFIED_BY="Emma J Welsh">
<P>Global assessment by patient and doctor, morning and evening PEFR, number of attacks</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-08-10 11:47:02 +0100" MODIFIED_BY="Emma J Welsh">
<P>Reduction in mite allergen. No data on dispersion (PEFR in the morning was 435 in the test group, 437 in the control group; doctor's global assessment was 3.1 versus 2.8 on a 10 cm analogue scale).</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-08-10 11:47:05 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Chen-1996">
<CHAR_METHODS MODIFIED="2011-08-10 11:47:02 +0100" MODIFIED_BY="Emma J Welsh">
<P>Randomisation method: not described.<BR/>Double-blind<BR/>Physical</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-08-10 11:47:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>N = 56 (35 in analyses)<BR/>Age range 5 to 14 years<BR/>Positive to DP1</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-08-10 11:47:05 +0100" MODIFIED_BY="Emma J Welsh">
<P>Test: Microstop (impermeable polyurethane-coated nylon ticking)<BR/>Control: new, conventional polyurethane mattresses (there was a second control group as well)<BR/>12 months</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-08-10 11:47:05 +0100" MODIFIED_BY="Emma J Welsh">
<P>Asthma symptoms and morning and evening PEFR</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>No reduction in mite counts. Odd that randomisation leads to 29, 29 and 15 patients. Two exclusions unclear, we allocated one to each group.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-08-10 11:47:10 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Cinti-1996">
<CHAR_METHODS MODIFIED="2011-08-10 11:47:06 +0100" MODIFIED_BY="Emma J Welsh">
<P>Randomisation method: sealed opaque envelopes<BR/>Double-blind<BR/>Physical<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-08-10 11:47:09 +0100" MODIFIED_BY="Emma J Welsh">
<P>N = 20 (20 in analyses)<BR/>Mean age 30 years (range 10 to 69)<BR/>RAST or skin test positive for D pter or D far</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-08-10 11:47:10 +0100" MODIFIED_BY="Emma J Welsh">
<P>Test: "mite-proof" mattress and pillow covers<BR/>Placebo: covers of cotton<BR/>12 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-08-10 11:47:10 +0100" MODIFIED_BY="Emma J Welsh">
<P>Daily symptom scores, number of acute episodes, medications, eosinophil cationic protein, PEFR</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>No assessment of mite counts. Additional data supplied by author.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-08-10 11:47:14 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Cloosterman-1999">
<CHAR_METHODS MODIFIED="2011-08-10 11:47:11 +0100" MODIFIED_BY="Emma J Welsh">
<P>Randomisation method: statistician informed investigators, open list of random numbers, open to investigators<BR/>Blind to patient and technician<BR/>Combination</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-08-10 11:47:12 +0100" MODIFIED_BY="Emma J Welsh">
<P>N = 204 (157 in analyses)<BR/>Mean age 33 years (range 16 to 60)<BR/>Mite sensitivity diagnosed at an allergy laboratory</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-08-10 11:47:13 +0100" MODIFIED_BY="Emma J Welsh">
<P>Test: Acarosan and mite impermeable covers for mattresses<BR/>Control: water and cotton covers<BR/>20 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-08-10 11:47:14 +0100" MODIFIED_BY="Emma J Welsh">
<P>Asthma symptoms, medication use, FEV1, morning and evening PEFR, PC20</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-07-29 14:08:14 +0100" MODIFIED_BY="Emma J Welsh">
<P>Mite antigen reduction achieved (ELISA). Table 2 and fig 4 and 5 used for data on symptoms and peak flow.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-08-10 11:47:19 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-de-Vries-2007">
<CHAR_METHODS MODIFIED="2011-08-10 11:47:16 +0100" MODIFIED_BY="Emma J Welsh">
<P>Randomisation method: "randomisation list", "patients were assigned according to the number on the list, in sequence of inclusion"<BR/>Double-blind: placebo covers were indistinguishable<BR/>Physical<BR/>Intention-to-treat (last observation carried forward)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-08-10 11:47:17 +0100" MODIFIED_BY="Emma J Welsh">
<P>N = 143 (105 completed 2 years)<BR/>Mean age 42 years (SD 12)<BR/>Mite sensitivity: RAST</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-08-10 11:47:17 +0100" MODIFIED_BY="Emma J Welsh">
<P>Test: impermeable mattress, duvet and pillow covers<BR/>Placebo: permeable covers<BR/>2 years</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-08-10 11:47:18 +0100" MODIFIED_BY="Emma J Welsh">
<P>Asthma symptoms, medication use, morning and evening PEFR</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-08-10 11:47:19 +0100" MODIFIED_BY="Emma J Welsh">
<P>Mite antigen reduction achieved, down to about 10% of placebo group levels (ng allergen per square metre). No data for PEFR provided, only P = 0.52 for difference. Funded partly by 2 drug companies.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-08-15 09:42:17 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Dharmage-2006">
<CHAR_METHODS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Randomisation method: "permuted blocks of size two", "randomized...by the toss of a coin"<BR/>Double-blind: "identically-appearing " placebo covers<BR/>Physical</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>N = 32 (30 in analyses)<BR/>Mean age 32 years (SD 6.3)<BR/>Positive skin test</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-08-15 09:42:17 +0100" MODIFIED_BY="[Empty name]">
<P>Test: impermeable mattress, doona and pillow covers<BR/>Placebo: permeable covers<BR/>6 months</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Asthma symptoms, medication use, FEV1, PEFR morning and evening, quality of life, time spent home, log PD20</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Reduction in mite allergens. Only data after 3 months, and none for FEV1 or PEFR. Data reported inadequately for meta-analysis, apart from log PD20.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Dietemann-1993">
<CHAR_METHODS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Randomisation method: not described<BR/>Double-blind<BR/>Chemical</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>N = 26 (23 in analyses)<BR/>Mean age 35 years (range 13 to 58)<BR/>Positive skin test to D pter, RAST positive</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Test: solidified benzyl benzoate and tenside agents at the beginning and after 6 months<BR/>Control: placebo powder<BR/>1 year</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Asthma symptoms (VAS 0 to 10), medication score (0 to 3), FEV1, FVC, FEF25-75, PEFR morning and evening, clinical score (0 to 4)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>No reduction in mite allergens (guanine determination and ELISA). Values after treatment calculated from percentage change and baseline values. SDs calculated from confidence intervals at baseline, assuming they were the same after treatment, which is reasonable, based on other trials.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Dorward-1988">
<CHAR_METHODS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Randomisation method: not described<BR/>Blinded assessment<BR/>Combination</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>N = 21 (18 in analyses)<BR/>Age range 13 to 53 years<BR/>Positive skin tests to D pter</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Test: liquid nitrogen, vacuum-cleaning, other cleaning, washing, airing, damp dusting; plants, soft toys, cushions and upholstered furniture removed<BR/>Control: normal cleaning activities<BR/>8 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Asthma symptom score (VAS 0 to 10), daily number of puffs of salbutamol, PEFR morning and evening, PC20, S-IgE.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Mite counts significantly reduced. For PC20, we used the logarithmic values for the means from Table 2 and calculated their SDs from Fig. 2.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Ehnert-1992">
<CHAR_METHODS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Randomisation method: not described<BR/>Test 1: double-blind, chemical<BR/>Test 2: not blind, combination</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>N = 24, 8 in each group (21 in analyses)<BR/>Age range 7 to 15 years<BR/>Skin positive D pter and D far positive serum IgE</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Test 1: mattresses treated with benzyl benzoate, carpets treated with powder on day 0 and after 4 and 8 months. Vacuum-cleaning after 4 hours<BR/>Test 2: polyurethane mattress covers and tannic acid 3% on carpets<BR/>Control: placebo foam<BR/>1 year</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>PC20</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>No reduction in mite allergens (ELISA). A within-group significant change was reported for the encasing group for PC20, but the time trends for the 3 groups were not compared. As the control group was used for both comparisons in the meta-analysis graph, its number of patients were split in half, one half being used in each analysis.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-08-15 09:45:33 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Fang-2001">
<CHAR_METHODS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Randomisation method: not described<BR/>Not blind<BR/>Physical</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-08-15 09:45:33 +0100" MODIFIED_BY="[Empty name]">
<P>N = 43 (not clear whether more were randomised)<BR/>Age 37 (SD 20)<BR/>Skin positive for <I>Dermatophagoides</I>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Test: washing bedclothes and clothes, sun exposure and ventilation<BR/>Control: untreated<BR/>2 years</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Asthma symptoms, medication use, PEFR morning and evening</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Mite reduction claimed (P &lt; 0.001). Reduction in IgE also claimed (P &lt; 0.001) which is surprising.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Frederick-1997">
<CHAR_METHODS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Cross-over<BR/>Randomisation method: not described<BR/>Single-blind<BR/>Physical</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>N = 31<BR/>Children aged 5 to 15 years<BR/>Positive skin prick test and/or IgE<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Test: covers (Intervent) for mattress, duvet and pillow, wiped down weekly<BR/>Control: polycotton covers<BR/>Each period lasted 3 months</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Asthma symptoms, medication use (bronchodilators), FEV1, PEFR morning and evening, PC20</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Reduction in mite allergens. No useful data (medians and ranges), PEFR in the morning was 257 versus 282.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Geller_x002d_Bernst-1995">
<CHAR_METHODS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Randomisation method: not described<BR/>Double-blind<BR/>Combination</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>N = 32 (14 in most analyses)<BR/>Age range 4 to 12 years<BR/>Positive skin tests only to house dust mites</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Test: change of bed sheet and blanket, dust removal with damp cloth, vacuuming of carpets and furniture, sprays on day 0 and 90 with Acardust<BR/>Control: placebo spray<BR/>6 months</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Asthma symptoms (0 to 3), medication use, FEV1, PEFR, doctor's and patient's opinion of clinical symptoms, serum IgE</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>No reduction in mite allergens. No useful data.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Ghazala-2004">
<CHAR_METHODS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Randomisation method: not described, "Studienunabhängige Person"<BR/>Double-blind, no details<BR/>Physical</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>N = 17 (12 in analyses)<BR/>Cross-over trial<BR/>Age not stated for asthma patients<BR/>Positive skin prick test and positive IgE</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Test: covers (VarioProtect) for mattress, washed weekly<BR/>Control: cotton covers<BR/>Each period lasted 9 to 11 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Asthma symptoms, medication use</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-08-09 15:53:44 +0100" MODIFIED_BY="[Empty name]">
<P>Unclear whether reduction in mite allergens. No data on medication use. Figure shows exactly the same asthma score, but authors claim that P = 0.025. Not clear what the box plot symbols mean. Data unusable for meta-analysis.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Gillies-1987">
<CHAR_METHODS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Randomisation method: not described<BR/>Not blind<BR/>Physical</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>N = 26 (25 in analyses)<BR/>Age range 6 to 16 years<BR/>Skin positive D pter</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Test: enclosing of mattresses and pillows, pets and soft toys excluded from bedroom, synthetic bedding employed, damp dusting, vacuum-cleaning<BR/>Control: no such measures<BR/>6 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Asthma symptoms, medication requirements, PEFR morning and evening, PC20, serum IgE</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>No reduction in mite counts<BR/>PC20 values omitted since they were calculated arithmetically. No useful data.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Halken-2003">
<CHAR_METHODS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Randomisation method: computer program, stratified by 4 factors<BR/>Described as double-blind, but the covers were different<BR/>Physical</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>N = 60 (47 in analyses)<BR/>Children aged 5 to 15 years<BR/>Positive skin prick test</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Test: mattress and pillow encasings coated with semi-permeable polyurethane (Allergy Control)<BR/>Controls: placebo encasings. 12 months</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Medication usage, FEV1, PEFR, asthma symptoms, PC20. Dose of inhaled steroids was reduced during the trial at lowest effective dose.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Reduction in mite allergens. Complicated randomisation, but no baseline imbalances according to individual patient data obtained from author. Symptom scores not used, as distribution was very far from being Gaussian.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Howarth-1992">
<CHAR_METHODS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Randomisation method: not described<BR/>Double-blind<BR/>Physical</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>N = 35 (number in analyses not reported, some had rhinitis)<BR/>Age 13 to 23 years<BR/>Positive skin prick test</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Test: covers of mattress, duvet and pillow<BR/>Control: placebo covers<BR/>6 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Asthma symptoms</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Very promising abstract, but never published and author did not respond to our letters</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Htut-2001">
<CHAR_METHODS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Randomisation method: open table of random numbers<BR/>Double-blind<BR/>Physical</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>N = 30 in trial report, N = 33 in previous abstract (23 in analyses)<BR/>Age 18 to 45 years<BR/>Positive skin prick test</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Test 1: steam-cleaning once of mattresses and duvets, and new pillows<BR/>Test 2: same treatment, but in addition, a ventilation system (Nuaire) was installed in bedrooms<BR/>Control: sham steam cleaning<BR/>1 year</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>PD20<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Reduction in mite allergens. We combined the 2 test groups for meta-analysis.<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Huss-1992">
<CHAR_METHODS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Randomisation method: not described<BR/>Not blind<BR/>Physical</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>N = 52 (52 in analyses)<BR/>Age range 18 to 75 years<BR/>Skin positive to D far or D pter</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Test: computer-assisted instruction in addition to conventional mite avoidance instruction (encasing mattresses, box springs and pillows, removing carpeting and upholstered furniture, laundering bedding, controlling indoor temperature (&lt; 70 degrees F) and humidity (&lt; 45% RH))<BR/>Control: verbal and written guidance<BR/>12 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Asthma symptoms, medication usage (inhaled bronchodilator use), FEV1</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Reduction in mite allergens (ELISA). Authors report that there was no difference for FEV1, but give no data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Jooma-1995">
<CHAR_METHODS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Randomisation method: open table of random numbers<BR/>Not blind<BR/>Combination</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>N = 60 (not all included in analyses, numbers not stated)<BR/>Children aged 6 to 14 years<BR/>Positive skin prick test</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Test 1: mattress and pillow covers (Allergy Control Products) + tannic acid to carpets every 8 weeks<BR/>Test 2: acaricide (benzyl benzoate + bromopol) applied to carpets and mattresses<BR/>Control: none<BR/>6 months</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>PC20</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>No reduction in mite allergens. No useable data, no significant changes in PC20.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Korsgaard-1983">
<CHAR_METHODS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Randomisation method: not described<BR/>Not blind<BR/>Physical</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>N = 51 (46 in analyses)<BR/>Median age 30 years<BR/>Positive skin prick test and IgE, and bronchial provocation test for mite extract</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Test: vacuum-cleaning and wash of bed linen twice-weekly, new synthetic quilts and pillows, bedroom aired for 20 minutes daily and permanently half-open window<BR/>Control: none<BR/>12 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>PEFR morning and evening, use of bronchodilator, asthma symptoms</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>No reduction in mite counts on mattress, but reduction on bedroom floor. Data presented as medians and interquartile ranges. Morning PEFR 490 versus 460 (P = 0.33), evening PEFR 490 for both groups (P = 0.82); less symptoms in test group (P = 0.02).</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Kroidl-1998">
<CHAR_METHODS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Randomisation method: sealed envelopes with consecutive numbers<BR/>Double-blind<BR/>Chemical</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>N = 118 (78 in analyses)<BR/>Age range 8 to 50 years<BR/>Skin test and RAST positive to D pter</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Test: acaricide, benzyl benzoate (Acarosan)<BR/>Control: cleaning product without acaricide<BR/>1 year</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Well-being, PC20, RAST, changes in skin prick test</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>No assessment of mite reduction. Drop-outs not described per group but provided by author: 18 versus 22 patients.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Lee-2003">
<CHAR_METHODS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Randomisation method: "assigned at random by coin tossing"<BR/>Not blind<BR/>Physical</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Conflicting information, see Notes<BR/>N = 42 in analyses<BR/>Age: most were above 30 years<BR/>Positive skin prick test and RAST</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Test: outer cotton bed covers, boiled 10 minutes, 3 hours sunlight every 14 days<BR/>Control: no intervention<BR/>4 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>PEFR morning and evening, frequency of 6 different asthma symptoms</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Two partly conflicting trial reports, the most recent does not quote the earlier one. No reduction in mite allergens. Frequency of 6 different asthma symptoms not used in our meta-analysis due to lack of a severity score and of an acceptable way of combining the data (SD far bigger than mean for most symptoms, i.e. a gross violation of the Gaussian assumption).</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Luczynska-2003">
<CHAR_METHODS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Randomisation method: statistical program generated a list of 1s and 2s where patient number were written; not adequately concealed as blinding could be broken<BR/>Double-blind<BR/>Physical</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>N = 58, only 45 started the trial, and only 31 in analyses<BR/>Age 18 to 54<BR/>Serum IgE &gt; 0.7 kU/L specific for mite antigen in all patients<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Test: allergen-impermeable Micro fibre bedcovers (Allerguard) on bed, blankets and pillows<BR/>Control: sham bedcovers<BR/>1 year<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>PEFR morning and evening, number of days with chest tightness, quality of life, asthma attacks and medication use</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>No reduction in mite allergens. Data not shown for medication use and asthma attacks. No significant differences in number of days with chest tightness and quality of life (the former favoured the test, the latter the control); data not entered in our meta-analysis as it is not straightforward how these 2 measures of asthma symptoms should be combined.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Maesen-1977">
<CHAR_METHODS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Cross-over trial<BR/>Randomisation method: unclear, a table of random numbers was used<BR/>Double-blind<BR/>Physical</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>N = 30 (28 in analyses)<BR/>25 adults (15 to 55 years) and 5 children (7 to 14 years)<BR/>Positive skin test and bronchial provocation test to house dust</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Test: air-filtration apparatus<BR/>Control: placebo (the filter was covered with plastic)<BR/>Each period lasted 1 month</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Subjective improvement, medication usage, PEFR morning and evening</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>No assessment of mite reduction</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Manjra-1994">
<CHAR_METHODS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Randomisation method: unclear, "system of random numbers" after matching for 3 factors<BR/>Not blind<BR/>Chemical</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>N = 60 (59 in analyses)<BR/>Children aged 5 to 12 years<BR/>Positive skin prick test</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Test 1: detergent (Metsan) for carpets and bedding<BR/>Test 2: Metsan + acaricide (Acarosan) for carpets and bedding<BR/>Control: none<BR/>3 months</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>PC20</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>No mite reduction in mattresses. PC20 given as medians, no difference between the groups. Patients not divided on treatment groups. The first author did not answer our letter.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Marks-1994">
<CHAR_METHODS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Randomisation method: not described<BR/>Blinded participants<BR/>Combination</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>N = 39 (35 in analyses)<BR/>Age range 13 to 60 years<BR/>All but 2 subjects had a positive skin test to D pter</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Test: tannic acid/acaricide solution (Allersearch) + impermeable covers on mattress, pillows and duvets<BR/>Control: inactive placebo spray<BR/>6 months</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Symptom score (0 to 10), FEV1, PEFR morning and evening, PD20</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>No reduction in mite allergens (ELISA). Values after treatment calculated from percentage change and baseline values. SDs calculated from confidence intervals at baseline, assuming they were the same after treatment, which is reasonable, based on other trials.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Matthys-1996">
<CHAR_METHODS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Cross-over trial<BR/>Randomisation method: not described<BR/>Single-blind (according to thesis)<BR/>Physical</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>N = 14 (10 to 14 in analyses)<BR/>Positive skin prick test</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Test: air-dryer in bedroom with water filter<BR/>Control: air-dryer in bedroom without water filter<BR/>Each period lasted 4 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Medication usage, PEFR, symptoms</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Significant difference with Acarex-test. Published only as an abstract. Data exist in a thesis, but significant carry-over and period effects for medication usage and PEFR precludes usage of the data.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Mitchell-1980">
<CHAR_METHODS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Cross-over trial<BR/>Randomisation method: not described<BR/>Not blind<BR/>Physical<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>N = 10 (10 in analyses)<BR/>Age range 7 to 14 years<BR/>Positive skin test to D pter and D far</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Test: electrostatic precipitator plus standard mite-avoidance measures<BR/>Control: standard mite-avoidance measures<BR/>Each period lasted 2 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Medication usage, PEFR 3 times a day</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>No assessment of mite reduction. Percent expected PEFR calculated from Table II. Numbers improved are omitted, since they are unclear.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Popplewell-2000">
<CHAR_METHODS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Randomisation method: not described<BR/>Not blind<BR/>Physical</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>N = 60 (51 in analyses)<BR/>Age: 5 to 15 years for 21 children and 22 to 63 years for 39 adults<BR/>Positive skin prick test<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Test: high efficiency vacuum cleaner (Electrolux Z1730 and Z5028)<BR/>Control: standard efficiency vacuum cleaner (Z1501 and Z2630)<BR/>1 year</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Medication usage, FEV1, PEFR morning and evening, PC20</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-07-20 18:43:37 +0100" MODIFIED_BY="Emma J Welsh">
<P>No reduction in mite allergens. First author funded by Electrolux. Non-parametric analysis was used but it is not clear what the reported data mean, i.e. whether they are medians, and the authors have only tested the data within groups which also hampers the interpretation. No useful data could be extracted for our meta-analysis.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Reiser-1990">
<CHAR_METHODS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Randomisation method: not described<BR/>Double-blind<BR/>Chemical</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>N = 51 (46 in analyses)<BR/>Age range 5 to 16 years<BR/>Positive skin test to D pter</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Test: mattresses sprayed every 2 weeks for 3 months with natamycin<BR/>Control: sprayed with placebo<BR/>3 months</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Asthma symptoms, medication usage, FEV1, PEFR 3 times a day, histamine bronchial provocation test</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>No reduction in mite allergens (ELISA). We used 3 months data, since the intervention was stopped at 3 months (the effect on PC20 was larger after 3 months than after 6 months).</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Rijssenbeek-2002">
<CHAR_METHODS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Randomisation method: Zelen design with consent after randomisation; method not described<BR/>Double-blind<BR/>Physical</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>N = 38 (30 in analyses; however, a separate publication from the same year describes only 27 patients in total)<BR/>Age range 11 to 44 years<BR/>Positive skin prick test or IgE</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Test: allergen-impermeable covers for mattress, pillow and bedding (Allergy Control)<BR/>Control: matching placebo covers<BR/>1 year</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>PEFR morning and evening, FEV1, asthma symptoms, medication use, PC20, quality of life</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Reduction in mite allergens. The study was published twice, both in 2002, with almost the same outcome measures and population, with no cross-references between the articles. Data exist on FEV1, but not published.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Sette-1994">
<CHAR_METHODS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Randomisation method: not described<BR/>Double-blind<BR/>Chemical</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>N = 24 (24 in analyses)<BR/>Mean age 13 years<BR/>Skin positive to D pter</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Test: treatment of mattresses with benzyl benzoate foam (Acarosan)<BR/>Control: placebo foam<BR/>Ca 2 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>PC20, serum IgE</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>No reduction in mite allergens (Acarex test). PC20 read from Fig. 2, weighted averages of the 2 exposure periods were used (1 was added to zero values to get a logarithmic value of zero).</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Shapiro-1999">
<CHAR_METHODS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Randomisation method: random number generation, sealed and opaque envelopes<BR/>Double-blind, but intervention frequency differs between the groups<BR/>Combination</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>N = 44 (36 in analyses)<BR/>Children 6 to 16 years<BR/>Positive skin prick test</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Test: dust-mite impermeable covers (Allergen Control Products), delivery of clean blankets and 4 sets of bed linens every month, tannic acid application to the bedroom and living room every month<BR/>Control: placebo tannic acid every 4 months and phone call reminders<BR/>1 year</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>FEV1, PEFR morning and evening, asthma symptoms, PD20, emergency department visits and admission to hospital, steroid courses</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Reduction in mite allergens. Author provided data on FEV1, but data for symptoms and peak flow were not useable.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Sheikh-2002">
<CHAR_METHODS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Randomisation method: centralised, using numbers generated from a random numbers table<BR/>Double-blind, with blinded data analysis<BR/>Physical</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>N = 47 (43 in analyses)<BR/>Children, aged 5 to 14 years<BR/>Positive skin prick test</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Test: mite impermeable covers (Allerayde Perfect)<BR/>Control: placebo covers<BR/>6 months</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>PEFR, asthma symptoms, night-time waking, use of medication, unscheduled visits to doctor, emergency department visits and admission to hospital (there were none), steroid courses</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Mite antigen levels were not measured. After 2 months, dosage of inhaled steroids could be reduced by 50%.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Sooltangos-1992">
<CHAR_METHODS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Randomisation method: "randomly divided into 2 age, sex and symptom-matched groups"<BR/>Not blind<BR/>Chemical</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>N = 33 (no information on possibly missing recordings)<BR/>Mean age 34 years<BR/>Positive skin prick test</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Test: cleaning and spraying mattresses with acaricide (benzyl benzoate + tannic acid) every 3 months<BR/>Control: none<BR/>8 months</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Asthma symptoms, PEFR, FEV1, medication usage</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Abstract only, authors could not be traced</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Thiam-1999">
<CHAR_METHODS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Randomisation method: not described<BR/>Not blind<BR/>Physical</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>N = 24 (24 in analyses)<BR/>Children, aged 6 to 14 years<BR/>Positive skin prick test or IgE<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Test 1: Allergen Control Covers (ACC) and Vellux blankets if own blankets not washed regularly<BR/>Test 2: HEPA filters (Enviracaire)<BR/>Control: none<BR/>4 months</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>FEV1, PEFR morning and evening, asthma symptoms, exercise broncho-provocation test</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>No reduction in mite allergens. Sponsored by Honeywell. No data shown for PEFR ("did not improve significantly"). We lumped the 2 active groups for the meta-analyses. The corresponding author did not answer our letters.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-van-den-Bemt-2004">
<CHAR_METHODS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Randomisation method: not described ("randomly allocated")<BR/>Double-blind<BR/>Physical<BR/>Intention-to-treat (as long as the patients participated)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>N = 52 (51 in some of the analyses)<BR/>Positive RAST</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Test: impermeable mattress, duvet and pillow covers<BR/>Placebo: permeable covers<BR/>9 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Asthma symptoms, PEFR morning and evening, medication use</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Mite antigen reduction of 87%. No useful data in trial report but data obtained from author on PEFR. Very few symptoms in both groups and skewed distribution precluded use in meta-analysis.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-van-der-Heide-1997A">
<CHAR_METHODS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Randomisation method: not clear whether randomised<BR/>Double-blind<BR/>Chemical</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>N = 59 (40 in analyses)<BR/>Mean age 31 years<BR/>SPT positive to D pter</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Test: Acarosan powder and foam on textile floors and mattresses<BR/>Control: Sapur (detergent) on textile floors and Groupriem (detergent) on mattresses<BR/>1 year</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>FEV1, PC20, serum total IgE</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>No reduction in mite allergens</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-van-der-Heide-1997B">
<CHAR_METHODS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Randomisation method: computer using minimisation (2 factors)<BR/>Double-blind<BR/>Physical</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>N = 30 (for relevant comparison; no information on possibly missing recordings)<BR/>Age range 18 to 45 years<BR/>Positive skin prick test</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Test 1: air-cleaners<BR/>Test 2: air-cleaners + mattress and pillow covers<BR/>Control: placebo air-cleaners + mattress and pillow covers<BR/>6 months</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>FEV1, PEFR morning and evening, PC20</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>No reduction in mite allergens. Supported by maker of air-cleaners. No data on FEV1 and PEFR and no useable data on PC20.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-van-der-Heide-1999">
<CHAR_METHODS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Cross-over<BR/>Randomisation method: computer using minimisation (2 factors)<BR/>Double-blind<BR/>Physical</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>N = 22 (20 in analyses)<BR/>Mean age 12 years<BR/>Positive IgE</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Test: air-cleaners<BR/>Control: placebo air-cleaners<BR/>Each period lasted 3 months</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Asthma symptoms, FEV1, PEFR morning and evening, PC20</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>No data on mite reduction. Supported by maker of air-cleaners. No data on FEV1 and PEFR and no useable data on PC20. Author provided additional data but only at baseline.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Verrall-1988">
<CHAR_METHODS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Cross-over trial<BR/>Randomisation method: not described<BR/>Double-blind<BR/>Physical</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>N = 16 (13 in analyses)<BR/>Mean age 14 years, range 7 to 27<BR/>Positive skin test to D pter</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Test: HEPA-filter in the bedroom at night<BR/>Control: non-use of HEPA-filter (foam plug)<BR/>There were 4 controlled trial phases of 3 weeks each</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Asthma symptoms, medication usage (analysed for the final 2 weeks of each 3-week period, allowing 1-week washout for each period), PEFR</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>No mite assessment. Medication use read from Fig. 5; no data on symptoms apart from average scores without SD (which did not favour the experimental treatment).</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Walshaw-1986">
<CHAR_METHODS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Randomisation method: not described<BR/>Not blind<BR/>Physical</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>N = 50 (42 in analyses)<BR/>Mean age 34 years<BR/>Positive skin test to D pter (but only 38 of the 50 were allergic)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Test: plastic mattress and pillow covers, vacuum-cleaning, damp dusting of the covers, synthetic or cotton blankets, washing and shaking, linoleum carpets<BR/>Control: no such measures<BR/>1 year</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Asthma symptom score, medication use, FEV1, PEFR, PC20, serum immunoglobulins, RAST to D pter</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Mite counts reduced</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Warburton-1994">
<CHAR_METHODS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Cross-over trial<BR/>Randomisation method: not described<BR/>Double-blind<BR/>Physical</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>N = 13 (12 in analyses)<BR/>Mean age 46 years (range 19 to 64)<BR/>Positive skin test to D pter</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Test: air filtration unit in the main living room<BR/>Control: placebo air filtration unit<BR/>Each period lasted 4 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Asthma symptom score (VAS), medication usage, frequency of nocturnal wakening, FEV1, PEFR twice daily, PD20</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>No reduction in mite allergens (ELISA)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Warner-1993">
<CHAR_METHODS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Cross-over trial<BR/>Randomisation method: not described<BR/>Double-blind<BR/>Physical</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>N = 20 (14 in analyses)<BR/>Age range 3 to 11 years<BR/>Positive skin test</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Test: ioniser (Clean Air)<BR/>Control: placebo<BR/>Each period lasted 6 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Asthma symptom score, medication usage, PEFR morning and evening</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Reduction in mite allergens (ELISA)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Warner-2000">
<CHAR_METHODS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Randomisation method: not described<BR/>Double-blind<BR/>Physical</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>N = 40<BR/>27 children aged 4 to 16 years and 13 adults aged 20 to 67 years<BR/>Positive skin prick test</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Test 1: mechanical ventilation system with heat recovery and high-efficiency vacuum cleaner<BR/>Test 2: mechanical ventilation system with heat recovery<BR/>Test 3: high-efficiency vacuum cleaner<BR/>Control: no intervention<BR/>12 months</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>PEFR morning and evening, FEV1, PC20, asthma symptoms, medication usage</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>No reduction in mite allergens. Ten homes that were unsuitable for ventilation system were randomised to test 3 or control. Numbers in each group not stated. No useable data in article.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Woodcock-2003">
<CHAR_METHODS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Randomisation method: co-ordination centre, using minimisation within each practice (3 factors)<BR/>Double-blind<BR/>Physical</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>N = 1122, N = 732 were mite sensitive (628 of these in analyses)<BR/>Mean age 36 years<BR/>Mite sensitisation: serum IgE</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Test: allergen-impermeable covers for mattress, pillow and quilt (Allergy Control Products)<BR/>Control: non-impermeable polyester-cotton covers<BR/>Duration 1 year, after 6 months, controlled reduction in steroid therapy. Dust sampled for mite allergens in a 10% random sample of participants.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>PEFR morning and evening, medication usage (beta-agonists), asthma symptoms, exacerbations and hospital visits, days of work missed, quality of life</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Reduction in mite allergens after 6 months. In accordance with the authors who used 6-month data for their power calculation, we used 6-month data for our meta-analysis as this part-investigated the effects of allergen reduction on asthma symptoms and was not confounded by the planned reduction of steroids.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Wright-2009">
<CHAR_METHODS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Random number generator, sequential blocks of 4, automated telephone-answering system</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>N = 119 (100 in analyses)<BR/>Age range 16 to 60 years<BR/>Positive skin test</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Test: mechanical heat recovery ventilation system</P>
<P>Control: placebo mechanical heat recovery ventilation system</P>
<P>Allergen eradication was carried out in all homes. Carpets were cleaned, new pillows, duvets and mattress covers were supplied to all participants.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Peak flow, asthma symptoms, medication usage, visits to hospital</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>18 major protocol violators (machine inadvertently turned on)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Zwemer-1973">
<CHAR_METHODS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Cross-over trial<BR/>Randomisation method: not described<BR/>Double-blind<BR/>Physical</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>N = 18 (12 in analyses)<BR/>Age range 6 to 16 years<BR/>Positive skin tests to house dust</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Test: active laminar air flow system (Pure-zone system)<BR/>Control: dummy filter<BR/>Each period lasted 4 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Asthma symptoms<BR/>Three patients had sick days in the control group, none in the experimental group</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>No assessment of mite reduction. Daytime wheeze was selected blindly as the most relevant variable (other variables yielded closely similar results). Since the data were extremely skewed, the logarithm of the scores was used.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>D pter: <I>Dermatophagoides pteronyssinus</I>; D far: <I>Dermatophagoides farinae</I>; DP1: D(2) receptor type 1; ELISA: enzyme-linked immunosorbent assay; FEV1: forced expiratory volume in 1 second; FVC: forced vital capacity; HEPA: high-efficiency particulate air; PD20 provocative dose producing a 20% fall in FEV1; PEFR: peak expiratory flow rate; RAST: radioallergosorbent test; SD: standard deviation; SEM: standard error of the mean; SPT: skin prick test; VAS: visual analogue scale</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Bowler-1985">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Not a RCT against no treatment, N = 12</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Brown-1991">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Not a RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Burr-1988">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>No clinical data</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Carswell-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>No clinical data</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Carter-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Only some (exact number not stated) of 104 enrolled patients were allergic to mites; no outcome data or number of patients provided for this group</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Chew-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>No clinical data</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Cloosterman-1997">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Not asthma</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-de-Blay-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>No clinical data</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Elixmann-1988">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Not a RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Gallardo-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Some patients did not have asthma, but rhinitis (N = 17 in whole trial)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Glasgow-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Compares active interventions and co-interventions are not the same in the 2 randomised groups</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Griffin-1989">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Only published as abstract, author cannot be traced. Acaricide versus placebo (N = 60), FEV 1.86 in both groups after treatment</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Hannaway-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Not relevant comparison: acaricide + encasings versus carpet cleaner + placebo encasings (N = 23)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Harving-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Not a RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Hayden-1997">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Only 15 of 23 patients were sensitive to mites</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-08-09 15:54:09 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hegarty-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-08-09 15:54:09 +0100" MODIFIED_BY="[Empty name]">
<P>Not clear whether randomised and how sensitivity to mites was assessed. No response to letter. Small trial (N = 23), published only as an abstract.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Huss-1991">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>No clinical data</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Huss-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>No clinical data, authors did not respond to our letters</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Hyndman-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>No clinical data</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Joseph-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>No clinical data, not fully randomised</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Korsgaard-1982">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Not a RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Krieger-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Multifactor intervention trial, 274 children. No clear how many were allergic to mites</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Lau-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>No clinical data</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Lau_x002d_Schadendorf-1991">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>No clinical data</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Leclercq-1985">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Unknown whether trial was randomised, authors did not respond to our letters</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Massey-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>No clinical data</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Medina-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>No clinical data, mixture of patients with rhinitis and/or asthma, N = 17</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Morgan-2004">
<CHAR_REASON_FOR_EXCLUSION>
<P>Multiple interventions and multiple allergies, 937 children. Furthermore, the intervention group received more home visits than the control group; the study was not blinded and the only positive effects were found on subjective outcomes obtained through telephone interviews; no effect was found on FEV1 or on PEFR. Allergen levels decreased by less than 50%, compared with the control group.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Mosbech-1988">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>No clinical data</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Munir-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>No clinical data</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Murray-1983">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Not a RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Nambu-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Data on asthma symptoms only for 9 of 20 randomised patients</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Nishioka-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Not a RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Olaguibel-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>No clinical data</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Owen-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>No clinical data</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Peroni-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Not a RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Quek-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Not a RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Rebmann-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Study of mattresses, not patients</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Reisman-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Only 11 of the 32 patients had asthma (results were quite similar in the 2 groups)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Sarsfield-1974">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Not a RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Scherr-1977">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>No information on mite sensitisation. Aimed more generally at filtrating air</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Shedd-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Failed trial (many missing data, the report describes only 177 of 902 randomised patients) and not clear whether patients were allergic to mites</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Sporik-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>No clinical data</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Terreehorst-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Only 111 of 224 enrolled patients had asthma; no data for asthma patients separately, and none of the data we included, only modelled quality of life data (SF-36) were available</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Tobias-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>No clinical data and mixture of 24 patients with asthma, rhinitis and atopic dermatitis</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Villaveces-1977">
<CHAR_REASON_FOR_EXCLUSION>
<P>13 patients took part, but 15 measurements were made, since 2 patients were measured twice. Authors did not respond to our letters.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Warner-1993B">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Not a RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Weeks-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>No clinical data, duplicate publication with <LINK REF="STD-Carswell-1999" TYPE="STUDY">Carswell 1999</LINK> (see above in this table)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" STUDY_ID="STD-Williams-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<P>Multifactor intervention trial and only 93 of the 161 patients were allergic to mites. Trial lasted 14 months; no significant difference in asthma severity scores.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES>
<P>FEV1: forced expiratory volume in 1 second; PEFR: peak expiratory flow rate; RCT: randomised clinical trial.</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-28 11:07:14 +0100" MODIFIED_BY="Toby J Lasserson" RESULT="UNKNOWN" STUDY_ID="STD-Antonicelli-1991">
<DESCRIPTION>
<P>Information not available </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-28 11:07:27 +0100" MODIFIED_BY="Toby J Lasserson" RESULT="UNKNOWN" STUDY_ID="STD-Bahir-1997">
<DESCRIPTION>
<P>Information not available</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-28 11:07:30 +0100" MODIFIED_BY="Toby J Lasserson" RESULT="UNKNOWN" STUDY_ID="STD-Burr-1976">
<DESCRIPTION>
<P>Information not available</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-28 11:07:36 +0100" MODIFIED_BY="Toby J Lasserson" RESULT="UNKNOWN" STUDY_ID="STD-Burr-1980A">
<DESCRIPTION>
<P>Information not available</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-28 11:07:39 +0100" MODIFIED_BY="Toby J Lasserson" RESULT="UNKNOWN" STUDY_ID="STD-Burr-1980B">
<DESCRIPTION>
<P>Information not available</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-28 11:07:43 +0100" MODIFIED_BY="Toby J Lasserson" RESULT="UNKNOWN" STUDY_ID="STD-Carswell-1996">
<DESCRIPTION>
<P>Information not available</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-28 11:07:47 +0100" MODIFIED_BY="Toby J Lasserson" RESULT="UNKNOWN" STUDY_ID="STD-Chang-1996">
<DESCRIPTION>
<P>Information not available</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-28 11:07:59 +0100" MODIFIED_BY="Toby J Lasserson" RESULT="NO" STUDY_ID="STD-Charpin-1990">
<DESCRIPTION>
<P>Table provided by laboratory</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-28 11:08:09 +0100" MODIFIED_BY="Toby J Lasserson" RESULT="UNKNOWN" STUDY_ID="STD-Chen-1996">
<DESCRIPTION>
<P>Information not available </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-28 11:08:19 +0100" MODIFIED_BY="Toby J Lasserson" RESULT="YES" STUDY_ID="STD-Cinti-1996">
<DESCRIPTION>
<P>Sealed opaque envelopes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-10 11:47:14 +0100" MODIFIED_BY="Emma J Welsh" RESULT="NO" STUDY_ID="STD-Cloosterman-1999">
<DESCRIPTION>
<P>Statistician informed investigators, open list of random numbers, open to investigators</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-28 11:09:06 +0100" MODIFIED_BY="Toby J Lasserson" RESULT="NO" STUDY_ID="STD-Dharmage-2006">
<DESCRIPTION>
<P>Coin toss </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-28 11:09:13 +0100" MODIFIED_BY="Toby J Lasserson" RESULT="UNKNOWN" STUDY_ID="STD-Dietemann-1993">
<DESCRIPTION>
<P>Information not available </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-28 11:09:21 +0100" MODIFIED_BY="Toby J Lasserson" RESULT="UNKNOWN" STUDY_ID="STD-Dorward-1988">
<DESCRIPTION>
<P>Information not available</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-28 11:09:24 +0100" MODIFIED_BY="Toby J Lasserson" RESULT="UNKNOWN" STUDY_ID="STD-Ehnert-1992">
<DESCRIPTION>
<P>Information not available</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-28 11:09:30 +0100" MODIFIED_BY="Toby J Lasserson" RESULT="UNKNOWN" STUDY_ID="STD-Fang-2001">
<DESCRIPTION>
<P>Information not available</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-28 11:09:35 +0100" MODIFIED_BY="Toby J Lasserson" RESULT="UNKNOWN" STUDY_ID="STD-Frederick-1997">
<DESCRIPTION>
<P>Information not available</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-28 11:09:46 +0100" MODIFIED_BY="Toby J Lasserson" RESULT="UNKNOWN" STUDY_ID="STD-Geller_x002d_Bernst-1995">
<DESCRIPTION>
<P>Information not available</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-09 18:18:40 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ghazala-2004">
<DESCRIPTION>
<P>Information not available</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-28 11:09:54 +0100" MODIFIED_BY="Toby J Lasserson" RESULT="UNKNOWN" STUDY_ID="STD-Gillies-1987">
<DESCRIPTION>
<P>Information not available</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-28 11:10:12 +0100" MODIFIED_BY="Toby J Lasserson" RESULT="YES" STUDY_ID="STD-Halken-2003">
<DESCRIPTION>
<P>Computer program, stratified by 4 factors.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-28 11:10:25 +0100" MODIFIED_BY="Toby J Lasserson" RESULT="UNKNOWN" STUDY_ID="STD-Howarth-1992">
<DESCRIPTION>
<P>Information not available </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" RESULT="NO" STUDY_ID="STD-Htut-2001">
<DESCRIPTION>
<P>Open table of random numbers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-28 11:10:46 +0100" MODIFIED_BY="Toby J Lasserson" RESULT="UNKNOWN" STUDY_ID="STD-Huss-1992">
<DESCRIPTION>
<P>Information not available </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-28 11:10:54 +0100" MODIFIED_BY="Toby J Lasserson" RESULT="NO" STUDY_ID="STD-Jooma-1995">
<DESCRIPTION>
<P>Open table of random numbers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-28 11:11:11 +0100" MODIFIED_BY="Toby J Lasserson" RESULT="UNKNOWN" STUDY_ID="STD-Korsgaard-1983">
<DESCRIPTION>
<P>Information not available </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-28 11:11:21 +0100" MODIFIED_BY="Toby J Lasserson" RESULT="YES" STUDY_ID="STD-Kroidl-1998">
<DESCRIPTION>
<P>Sealed envelopes with consecutive numbers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-28 11:11:32 +0100" MODIFIED_BY="Toby J Lasserson" RESULT="NO" STUDY_ID="STD-Lee-2003">
<DESCRIPTION>
<P>Coin toss </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" RESULT="NO" STUDY_ID="STD-Luczynska-2003">
<DESCRIPTION>
<P>Statistical program generated a list of 1s and 2s where patient number were written; not adequately concealed as blinding could be broken</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-28 11:11:53 +0100" MODIFIED_BY="Toby J Lasserson" RESULT="UNKNOWN" STUDY_ID="STD-Maesen-1977">
<DESCRIPTION>
<P>Information not available </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-28 11:12:04 +0100" MODIFIED_BY="Toby J Lasserson" RESULT="UNKNOWN" STUDY_ID="STD-Manjra-1994">
<DESCRIPTION>
<P>Information not available</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-28 11:12:08 +0100" MODIFIED_BY="Toby J Lasserson" RESULT="UNKNOWN" STUDY_ID="STD-Marks-1994">
<DESCRIPTION>
<P>Information not available</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-28 11:12:11 +0100" MODIFIED_BY="Toby J Lasserson" RESULT="UNKNOWN" STUDY_ID="STD-Matthys-1996">
<DESCRIPTION>
<P>Information not available</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-28 11:12:14 +0100" MODIFIED_BY="Toby J Lasserson" RESULT="UNKNOWN" STUDY_ID="STD-Mitchell-1980">
<DESCRIPTION>
<P>Information not available</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-28 11:12:24 +0100" MODIFIED_BY="Toby J Lasserson" RESULT="UNKNOWN" STUDY_ID="STD-Popplewell-2000">
<DESCRIPTION>
<P>Information not available</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-28 11:12:28 +0100" MODIFIED_BY="Toby J Lasserson" RESULT="UNKNOWN" STUDY_ID="STD-Reiser-1990">
<DESCRIPTION>
<P>Information not available</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-28 11:12:33 +0100" MODIFIED_BY="Toby J Lasserson" RESULT="UNKNOWN" STUDY_ID="STD-Rijssenbeek-2002">
<DESCRIPTION>
<P>Information not available</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-28 11:12:36 +0100" MODIFIED_BY="Toby J Lasserson" RESULT="UNKNOWN" STUDY_ID="STD-Sette-1994">
<DESCRIPTION>
<P>Information not available</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" RESULT="YES" STUDY_ID="STD-Shapiro-1999">
<DESCRIPTION>
<P>Random number generation, sealed and opaque envelopes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" RESULT="YES" STUDY_ID="STD-Sheikh-2002">
<DESCRIPTION>
<P>Centralised, using numbers generated from a random numbers table</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-28 11:13:03 +0100" MODIFIED_BY="Toby J Lasserson" RESULT="UNKNOWN" STUDY_ID="STD-Sooltangos-1992">
<DESCRIPTION>
<P>Information not available </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-28 11:13:10 +0100" MODIFIED_BY="Toby J Lasserson" RESULT="UNKNOWN" STUDY_ID="STD-Thiam-1999">
<DESCRIPTION>
<P>Information not available</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-28 11:13:48 +0100" MODIFIED_BY="Toby J Lasserson" RESULT="UNKNOWN" STUDY_ID="STD-Verrall-1988">
<DESCRIPTION>
<P>Information not available </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-28 11:13:55 +0100" MODIFIED_BY="Toby J Lasserson" RESULT="UNKNOWN" STUDY_ID="STD-Walshaw-1986">
<DESCRIPTION>
<P>Information not available</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-28 11:13:58 +0100" MODIFIED_BY="Toby J Lasserson" RESULT="UNKNOWN" STUDY_ID="STD-Warburton-1994">
<DESCRIPTION>
<P>Information not available</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-28 11:14:02 +0100" MODIFIED_BY="Toby J Lasserson" RESULT="UNKNOWN" STUDY_ID="STD-Warner-1993">
<DESCRIPTION>
<P>Information not available</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-28 11:14:05 +0100" MODIFIED_BY="Toby J Lasserson" RESULT="UNKNOWN" STUDY_ID="STD-Warner-2000">
<DESCRIPTION>
<P>Information not available</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" RESULT="YES" STUDY_ID="STD-Woodcock-2003">
<DESCRIPTION>
<P>Co-ordination centre, using minimisation within each practice (3 factors)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" RESULT="YES" STUDY_ID="STD-Wright-2009">
<DESCRIPTION>
<P>See above</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-28 11:14:24 +0100" MODIFIED_BY="Toby J Lasserson" RESULT="UNKNOWN" STUDY_ID="STD-Zwemer-1973">
<DESCRIPTION>
<P>Information not available </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" RESULT="NO" STUDY_ID="STD-de-Vries-2007">
<DESCRIPTION>
<P>"randomisation list","patients were assigned according to the number on the list, in sequence of inclusion"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-28 11:13:13 +0100" MODIFIED_BY="Toby J Lasserson" RESULT="UNKNOWN" STUDY_ID="STD-van-den-Bemt-2004">
<DESCRIPTION>
<P>Information not available</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-28 11:13:18 +0100" MODIFIED_BY="Toby J Lasserson" RESULT="UNKNOWN" STUDY_ID="STD-van-der-Heide-1997A">
<DESCRIPTION>
<P>Information not available</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" RESULT="YES" STUDY_ID="STD-van-der-Heide-1997B">
<DESCRIPTION>
<P>Computer using minimisation (2 factors)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" RESULT="YES" STUDY_ID="STD-van-der-Heide-1999">
<DESCRIPTION>
<P>Computer using minimisation (2 factors)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2009-10-08 09:02:05 +0100" MODIFIED_BY="Toby J Lasserson" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2011-08-09 17:56:24 +0100" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2011-08-09 17:56:24 +0100" MODIFIED_BY="[Empty name]" NO="1">
<NAME>House dust mite reduction versus control</NAME>
<DICH_OUTCOME CHI2="4.886974853497478" CI_END="1.268901204870409" CI_START="0.8016679606336413" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="RR" EFFECT_SIZE="1.008581896106623" ESTIMABLE="YES" EVENTS_1="69" EVENTS_2="74" I2="0.0" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="0.10342780976224702" LOG_CI_START="-0.0960054730173836" LOG_EFFECT_SIZE="0.003711168372431717" METHOD="MH" MODIFIED="2011-08-09 17:54:12 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.5583892392370478" P_Q="0.8847656562911582" P_Z="0.9418504754622108" Q="0.6505631844155246" RANDOM="NO" SCALE="8.092923526092896" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="163" TOTAL_2="175" WEIGHT="100.00000000000001" Z="0.0729442573391086">
<NAME>Numbers improved</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.6379223887720945" CI_END="1.2403593236021737" CI_START="0.717378463900038" DF="2" EFFECT_SIZE="0.9432958529802925" ESTIMABLE="YES" EVENTS_1="38" EVENTS_2="45" I2="0.0" ID="CMP-001.01.01" LOG_CI_END="0.0935475155266088" LOG_CI_START="-0.14425166522593605" LOG_EFFECT_SIZE="-0.025352074849663616" NO="1" P_CHI2="0.7269038071484342" P_Z="0.6760139930487393" STUDIES="3" TAU2="0.0" TOTAL_1="65" TOTAL_2="73" WEIGHT="59.83481416217185" Z="0.41790853510476306">
<NAME>Chemical methods</NAME>
<DICH_DATA CI_END="1.9954135557355812" CI_START="0.5184289926441329" EFFECT_SIZE="1.017094017094017" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="9" LOG_CI_END="0.3000329182487262" LOG_CI_START="-0.28531071895598803" LOG_EFFECT_SIZE="0.00736109964636909" ORDER="235" O_E="0.0" SE="0.34383374999178357" STUDY_ID="STD-Bahir-1997" TOTAL_1="13" TOTAL_2="17" VAR="0.11822164763341232" WEIGHT="11.003355379115389"/>
<DICH_DATA CI_END="1.9193150074463585" CI_START="0.6432335997190769" EFFECT_SIZE="1.1111111111111112" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="9" LOG_CI_END="0.28314625913800423" LOG_CI_START="-0.19163127801665394" LOG_EFFECT_SIZE="0.04575749056067514" ORDER="236" O_E="0.0" SE="0.2788866755113585" STUDY_ID="STD-Geller_x002d_Bernst-1995" TOTAL_1="15" TOTAL_2="15" VAR="0.07777777777777777" WEIGHT="12.69617928359468"/>
<DICH_DATA CI_END="1.2320394091896016" CI_START="0.6029075558716019" EFFECT_SIZE="0.8618618618618619" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="27" LOG_CI_END="0.09062459980880104" LOG_CI_START="-0.21974927335345606" LOG_EFFECT_SIZE="-0.06456233677232755" ORDER="237" O_E="0.0" SE="0.1823151494709603" STUDY_ID="STD-Kroidl-1998" TOTAL_1="37" TOTAL_2="41" VAR="0.0332388137266186" WEIGHT="36.13527949946178"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.7442618326595263" CI_START="0.7034392575396178" DF="0" EFFECT_SIZE="1.1076923076923078" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="15" I2="0.0" ID="CMP-001.01.02" LOG_CI_END="0.2416116778121721" LOG_CI_START="-0.15277339823534627" LOG_EFFECT_SIZE="0.04441913978841291" MODIFIED="2011-08-09 17:54:08 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.6588532332712584" STUDIES="1" TAU2="0.0" TOTAL_1="26" TOTAL_2="27" WEIGHT="20.76104788512337" Z="0.44149700126609165">
<NAME>Physical methods - parallel-group studies</NAME>
<DICH_DATA CI_END="1.7442618326595263" CI_START="0.7034392575396178" EFFECT_SIZE="1.1076923076923078" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="15" LOG_CI_END="0.2416116778121721" LOG_CI_START="-0.15277339823534627" LOG_EFFECT_SIZE="0.04441913978841291" ORDER="238" O_E="0.0" SE="0.23166374590792396" STUDY_ID="STD-Burr-1980A" TOTAL_1="26" TOTAL_2="27" VAR="0.05366809116809115" WEIGHT="20.76104788512337"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="4.091917390523779" CI_END="2.5403988806773667" CI_START="0.5668401174921165" DF="1" EFFECT_SIZE="1.2" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="10" I2="75.56157897234586" ID="CMP-001.01.03" LOG_CI_END="0.4049019127130177" LOG_CI_START="-0.2465394206177681" LOG_EFFECT_SIZE="0.07918124604762482" MODIFIED="2011-08-09 17:54:12 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.04308883792009999" P_Z="0.6337477454901272" STUDIES="2" TAU2="0.0" TOTAL_1="49" TOTAL_2="49" WEIGHT="14.106865870660755" Z="0.4764585314562664">
<NAME>Physical methods - cross-over studies</NAME>
<DICH_DATA CI_END="45.627697532358866" CI_START="0.7889944473851442" EFFECT_SIZE="6.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="1" LOG_CI_END="1.6592285539310956" LOG_CI_START="-0.10292605316380837" LOG_EFFECT_SIZE="0.7781512503836436" ORDER="239" O_E="0.0" SE="1.0350983390135313" STUDY_ID="STD-Burr-1980B" TOTAL_1="21" TOTAL_2="21" VAR="1.0714285714285714" WEIGHT="1.4106865870660754"/>
<DICH_DATA CI_END="1.6239505410892412" CI_START="0.2736810224197713" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="9" LOG_CI_END="0.21057279826777184" LOG_CI_START="-0.5627553163791343" LOG_EFFECT_SIZE="-0.17609125905568127" ORDER="240" O_E="0.0" SE="0.454256762579498" STUDY_ID="STD-Maesen-1977" TOTAL_1="28" TOTAL_2="28" VAR="0.2063492063492064" WEIGHT="12.69617928359468"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="3.396529022017759" CI_START="0.2116304819020767" DF="0" EFFECT_SIZE="0.8478260869565217" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" I2="0.0" ID="CMP-001.01.04" LOG_CI_END="0.5310353298198174" LOG_CI_START="-0.674421779129967" LOG_EFFECT_SIZE="-0.07169322465507487" NO="4" P_CHI2="1.0" P_Z="0.8156578444854209" STUDIES="1" TAU2="0.0" TOTAL_1="23" TOTAL_2="26" WEIGHT="5.297272082044039" Z="0.2331333686055507">
<NAME>Combination methods</NAME>
<DICH_DATA CI_END="3.396529022017759" CI_START="0.2116304819020767" EFFECT_SIZE="0.8478260869565217" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.5310353298198174" LOG_CI_START="-0.674421779129967" LOG_EFFECT_SIZE="-0.07169322465507487" ORDER="241" O_E="0.0" SE="0.708091472906029" STUDY_ID="STD-Carswell-1996" TOTAL_1="23" TOTAL_2="26" VAR="0.5013935340022296" WEIGHT="5.297272082044039"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="48.24901061892894" CI_END="0.04762709890147122" CI_START="-0.15824437881422448" CI_STUDY="95" CI_TOTAL="95" DF="19" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.05530863995637663" ESTIMABLE="YES" I2="60.62095417860037" I2_Q="67.78368837317173" ID="CMP-001.02" MODIFIED="2011-08-09 17:54:33 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="2.3610927538142423E-4" P_Q="0.025417249488254967" P_Z="0.29228932059759904" Q="9.31205295860665" RANDOM="NO" SCALE="4.0" SORT_BY="STUDY" STUDIES="20" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="753" TOTAL_2="732" UNITS="" WEIGHT="100.00000000000001" Z="1.0531127823164843">
<NAME>Asthma symptoms score</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="1.0996247893581068" CI_END="0.7481890452965898" CI_START="0.035566982990432316" DF="3" EFFECT_SIZE="0.3918780141435111" ESTIMABLE="YES" I2="0.0" ID="CMP-001.02.01" NO="1" P_CHI2="0.7771646935128428" P_Z="0.031114312615579922" STUDIES="4" TAU2="0.0" TOTAL_1="59" TOTAL_2="66" WEIGHT="8.345912674995926" Z="2.1556076767221444">
<NAME>Chemical methods</NAME>
<CONT_DATA CI_END="0.8527134253380716" CI_START="-0.5932539658786119" EFFECT_SIZE="0.12972972972972985" ESTIMABLE="YES" MEAN_1="1.6" MEAN_2="1.4" ORDER="242" SD_1="1.5" SD_2="1.5" SE="0.3688760106364938" STUDY_ID="STD-Bahir-1997" TOTAL_1="13" TOTAL_2="17" WEIGHT="2.0271008957178607"/>
<CONT_DATA CI_END="1.3496465947564569" CI_START="-0.22758724263029861" EFFECT_SIZE="0.5610296760630791" ESTIMABLE="YES" MEAN_1="1.1" MEAN_2="0.4" ORDER="243" SD_1="1.7" SD_2="0.5" SE="0.40236296427581697" STUDY_ID="STD-Chang-1996" TOTAL_1="12" TOTAL_2="14" WEIGHT="1.7037277308426333"/>
<CONT_DATA CI_END="1.0586548364933743" CI_START="-0.5845232401087775" EFFECT_SIZE="0.23706579819229834" ESTIMABLE="YES" MEAN_1="1.4" MEAN_2="1.18" ORDER="244" SD_1="1.24" SD_2="0.36" SE="0.4191857834029938" STUDY_ID="STD-Dietemann-1993" TOTAL_1="11" TOTAL_2="12" WEIGHT="1.569723282447056"/>
<CONT_DATA CI_END="1.1413959967317002" CI_START="-0.03831820517002327" EFFECT_SIZE="0.5515388957808385" ESTIMABLE="YES" MEAN_1="5.5" MEAN_2="3.3" ORDER="245" SD_1="4.3" SD_2="3.5" SE="0.30095303056769374" STUDY_ID="STD-Reiser-1990" TOTAL_1="23" TOTAL_2="23" WEIGHT="3.0453607659883755"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="28.612826229288086" CI_END="0.030387464823298876" CI_START="-0.2087354664540484" DF="10" EFFECT_SIZE="-0.08917400081537476" ESTIMABLE="YES" I2="65.05063875946654" ID="CMP-001.02.02" MODIFIED="2011-08-09 17:54:26 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0014390699165368614" P_Z="0.143789422617317" STUDIES="11" TAU2="0.0" TOTAL_1="566" TOTAL_2="532" WEIGHT="74.12247495013972" Z="1.461824083720047">
<NAME>Physical methods - parallel-group studies</NAME>
<CONT_DATA CI_END="0.2978495463116503" CI_START="-1.0542072715020927" EFFECT_SIZE="-0.37817886259522127" ESTIMABLE="YES" MEAN_1="0.5" MEAN_2="0.82" ORDER="246" SD_1="0.66" SD_2="1.01" SE="0.3449187914876484" STUDY_ID="STD-Chen-1996" TOTAL_1="20" TOTAL_2="15" WEIGHT="2.3184753282386157"/>
<CONT_DATA CI_END="0.20056297233012066" CI_START="-1.6199036601088173" EFFECT_SIZE="-0.7096703438893484" ESTIMABLE="YES" MEAN_1="0.3" MEAN_2="1.0" ORDER="247" SD_1="0.68" SD_2="1.15" SE="0.46441328687632694" STUDY_ID="STD-Cinti-1996" TOTAL_1="10" TOTAL_2="10" WEIGHT="1.2788715246102242"/>
<CONT_DATA CI_END="0.5178130184916269" CI_START="-0.28305710372700166" EFFECT_SIZE="0.11737795738231259" ESTIMABLE="YES" MEAN_1="1.23" MEAN_2="1.13" ORDER="255" SD_1="0.86" SD_2="0.83" SE="0.20430735680241827" STUDY_ID="STD-de-Vries-2007" TOTAL_1="48" TOTAL_2="48" WEIGHT="6.607971784053473"/>
<CONT_DATA CI_END="0.8378207334544667" CI_START="-0.5950511873370072" EFFECT_SIZE="0.12138477305872969" ESTIMABLE="YES" MEAN_1="-0.02" MEAN_2="-0.04" ORDER="248" SD_1="0.15" SD_2="0.17" SE="0.3655352680186434" STUDY_ID="STD-Dharmage-2006" TOTAL_1="15" TOTAL_2="15" WEIGHT="2.0643228481643643"/>
<CONT_DATA CI_END="-0.1997199725489529" CI_START="-1.4503350851796013" EFFECT_SIZE="-0.8250275288642771" ESTIMABLE="YES" MEAN_1="10.0" MEAN_2="17.3" ORDER="249" SD_1="6.8" SD_2="10.3" SE="0.31904032994874926" STUDY_ID="STD-Fang-2001" TOTAL_1="22" TOTAL_2="21" WEIGHT="2.7098485460524517"/>
<CONT_DATA CI_END="0.16239163018116204" CI_START="-0.9357382061640485" EFFECT_SIZE="-0.38667328799144324" ESTIMABLE="YES" MEAN_1="8.8" MEAN_2="13.1" ORDER="250" SD_1="10.7" SD_2="11.2" SE="0.28014030997689715" STUDY_ID="STD-Huss-1992" TOTAL_1="26" TOTAL_2="26" WEIGHT="3.51467344881393"/>
<CONT_DATA CI_END="0.6743126617221787" CI_START="-0.7604245627958769" EFFECT_SIZE="-0.04305595053684905" ESTIMABLE="YES" MEAN_1="2.25" MEAN_2="2.37" ORDER="251" SD_1="2.24" SD_2="3.17" SE="0.3660111195499202" STUDY_ID="STD-Rijssenbeek-2002" TOTAL_1="16" TOTAL_2="14" WEIGHT="2.0589586797886557"/>
<CONT_DATA CI_END="1.1118449809716786" CI_START="-0.10717343076333374" EFFECT_SIZE="0.5023357751041724" ESTIMABLE="YES" MEAN_1="-3.4" MEAN_2="-18.1" ORDER="252" SD_1="29.5" SD_2="27.8" SE="0.3109797989530608" STUDY_ID="STD-Sheikh-2002" TOTAL_1="23" TOTAL_2="20" WEIGHT="2.852146527470279"/>
<CONT_DATA CI_END="-1.0164005110171375" CI_START="-3.2956477971306586" EFFECT_SIZE="-2.156024154073898" ESTIMABLE="YES" MEAN_1="0.8" MEAN_2="1.8" MODIFIED="2011-07-12 18:46:00 +0100" MODIFIED_BY="[Empty name]" ORDER="253" SD_1="0.5" SD_2="0.18" SE="0.5814513185170577" STUDY_ID="STD-Thiam-1999" TOTAL_1="18" TOTAL_2="6" WEIGHT="0.8158484090082244"/>
<CONT_DATA CI_END="0.156802136511858" CI_START="-0.156802136511858" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="1.03" MEAN_2="1.03" ORDER="254" SD_1="0.7" SD_2="0.73" SE="0.08000256012288656" STUDY_ID="STD-Woodcock-2003" TOTAL_1="315" TOTAL_2="310" WEIGHT="43.09515237125461"/>
<CONT_DATA CI_END="0.12392581171846034" CI_START="-0.6651952839342241" EFFECT_SIZE="-0.2706347361078819" ESTIMABLE="YES" MEAN_1="1.5" MEAN_2="1.8" MODIFIED="2011-07-12 12:57:42 +0100" MODIFIED_BY="[Empty name]" ORDER="102" SD_1="1.1" SD_2="1.1" SE="0.2013101010725633" STUDY_ID="STD-Wright-2009" TOTAL_1="53" TOTAL_2="47" WEIGHT="6.806205482684889"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="6.1656432238920384" CI_END="0.013304937908632741" CI_START="-0.9657478122642503" DF="2" EFFECT_SIZE="-0.4762214371778088" ESTIMABLE="YES" I2="67.56218406783667" ID="CMP-001.02.03" MODIFIED="2011-08-09 17:54:33 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.04582979207292648" P_Z="0.056560260593260955" STUDIES="3" TAU2="0.0" TOTAL_1="35" TOTAL_2="35" WEIGHT="4.421607419103236" Z="1.9066937207818306">
<NAME>Physical methods - cross-over studies</NAME>
<CONT_DATA CI_END="0.6415994896167838" CI_START="-1.2185352351552434" EFFECT_SIZE="-0.2884678727692298" ESTIMABLE="YES" MEAN_1="0.16" MEAN_2="0.26" ORDER="256" SD_1="0.32" SD_2="0.34" SE="0.47453288413576283" STUDY_ID="STD-Antonicelli-1991" TOTAL_1="9" TOTAL_2="9" WEIGHT="1.2249082601003354"/>
<CONT_DATA CI_END="0.7729307714692822" CI_START="-0.7087736257940308" EFFECT_SIZE="0.03207857283762574" ESTIMABLE="YES" MEAN_1="0.2" MEAN_2="0.19" ORDER="257" SD_1="0.26" SD_2="0.34" SE="0.3779927613340878" STUDY_ID="STD-Warner-1993" TOTAL_1="14" TOTAL_2="14" WEIGHT="1.9304974139427422"/>
<CONT_DATA CI_END="-0.5180487830232512" CI_START="-2.3476006580973907" EFFECT_SIZE="-1.432824720560321" ESTIMABLE="YES" MEAN_1="0.7" MEAN_2="1.4" MODIFIED="2011-07-12 18:46:02 +0100" MODIFIED_BY="[Empty name]" ORDER="258" SD_1="0.51" SD_2="0.43" SE="0.4667309934022797" STUDY_ID="STD-Zwemer-1973" TOTAL_1="12" TOTAL_2="12" WEIGHT="1.2662017450601593"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="3.058863417784065" CI_END="0.27773359101300366" CI_START="-0.29085056538755305" DF="1" EFFECT_SIZE="-0.006558487187274684" ESTIMABLE="YES" I2="67.30811862386354" ID="CMP-001.02.04" NO="4" P_CHI2="0.08029805709998317" P_Z="0.9639355670951677" STUDIES="2" TAU2="0.0" TOTAL_1="93" TOTAL_2="99" WEIGHT="13.110004955761134" Z="0.04521546559264343">
<NAME>Combination methods</NAME>
<CONT_DATA CI_END="0.18924081507871565" CI_START="-0.43738219682168084" EFFECT_SIZE="-0.12407069087148259" ESTIMABLE="YES" MEAN_1="5.5" MEAN_2="6.3" ORDER="259" SD_1="6.1" SD_2="6.7" SE="0.15985574654511991" STUDY_ID="STD-Cloosterman-1999" TOTAL_1="76" TOTAL_2="81" WEIGHT="10.793932160568044"/>
<CONT_DATA CI_END="1.2174797412054645" CI_START="-0.13527815975677504" EFFECT_SIZE="0.5411007907243447" ESTIMABLE="YES" MEAN_1="0.98" MEAN_2="0.67" ORDER="260" SD_1="0.57" SD_2="0.55" SE="0.3450976425160414" STUDY_ID="STD-Marks-1994" TOTAL_1="17" TOTAL_2="18" WEIGHT="2.316072795193091"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="9.01904708915841" CI_END="0.06595979135067023" CI_START="-0.16952963631191056" CI_STUDY="95" CI_TOTAL="95" DF="10" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.051784922480620166" ESTIMABLE="YES" I2="0.0" I2_Q="58.43017521289419" ID="CMP-001.03" MODIFIED="2011-08-09 17:54:54 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.5302969659271277" P_Q="0.09021219897825439" P_Z="0.3886845371399307" Q="4.811182174191803" RANDOM="NO" SCALE="4.0" SORT_BY="STUDY" STUDIES="11" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="564" TOTAL_2="551" UNITS="" WEIGHT="100.00000000000001" Z="0.8620054327843772">
<NAME>Medication usage</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="1.7517220784652654" CI_START="0.021349787715387425" DF="0" EFFECT_SIZE="0.8865359330903264" ESTIMABLE="YES" I2="0.0" ID="CMP-001.03.01" MODIFIED="2011-07-12 18:54:41 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.04460833312750844" STUDIES="1" TAU2="0.0" TOTAL_1="11" TOTAL_2="12" WEIGHT="1.85209698389995" Z="2.008329085187385">
<NAME>Chemical methods</NAME>
<CONT_DATA CI_END="1.7517220784652654" CI_START="0.021349787715387425" EFFECT_SIZE="0.8865359330903264" ESTIMABLE="YES" MEAN_1="2.0" MEAN_2="1.54" MODIFIED="2011-07-12 18:54:41 +0100" MODIFIED_BY="[Empty name]" ORDER="261" SD_1="0.55" SD_2="0.45" SE="0.44142961411506376" STUDY_ID="STD-Dietemann-1993" TOTAL_1="11" TOTAL_2="12" WEIGHT="1.85209698389995"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="4.016057270629093" CI_END="0.06080367152311492" CI_START="-0.18512415104277383" DF="6" EFFECT_SIZE="-0.06216023975982945" ESTIMABLE="YES" I2="0.0" ID="CMP-001.03.02" MODIFIED="2011-08-09 17:54:51 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.6745033433312085" P_Z="0.3217864879154444" STUDIES="7" TAU2="0.0" TOTAL_1="517" TOTAL_2="503" WEIGHT="91.69116677773629" Z="0.990793395627283">
<NAME>Physical methods - parallel-group studies</NAME>
<CONT_DATA CI_END="0.3100116556916516" CI_START="-0.38848759562091845" EFFECT_SIZE="-0.03923796996463341" ESTIMABLE="YES" MEAN_1="473.0" MEAN_2="490.0" ORDER="267" SD_1="441.0" SD_2="420.0" SE="0.1781918588357345" STUDY_ID="STD-de-Vries-2007" TOTAL_1="63" TOTAL_2="63" WEIGHT="11.366086018364745"/>
<CONT_DATA CI_END="0.3415068761773459" CI_START="-1.1047696723908187" EFFECT_SIZE="-0.3816313981067364" ESTIMABLE="YES" MEAN_1="-0.36" MEAN_2="-0.2" ORDER="262" SD_1="0.48" SD_2="0.32" SE="0.36895487875701016" STUDY_ID="STD-Dharmage-2006" TOTAL_1="15" TOTAL_2="15" WEIGHT="2.651185647894187"/>
<CONT_DATA CI_END="0.3024000905728252" CI_START="-0.8535629294703224" EFFECT_SIZE="-0.27558141944874864" ESTIMABLE="YES" MEAN_1="227.0" MEAN_2="291.0" ORDER="263" SD_1="193.0" SD_2="266.0" SE="0.2948939442666387" STUDY_ID="STD-Halken-2003" TOTAL_1="26" TOTAL_2="21" WEIGHT="4.150065454568253"/>
<CONT_DATA CI_END="0.32218817096852914" CI_START="-0.768661934773681" EFFECT_SIZE="-0.22323688190257598" ESTIMABLE="YES" MEAN_1="4.38" MEAN_2="5.23" ORDER="264" SD_1="3.71" SD_2="3.79" SE="0.27828320171867865" STUDY_ID="STD-Huss-1992" TOTAL_1="26" TOTAL_2="26" WEIGHT="4.66028709697746"/>
<CONT_DATA CI_END="0.13316386775471417" CI_START="-1.0971343237122695" EFFECT_SIZE="-0.4819852279787777" ESTIMABLE="YES" MEAN_1="2.18" MEAN_2="3.56" ORDER="265" SD_1="1.8" SD_2="3.61" SE="0.31385734665825976" STUDY_ID="STD-Walshaw-1986" TOTAL_1="22" TOTAL_2="20" WEIGHT="3.663718159932473"/>
<CONT_DATA CI_END="0.15185601999066517" CI_START="-0.16224211314239467" EFFECT_SIZE="-0.005193046575864759" ESTIMABLE="YES" MEAN_1="2.23" MEAN_2="2.24" ORDER="266" SD_1="2.03" SD_2="1.81" SE="0.08012854715969932" STUDY_ID="STD-Woodcock-2003" TOTAL_1="312" TOTAL_2="311" WEIGHT="56.20981010041231"/>
<CONT_DATA CI_END="0.3927002947607548" CI_START="-0.3927002947607548" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="3.5" MEAN_2="3.5" MODIFIED="2011-07-12 12:58:44 +0100" MODIFIED_BY="[Empty name]" ORDER="103" SD_1="2.8" SD_2="3.4" SE="0.20036097492521526" STUDY_ID="STD-Wright-2009" TOTAL_1="53" TOTAL_2="47" WEIGHT="8.990014299586857"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.1918076443375135" CI_END="0.28977614113686423" CI_START="-0.6369787598329606" DF="2" EFFECT_SIZE="-0.17360130934804816" ESTIMABLE="YES" I2="0.0" ID="CMP-001.03.03" MODIFIED="2011-08-09 17:54:54 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.9085514567902078" P_Z="0.46277348199103663" STUDIES="3" TAU2="0.0" TOTAL_1="36" TOTAL_2="36" WEIGHT="6.4567362383637725" Z="0.7342875956417514">
<NAME>Physical methods - cross-over studies</NAME>
<CONT_DATA CI_END="0.753682754215123" CI_START="-1.0985808343770982" EFFECT_SIZE="-0.17244904008098763" ESTIMABLE="YES" MEAN_1="0.02" MEAN_2="0.03" ORDER="268" SD_1="0.05" SD_2="0.06" SE="0.47252490433565103" STUDY_ID="STD-Antonicelli-1991" TOTAL_1="9" TOTAL_2="9" WEIGHT="1.6163568544852693"/>
<CONT_DATA CI_END="0.4749354855680232" CI_START="-1.0726700990788194" EFFECT_SIZE="-0.29886730675539813" ESTIMABLE="YES" MEAN_1="6.81" MEAN_2="9.13" ORDER="269" SD_1="6.73" SD_2="8.23" SE="0.39480459764928283" STUDY_ID="STD-Verrall-1988" TOTAL_1="13" TOTAL_2="13" WEIGHT="2.3153798630084985"/>
<CONT_DATA CI_END="0.6815150842321139" CI_START="-0.800459529247976" EFFECT_SIZE="-0.05947222250793101" ESTIMABLE="YES" MEAN_1="0.48" MEAN_2="0.53" ORDER="270" SD_1="0.67" SD_2="0.94" SE="0.37806169530912725" STUDY_ID="STD-Warner-1993" TOTAL_1="14" TOTAL_2="14" WEIGHT="2.524999520870005"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="9.629150011393136" CI_END="0.2845835792177256" CI_START="-0.02046522943337914" CI_STUDY="95" CI_TOTAL="95" DF="14" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.13205917489217323" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.04" MODIFIED="2011-08-09 17:55:28 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.7887633711946088" P_Q="0.5751962059269116" P_Z="0.08969999185507208" Q="1.9865827311030786" RANDOM="NO" SCALE="4.0" SORT_BY="STUDY" STUDIES="15" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="343" TOTAL_2="332" UNITS="" WEIGHT="100.0" Z="1.6969823797133414">
<NAME>FEV1 (forced expiratory volume in one second)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.8081568300600646" CI_END="0.29777919694149" CI_START="-0.4069339026696993" DF="3" EFFECT_SIZE="-0.054577352864104665" ESTIMABLE="YES" I2="0.0" ID="CMP-001.04.01" NO="1" P_CHI2="0.8475151047432361" P_Z="0.7614451996310813" STUDIES="4" TAU2="0.0" TOTAL_1="59" TOTAL_2="66" WEIGHT="18.73760059699988" Z="0.30358353220394907">
<NAME>Chemical methods</NAME>
<CONT_DATA CI_END="0.944381793950215" CI_START="-0.5047912685504954" EFFECT_SIZE="0.2197952626998598" ESTIMABLE="YES" MEAN_1="80.0" MEAN_2="77.5" ORDER="271" SD_1="8.8" SD_2="12.5" SE="0.3696937989502875" STUDY_ID="STD-Bahir-1997" TOTAL_1="13" TOTAL_2="17" WEIGHT="4.430963382782021"/>
<CONT_DATA CI_END="0.6063074713526561" CI_START="-0.938903668137039" EFFECT_SIZE="-0.16629809839219142" ESTIMABLE="YES" MEAN_1="87.0" MEAN_2="90.0" ORDER="272" SD_1="20.0" SD_2="15.0" SE="0.39419375857876043" STUDY_ID="STD-Chang-1996" TOTAL_1="12" TOTAL_2="14" WEIGHT="3.897292536366758"/>
<CONT_DATA CI_END="0.7852932935253013" CI_START="-0.8511103628162203" EFFECT_SIZE="-0.03290853464545952" ESTIMABLE="YES" MEAN_1="72.33" MEAN_2="72.79" ORDER="273" SD_1="11.87" SD_2="14.78" SE="0.4174575832130755" STUDY_ID="STD-Dietemann-1993" TOTAL_1="11" TOTAL_2="12" WEIGHT="3.475023805361654"/>
<CONT_DATA CI_END="0.40124435014729193" CI_START="-0.7571791688744505" EFFECT_SIZE="-0.1779674093635793" ESTIMABLE="YES" MEAN_1="76.0" MEAN_2="78.5" ORDER="274" SD_1="12.5" SD_2="15.0" SE="0.2955216341114529" STUDY_ID="STD-Reiser-1990" TOTAL_1="23" TOTAL_2="23" WEIGHT="6.934320872489447"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="3.912446650319788" CI_END="0.5063972914176784" CI_START="-0.0015083127634828997" DF="4" EFFECT_SIZE="0.25244448932709773" ESTIMABLE="YES" I2="0.0" ID="CMP-001.04.02" MODIFIED="2011-08-09 17:55:25 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.41798472598230263" P_Z="0.05137631643656067" STUDIES="5" TAU2="0.0" TOTAL_1="138" TOTAL_2="111" WEIGHT="36.07220220808681" Z="1.9483230864301995">
<NAME>Physical methods - parallel-group studies</NAME>
<CONT_DATA CI_END="0.6952289136552617" CI_START="-0.4559676865595571" EFFECT_SIZE="0.11963061354785232" ESTIMABLE="YES" MEAN_1="2.51" MEAN_2="2.42" ORDER="275" SD_1="0.77" SD_2="0.7" SE="0.2936779984977557" STUDY_ID="STD-Halken-2003" TOTAL_1="26" TOTAL_2="21" WEIGHT="7.021657952300857"/>
<CONT_DATA CI_END="0.7226255877266313" CI_START="-0.5864624917100948" EFFECT_SIZE="0.06808154800826825" ESTIMABLE="YES" MEAN_1="2.11" MEAN_2="2.05" ORDER="276" SD_1="1.03" SD_2="0.62" SE="0.333957177214134" STUDY_ID="STD-Shapiro-1999" TOTAL_1="19" TOTAL_2="17" WEIGHT="5.430013759286055"/>
<CONT_DATA CI_END="2.180969818906947" CI_START="0.19249828800783741" EFFECT_SIZE="1.186734053457392" ESTIMABLE="YES" MEAN_1="1.7" MEAN_2="1.3" MODIFIED="2011-07-12 18:54:33 +0100" MODIFIED_BY="[Empty name]" ORDER="277" SD_1="0.3" SD_2="0.4" SE="0.5072724668881466" STUDY_ID="STD-Thiam-1999" TOTAL_1="18" TOTAL_2="6" WEIGHT="2.3534225549332777"/>
<CONT_DATA CI_END="0.8676532187628048" CI_START="-0.3490278129118742" EFFECT_SIZE="0.2593127029254653" ESTIMABLE="YES" MEAN_1="77.4" MEAN_2="74.7" ORDER="278" SD_1="9.18" SD_2="11.25" SE="0.31038351757269617" STUDY_ID="STD-Walshaw-1986" TOTAL_1="22" TOTAL_2="20" WEIGHT="6.286156539444369"/>
<CONT_DATA CI_END="0.62593257620211" CI_START="-0.16220064765890999" EFFECT_SIZE="0.23186596427159997" ESTIMABLE="YES" MEAN_1="86.6" MEAN_2="82.5" MODIFIED="2011-07-12 13:00:02 +0100" MODIFIED_BY="[Empty name]" ORDER="104" SD_1="18.1" SD_2="16.9" SE="0.20105808833165154" STUDY_ID="STD-Wright-2009" TOTAL_1="53" TOTAL_2="47" WEIGHT="14.980951402122244"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.07565137367892802" CI_END="0.6788786372860012" CI_START="-0.5320572215476762" DF="1" EFFECT_SIZE="0.07341070786916253" ESTIMABLE="YES" I2="0.0" ID="CMP-001.04.03" MODIFIED="2011-08-09 17:55:28 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.7832794085675145" P_Z="0.8121616756384562" STUDIES="2" TAU2="0.0" TOTAL_1="21" TOTAL_2="21" WEIGHT="6.345946210097133" Z="0.2376382571439104">
<NAME>Physical methods - cross-over studies</NAME>
<CONT_DATA CI_END="1.0978678644201887" CI_START="-0.754360421274615" EFFECT_SIZE="0.17175372157278687" ESTIMABLE="YES" MEAN_1="3.27" MEAN_2="3.13" ORDER="279" SD_1="0.73" SD_2="0.82" SE="0.47251589832898566" STUDY_ID="STD-Antonicelli-1991" TOTAL_1="9" TOTAL_2="9" WEIGHT="2.712374434258966"/>
<CONT_DATA CI_END="0.8001519460592184" CI_START="-0.8001519460592184" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="1.88" MEAN_2="1.88" ORDER="280" SD_1="0.78" SD_2="0.77" SE="0.408248290463863" STUDY_ID="STD-Warburton-1994" TOTAL_1="12" TOTAL_2="12" WEIGHT="3.633571775838167"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="2.846312426231278" CI_END="0.36459924001067345" CI_START="-0.1248480829120607" DF="3" EFFECT_SIZE="0.11987557854930639" ESTIMABLE="YES" I2="0.0" ID="CMP-001.04.04" NO="4" P_CHI2="0.41593281672207427" P_Z="0.33702005769021903" STUDIES="4" TAU2="0.0" TOTAL_1="125" TOTAL_2="134" WEIGHT="38.844250984816185" Z="0.9600698811856945">
<NAME>Combination methods</NAME>
<CONT_DATA CI_END="1.0481518211569845" CI_START="-0.09119405735884939" EFFECT_SIZE="0.47847888189906757" ESTIMABLE="YES" MEAN_1="105.0" MEAN_2="98.6" ORDER="281" SD_1="10.2" SD_2="15.3" SE="0.2906547996552102" STUDY_ID="STD-Carswell-1996" TOTAL_1="23" TOTAL_2="26" WEIGHT="7.168486887082655"/>
<CONT_DATA CI_END="0.40208168287266066" CI_START="-0.22424139544968288" EFFECT_SIZE="0.0889201437114889" ESTIMABLE="YES" MEAN_1="81.3" MEAN_2="80.2" ORDER="282" SD_1="10.9" SD_2="13.5" SE="0.15977923147126682" STUDY_ID="STD-Cloosterman-1999" TOTAL_1="76" TOTAL_2="81" WEIGHT="23.7214830480296"/>
<CONT_DATA CI_END="1.1093316913927274" CI_START="-0.7434809807061757" EFFECT_SIZE="0.18292535534327575" ESTIMABLE="YES" MEAN_1="2.74" MEAN_2="2.61" ORDER="283" SD_1="0.81" SD_2="0.51" SE="0.4726649792326933" STUDY_ID="STD-Dorward-1988" TOTAL_1="9" TOTAL_2="9" WEIGHT="2.7106637111018834"/>
<CONT_DATA CI_END="0.40315466344460027" CI_START="-0.92899751037422" EFFECT_SIZE="-0.26292142346480984" ESTIMABLE="YES" MEAN_1="90.3" MEAN_2="96.2" ORDER="284" SD_1="17.8" SD_2="25.2" SE="0.33984098287689635" STUDY_ID="STD-Marks-1994" TOTAL_1="17" TOTAL_2="18" WEIGHT="5.243617338602041"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="12.612326408679825" CI_END="0.11016333799349652" CI_START="-0.08254373891115392" CI_STUDY="95" CI_TOTAL="95" DF="23" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.013809799541171296" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.05" MODIFIED="2011-08-09 17:55:49 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.9599018660578079" P_Q="0.6038772651607263" P_Z="0.7787791343000118" Q="1.851107202495805" RANDOM="NO" SCALE="4.0" SORT_BY="STUDY" STUDIES="24" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="837" TOTAL_2="828" UNITS="" WEIGHT="99.99999999999999" Z="0.2809103865739798">
<NAME>PEFR morning (Peak Expiratory Flow Rate)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="3.581862320426821" CI_END="0.14858885753888698" CI_START="-0.5628216974813824" DF="3" EFFECT_SIZE="-0.20711641997124772" ESTIMABLE="YES" I2="16.244686935858702" ID="CMP-001.05.01" NO="1" P_CHI2="0.3102991885922879" P_Z="0.2537751898059063" STUDIES="4" TAU2="0.0" TOTAL_1="59" TOTAL_2="66" WEIGHT="7.3376115862334315" Z="1.1412277225460956">
<NAME>Chemical methods</NAME>
<CONT_DATA CI_END="0.722125334193636" CI_START="-0.722125334193636" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="262.0" MEAN_2="262.0" ORDER="285" SD_1="82.0" SD_2="82.0" SE="0.368438063091806" STUDY_ID="STD-Bahir-1997" TOTAL_1="13" TOTAL_2="17" WEIGHT="1.7803696130766284"/>
<CONT_DATA CI_END="1.0794834533520457" CI_START="-0.4729584994309833" EFFECT_SIZE="0.30326247696053116" ESTIMABLE="YES" MEAN_1="411.0" MEAN_2="383.0" ORDER="286" SD_1="75.0" SD_2="100.0" SE="0.3960383877021447" STUDY_ID="STD-Chang-1996" TOTAL_1="12" TOTAL_2="14" WEIGHT="1.5408649864516226"/>
<CONT_DATA CI_END="0.18005258471085084" CI_START="-1.5097896914873026" EFFECT_SIZE="-0.6648685533882258" ESTIMABLE="YES" MEAN_1="67.88" MEAN_2="75.37" ORDER="287" SD_1="11.28" SD_2="10.46" SE="0.4310901346982428" STUDY_ID="STD-Dietemann-1993" TOTAL_1="11" TOTAL_2="12" WEIGHT="1.300477927850388"/>
<CONT_DATA CI_END="0.1714074648604032" CI_START="-0.9979326577395211" EFFECT_SIZE="-0.4132625964395589" ESTIMABLE="YES" MEAN_1="92.0" MEAN_2="100.0" ORDER="288" SD_1="20.0" SD_2="18.0" SE="0.298306533136203" STUDY_ID="STD-Reiser-1990" TOTAL_1="23" TOTAL_2="23" WEIGHT="2.715899058854792"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="6.926863062693576" CI_END="0.13262586718248637" CI_START="-0.09791665622573577" DF="11" EFFECT_SIZE="0.017354605478375296" ESTIMABLE="YES" I2="0.0" ID="CMP-001.05.02" MODIFIED="2011-08-09 17:55:46 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.8049750339415438" P_Z="0.7679317222052277" STUDIES="12" TAU2="0.0" TOTAL_1="593" TOTAL_2="569" WEIGHT="69.87040212934214" Z="0.2950813689437044">
<NAME>Physical methods - parallel-group studies</NAME>
<CONT_DATA CI_END="1.1966247587032672" CI_START="-0.5697732369763463" EFFECT_SIZE="0.3134257608634605" ESTIMABLE="YES" MEAN_1="98.2" MEAN_2="91.8" ORDER="289" SD_1="22.7" SD_2="15.8" SE="0.45062001384023775" STUDY_ID="STD-Cinti-1996" TOTAL_1="10" TOTAL_2="10" WEIGHT="1.1901952183121713"/>
<CONT_DATA CI_END="0.3552507850144072" CI_START="-0.4624572052275284" EFFECT_SIZE="-0.05360321010656058" ESTIMABLE="YES" MEAN_1="457.0" MEAN_2="464.0" ORDER="298" SD_1="145.0" SD_2="111.0" SE="0.20860281022812457" STUDY_ID="STD-de-Vries-2007" TOTAL_1="47" TOTAL_2="45" WEIGHT="5.553910087656"/>
<CONT_DATA CI_END="1.0875424356821204" CI_START="-0.2584160897395263" EFFECT_SIZE="0.414563172971297" ESTIMABLE="YES" MEAN_1="349.0" MEAN_2="304.0" ORDER="290" SD_1="96.0" SD_2="117.0" SE="0.343363076066294" STUDY_ID="STD-Fang-2001" TOTAL_1="19" TOTAL_2="16" WEIGHT="2.0498966810802375"/>
<CONT_DATA CI_END="0.7477600025810939" CI_START="-0.4046082498175819" EFFECT_SIZE="0.171575876381756" ESTIMABLE="YES" MEAN_1="358.0" MEAN_2="342.0" ORDER="291" SD_1="96.0" SD_2="86.0" SE="0.2939768948532752" STUDY_ID="STD-Halken-2003" TOTAL_1="26" TOTAL_2="21" WEIGHT="2.796486696357581"/>
<CONT_DATA CI_END="0.5531620483504736" CI_START="-0.6581575463433162" EFFECT_SIZE="-0.052497748996421394" ESTIMABLE="YES" MEAN_1="88.6" MEAN_2="89.43" ORDER="292" SD_1="13.66" SD_2="17.33" SE="0.30901577892464455" STUDY_ID="STD-Lee-2003" TOTAL_1="22" TOTAL_2="20" WEIGHT="2.530916647796716"/>
<CONT_DATA CI_END="0.540452996291077" CI_START="-0.8711115148682206" EFFECT_SIZE="-0.16532925928857176" ESTIMABLE="YES" MEAN_1="367.0" MEAN_2="388.0" ORDER="293" SD_1="156.0" SD_2="75.0" SE="0.3600996044553722" STUDY_ID="STD-Luczynska-2003" TOTAL_1="16" TOTAL_2="15" WEIGHT="1.863776646424328"/>
<CONT_DATA CI_END="0.6750621385846783" CI_START="-0.7596684840605891" EFFECT_SIZE="-0.04230317273795535" ESTIMABLE="YES" MEAN_1="435.0" MEAN_2="440.0" ORDER="294" SD_1="115.0" SD_2="115.0" SE="0.3660094353677515" STUDY_ID="STD-Rijssenbeek-2002" TOTAL_1="16" TOTAL_2="14" WEIGHT="1.8040750145630586"/>
<CONT_DATA CI_END="0.6755258497928865" CI_START="-0.523435791646849" EFFECT_SIZE="0.07604502907301883" ESTIMABLE="YES" MEAN_1="16.38" MEAN_2="13.68" ORDER="295" SD_1="25.62" SD_2="43.14" SE="0.3058631818995124" STUDY_ID="STD-Sheikh-2002" TOTAL_1="23" TOTAL_2="20" WEIGHT="2.583358923897555"/>
<CONT_DATA CI_END="0.8637348497369673" CI_START="-0.2307960386039266" EFFECT_SIZE="0.31646940556652037" ESTIMABLE="YES" MEAN_1="431.0" MEAN_2="395.0" ORDER="299" SD_1="115.0" SD_2="109.0" SE="0.27922219412560995" STUDY_ID="STD-van-den-Bemt-2004" TOTAL_1="26" TOTAL_2="26" WEIGHT="3.0998400379147757"/>
<CONT_DATA CI_END="0.9401392461827947" CI_START="-0.27999650320014413" EFFECT_SIZE="0.33007137149132526" ESTIMABLE="YES" MEAN_1="407.0" MEAN_2="369.0" ORDER="296" SD_1="112.0" SD_2="114.0" SE="0.31126483930501114" STUDY_ID="STD-Walshaw-1986" TOTAL_1="22" TOTAL_2="20" WEIGHT="2.4944742421379384"/>
<CONT_DATA CI_END="0.08012357400720625" CI_START="-0.2328370201191053" EFFECT_SIZE="-0.07635672305594952" ESTIMABLE="YES" MEAN_1="429.3" MEAN_2="436.2" ORDER="297" SD_1="91.7" SD_2="88.8" SE="0.07983835330518947" STUDY_ID="STD-Woodcock-2003" TOTAL_1="313" TOTAL_2="315" WEIGHT="37.91543233920193"/>
<CONT_DATA CI_END="0.597365425187978" CI_START="-0.1901432236928247" EFFECT_SIZE="0.20361110074757663" ESTIMABLE="YES" MEAN_1="419.2" MEAN_2="395.8" MODIFIED="2011-07-12 12:55:41 +0100" MODIFIED_BY="[Empty name]" ORDER="100" SD_1="127.9" SD_2="96.0" SE="0.20089875505176888" STUDY_ID="STD-Wright-2009" TOTAL_1="53" TOTAL_2="47" WEIGHT="5.98803959399986"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.1210245946863562" CI_END="0.37120290389705124" CI_START="-0.26084605382939485" DF="4" EFFECT_SIZE="0.055178425033828166" ESTIMABLE="YES" I2="0.0" ID="CMP-001.05.03" MODIFIED="2011-08-09 17:55:49 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.9982413417294419" P_Z="0.7321905060748548" STUDIES="5" TAU2="0.0" TOTAL_1="77" TOTAL_2="77" WEIGHT="9.29595234449054" Z="0.3422131291188788">
<NAME>Physical methods - cross-over studies</NAME>
<CONT_DATA CI_END="0.9068950836738766" CI_START="-0.9410197258851062" EFFECT_SIZE="-0.01706232110561483" ESTIMABLE="YES" MEAN_1="443.0" MEAN_2="445.0" ORDER="300" SD_1="106.0" SD_2="117.0" SE="0.47141550154367606" STUDY_ID="STD-Antonicelli-1991" TOTAL_1="9" TOTAL_2="9" WEIGHT="1.0875054338581083"/>
<CONT_DATA CI_END="0.5418194736183215" CI_START="-0.4383372318494396" EFFECT_SIZE="0.05174112088444093" ESTIMABLE="YES" MEAN_1="335.0" MEAN_2="329.0" ORDER="301" SD_1="111.0" SD_2="118.0" SE="0.2500445705122931" STUDY_ID="STD-Burr-1976" TOTAL_1="32" TOTAL_2="32" WEIGHT="3.8654877109463692"/>
<CONT_DATA CI_END="1.0649497150370513" CI_START="-0.6928129407149668" EFFECT_SIZE="0.18606838716104218" ESTIMABLE="YES" MEAN_1="67.0" MEAN_2="64.3" ORDER="302" SD_1="15.0" SD_2="12.7" SE="0.44841708052214874" STUDY_ID="STD-Mitchell-1980" TOTAL_1="10" TOTAL_2="10" WEIGHT="1.2019180591900778"/>
<CONT_DATA CI_END="0.8588609686355223" CI_START="-0.7418524501584639" EFFECT_SIZE="0.058504259238529165" ESTIMABLE="YES" MEAN_1="350.0" MEAN_2="344.0" ORDER="303" SD_1="101.0" SD_2="97.0" SE="0.40835276347428046" STUDY_ID="STD-Warburton-1994" TOTAL_1="12" TOTAL_2="12" WEIGHT="1.44933291834186"/>
<CONT_DATA CI_END="0.7544353572504966" CI_START="-0.7271781675141841" EFFECT_SIZE="0.013628594868156298" ESTIMABLE="YES" MEAN_1="232.6" MEAN_2="231.3" ORDER="304" SD_1="88.0" SD_2="97.0" SE="0.3779695791482545" STUDY_ID="STD-Warner-1993" TOTAL_1="14" TOTAL_2="14" WEIGHT="1.6917082221541253"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.1314692283772653" CI_END="0.3493578584970076" CI_START="-0.17520143163869942" DF="2" EFFECT_SIZE="0.08707821342915409" ESTIMABLE="YES" I2="0.0" ID="CMP-001.05.04" NO="4" P_CHI2="0.9363793427923532" P_Z="0.5152283582672947" STUDIES="3" TAU2="0.0" TOTAL_1="108" TOTAL_2="116" WEIGHT="13.496033939933872" Z="0.6507182900719596">
<NAME>Combination methods</NAME>
<CONT_DATA CI_END="0.6038154329743602" CI_START="-0.5184075375838145" EFFECT_SIZE="0.042703947695272894" ESTIMABLE="YES" MEAN_1="99.6" MEAN_2="98.9" ORDER="305" SD_1="17.8" SD_2="14.5" SE="0.2862866306243702" STUDY_ID="STD-Carswell-1996" TOTAL_1="23" TOTAL_2="26" WEIGHT="2.948743657413255"/>
<CONT_DATA CI_END="0.4290427165217101" CI_START="-0.1975005623128021" EFFECT_SIZE="0.115771077104454" ESTIMABLE="YES" MEAN_1="544.0" MEAN_2="529.0" ORDER="306" SD_1="132.0" SD_2="126.0" SE="0.15983540610353192" STUDY_ID="STD-Cloosterman-1999" TOTAL_1="76" TOTAL_2="81" WEIGHT="9.460044441306687"/>
<CONT_DATA CI_END="0.8818398959151554" CI_START="-0.9662955061000438" EFFECT_SIZE="-0.04222780509244416" ESTIMABLE="YES" MEAN_1="388.0" MEAN_2="392.0" ORDER="307" SD_1="106.0" SD_2="71.0" SE="0.4714717761635049" STUDY_ID="STD-Dorward-1988" TOTAL_1="9" TOTAL_2="9" WEIGHT="1.08724584121393"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="8.461405930413049" CI_END="0.24004260394005988" CI_START="-0.12551881614106936" CI_STUDY="95" CI_TOTAL="95" DF="12" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.057261893899495264" ESTIMABLE="YES" I2="0.0" I2_Q="30.69104553597115" ID="CMP-001.06" MODIFIED="2011-08-09 17:56:04 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.7481142605160609" P_Q="0.22811280472240825" P_Z="0.5392012534965245" Q="4.32844503744028" RANDOM="NO" SCALE="4.0" SORT_BY="STUDY" STUDIES="13" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="240" TOTAL_2="227" UNITS="" WEIGHT="100.00000000000001" Z="0.6140213029299264">
<NAME>PEFR evening (Peak Expiratory Flow Rate)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="2.8740107520771896" CI_END="0.07196668064638934" CI_START="-1.04872802685999" DF="1" EFFECT_SIZE="-0.4883806731068002" ESTIMABLE="YES" I2="65.20541896799618" ID="CMP-001.06.01" NO="1" P_CHI2="0.09002040403873035" P_Z="0.0875915655680132" STUDIES="2" TAU2="0.0" TOTAL_1="24" TOTAL_2="29" WEIGHT="10.64010881688516" Z="1.708241367829087">
<NAME>Chemical methods</NAME>
<CONT_DATA CI_END="0.6287934897038022" CI_START="-0.8163545447347368" EFFECT_SIZE="-0.09378052751546728" ESTIMABLE="YES" MEAN_1="263.0" MEAN_2="271.0" ORDER="308" SD_1="83.0" SD_2="83.0" SE="0.3686669872093779" STUDY_ID="STD-Bahir-1997" TOTAL_1="13" TOTAL_2="17" WEIGHT="6.398763199244135"/>
<CONT_DATA CI_END="-0.19617872215892473" CI_START="-1.9712202742966953" EFFECT_SIZE="-1.08369949822781" ESTIMABLE="YES" MEAN_1="67.16" MEAN_2="79.23" ORDER="309" SD_1="11.03" SD_2="10.46" SE="0.4528250432505576" STUDY_ID="STD-Dietemann-1993" TOTAL_1="11" TOTAL_2="12" WEIGHT="4.241345617641026"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.222633660905761" CI_END="0.37497590296392447" CI_START="-0.07535929662167765" DF="5" EFFECT_SIZE="0.14980830317112342" ESTIMABLE="YES" I2="0.0" ID="CMP-001.06.02" MODIFIED="2011-08-09 17:56:01 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.9426876339723532" P_Z="0.19223308469032402" STUDIES="6" TAU2="0.0" TOTAL_1="162" TOTAL_2="144" WEIGHT="65.89446303368274" Z="1.3040014596711393">
<NAME>Physical methods - parallel-group studies</NAME>
<CONT_DATA CI_END="0.9083020118366187" CI_START="-0.42714159628163123" EFFECT_SIZE="0.24058020777749373" ESTIMABLE="YES" MEAN_1="368.0" MEAN_2="341.0" ORDER="310" SD_1="95.0" SD_2="125.0" SE="0.34068064991297253" STUDY_ID="STD-Fang-2001" TOTAL_1="19" TOTAL_2="16" WEIGHT="7.493239330381516"/>
<CONT_DATA CI_END="0.7394487713241129" CI_START="-0.41270670769149564" EFFECT_SIZE="0.16337103181630863" ESTIMABLE="YES" MEAN_1="363.0" MEAN_2="348.0" ORDER="311" SD_1="95.0" SD_2="84.0" SE="0.2939226149316171" STUDY_ID="STD-Halken-2003" TOTAL_1="26" TOTAL_2="21" WEIGHT="10.066964395456006"/>
<CONT_DATA CI_END="0.5527588772337417" CI_START="-0.658564273864497" EFFECT_SIZE="-0.052902698315377666" ESTIMABLE="YES" MEAN_1="90.27" MEAN_2="91.1" ORDER="312" SD_1="13.46" SD_2="17.28" SE="0.3090166861873486" STUDY_ID="STD-Lee-2003" TOTAL_1="22" TOTAL_2="20" WEIGHT="9.107531378459777"/>
<CONT_DATA CI_END="0.6467340167246258" CI_START="-0.7883276699878254" EFFECT_SIZE="-0.07079682663159985" ESTIMABLE="YES" MEAN_1="445.0" MEAN_2="454.0" ORDER="313" SD_1="114.0" SD_2="134.0" SE="0.36609389203884224" STUDY_ID="STD-Rijssenbeek-2002" TOTAL_1="16" TOTAL_2="14" WEIGHT="6.489026860859825"/>
<CONT_DATA CI_END="0.6841595733172378" CI_START="-0.4044696875163959" EFFECT_SIZE="0.1398449429004209" ESTIMABLE="YES" MEAN_1="437.0" MEAN_2="421.0" ORDER="314" SD_1="119.0" SD_2="106.0" SE="0.27771664923962947" STUDY_ID="STD-van-den-Bemt-2004" TOTAL_1="26" TOTAL_2="26" WEIGHT="11.276146374108238"/>
<CONT_DATA CI_END="0.6642611830078344" CI_START="-0.12483467909800355" EFFECT_SIZE="0.26971325195491547" ESTIMABLE="YES" MEAN_1="436.1" MEAN_2="405.9" MODIFIED="2011-07-12 12:56:45 +0100" MODIFIED_BY="[Empty name]" ORDER="101" SD_1="124.7" SD_2="93.4" SE="0.20130366382497983" STUDY_ID="STD-Wright-2009" TOTAL_1="53" TOTAL_2="47" WEIGHT="21.461554694417373"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0363164799898177" CI_END="0.4737563348506095" CI_START="-0.3529648710642997" DF="3" EFFECT_SIZE="0.06039573189315487" ESTIMABLE="YES" I2="0.0" ID="CMP-001.06.03" MODIFIED="2011-08-09 17:56:04 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.9981792611445571" P_Z="0.7745958921115754" STUDIES="4" TAU2="0.0" TOTAL_1="45" TOTAL_2="45" WEIGHT="19.552511774719772" Z="0.2863685084732285">
<NAME>Physical methods - cross-over studies</NAME>
<CONT_DATA CI_END="0.9067414437428281" CI_START="-0.9411741464706445" EFFECT_SIZE="-0.017216351363908203" ESTIMABLE="YES" MEAN_1="442.0" MEAN_2="444.0" ORDER="315" SD_1="105.0" SD_2="116.0" SE="0.471415700693889" STUDY_ID="STD-Antonicelli-1991" TOTAL_1="9" TOTAL_2="9" WEIGHT="3.913419931120069"/>
<CONT_DATA CI_END="0.9681993923641518" CI_START="-0.7859779748852479" EFFECT_SIZE="0.09111070873945191" ESTIMABLE="YES" MEAN_1="72.0" MEAN_2="70.9" ORDER="316" SD_1="12.1" SD_2="11.0" SE="0.44750244930165217" STUDY_ID="STD-Mitchell-1980" TOTAL_1="10" TOTAL_2="10" WEIGHT="4.3428387551230845"/>
<CONT_DATA CI_END="0.8878733171021752" CI_START="-0.7133415950931433" EFFECT_SIZE="0.0872658610045159" ESTIMABLE="YES" MEAN_1="370.0" MEAN_2="362.0" ORDER="317" SD_1="87.0" SD_2="90.0" SE="0.4084806978152398" STUDY_ID="STD-Warburton-1994" TOTAL_1="12" TOTAL_2="12" WEIGHT="5.212204650280174"/>
<CONT_DATA CI_END="0.8064006396936153" CI_START="-0.6756533479408054" EFFECT_SIZE="0.06537364587640497" ESTIMABLE="YES" MEAN_1="239.2" MEAN_2="232.8" ORDER="318" SD_1="92.0" SD_2="98.0" SE="0.37808194418996305" STUDY_ID="STD-Warner-1993" TOTAL_1="14" TOTAL_2="14" WEIGHT="6.084048438196444"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.890841719728837" CI_START="-0.9571927715435333" DF="0" EFFECT_SIZE="-0.03317552590734815" ESTIMABLE="YES" I2="0.0" ID="CMP-001.06.04" NO="4" P_CHI2="1.0" P_Z="0.9438993904800447" STUDIES="1" TAU2="0.0" TOTAL_1="9" TOTAL_2="9" WEIGHT="3.91291637471234" Z="0.0703697211861124">
<NAME>Combination methods</NAME>
<CONT_DATA CI_END="0.890841719728837" CI_START="-0.9571927715435333" EFFECT_SIZE="-0.03317552590734815" ESTIMABLE="YES" MEAN_1="392.0" MEAN_2="395.0" ORDER="319" SD_1="103.0" SD_2="65.0" SE="0.4714460331540351" STUDY_ID="STD-Dorward-1988" TOTAL_1="9" TOTAL_2="9" WEIGHT="3.91291637471234"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="6.396771870637649" CI_END="0.22437646557824498" CI_START="-0.13265431761516822" CI_STUDY="95" CI_TOTAL="95" DF="13" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.045861073981538394" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.07" MODIFIED="2011-08-09 17:56:24 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.9305137287805475" P_Q="0.6966989508377971" P_Z="0.6145987900808532" Q="1.4377986223911277" RANDOM="NO" SCALE="4.0" SORT_BY="STUDY" STUDIES="13" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="254" TOTAL_2="239" UNITS="" WEIGHT="100.0" Z="0.5035199065591411">
<NAME>PC20 (provocative concentration for 20% fall in FEV1)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.6323323212874491" CI_END="0.22593286266092588" CI_START="-0.4259985623664088" DF="4" EFFECT_SIZE="-0.10003284985274145" ESTIMABLE="YES" I2="0.0" ID="CMP-001.07.01" NO="1" P_CHI2="0.9594039508559354" P_Z="0.547522525465296" STUDIES="5" TAU2="0.0" TOTAL_1="77" TOTAL_2="70" WEIGHT="29.992142685194825" Z="0.6014767058484888">
<NAME>Chemical methods</NAME>
<CONT_DATA CI_END="0.7860798639151655" CI_START="-0.7560370324699771" EFFECT_SIZE="0.015021415722594179" ESTIMABLE="YES" MEAN_1="0.87" MEAN_2="0.82" ORDER="320" SD_1="2.29" SD_2="3.84" SE="0.39340439634329094" STUDY_ID="STD-Chang-1996" TOTAL_1="12" TOTAL_2="14" WEIGHT="5.360147417102116"/>
<CONT_DATA CI_END="0.7658008451255466" CI_START="-1.743510355519343" EFFECT_SIZE="-0.48885475519689814" ESTIMABLE="YES" MEAN_1="-0.57" MEAN_2="-0.29" ORDER="321" SD_1="0.51" SD_2="0.55" SE="0.6401421710903914" STUDY_ID="STD-Ehnert-1992" TOTAL_1="7" TOTAL_2="4" WEIGHT="2.0244277178638903"/>
<CONT_DATA CI_END="0.4228113065841041" CI_START="-0.7350364201978956" EFFECT_SIZE="-0.15611255680689579" ESTIMABLE="YES" MEAN_1="0.48" MEAN_2="0.7" ORDER="322" SD_1="1.13" SD_2="1.6" SE="0.29537474563689814" STUDY_ID="STD-Reiser-1990" TOTAL_1="23" TOTAL_2="23" WEIGHT="9.508421612844034"/>
<CONT_DATA CI_END="0.8674121837172808" CI_START="-0.7559585624563832" EFFECT_SIZE="0.05572681063044882" ESTIMABLE="YES" MEAN_1="0.5" MEAN_2="0.47" ORDER="323" SD_1="0.49" SD_2="0.56" SE="0.41413280013780995" STUDY_ID="STD-Sette-1994" TOTAL_1="14" TOTAL_2="10" WEIGHT="4.836997847547498"/>
<CONT_DATA CI_END="0.5149999800948306" CI_START="-0.7271074941723226" EFFECT_SIZE="-0.10605375703874598" ESTIMABLE="YES" MEAN_1="1.75" MEAN_2="1.95" ORDER="324" SD_1="1.6" SD_2="2.09" SE="0.3168699741588974" STUDY_ID="STD-van-der-Heide-1997A" TOTAL_1="21" TOTAL_2="19" WEIGHT="8.26214808983729"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.67686881761426" CI_END="0.429008484643569" CI_START="-0.2690243476095713" DF="3" EFFECT_SIZE="0.07999206851699886" ESTIMABLE="YES" I2="0.0" ID="CMP-001.07.02" MODIFIED="2011-08-09 17:56:21 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.642088649683923" P_Z="0.6532803637035871" STUDIES="4" TAU2="0.0" TOTAL_1="72" TOTAL_2="58" WEIGHT="26.16131828407687" Z="0.4492097394218889">
<NAME>Physical methods, parallel-group studies</NAME>
<CONT_DATA CI_END="1.0929383851464058" CI_START="-0.35246470775994987" EFFECT_SIZE="0.370236838693228" ESTIMABLE="YES" MEAN_1="-1.7" MEAN_2="-2.1" ORDER="325" SD_1="1.0" SD_2="1.1" SE="0.36873205434066925" STUDY_ID="STD-Dharmage-2006" TOTAL_1="15" TOTAL_2="15" WEIGHT="6.101454342891481"/>
<CONT_DATA CI_END="0.502308396671459" CI_START="-0.6481912340908347" EFFECT_SIZE="-0.07294141870968783" ESTIMABLE="YES" MEAN_1="3.84" MEAN_2="3.89" ORDER="326" SD_1="0.7" SD_2="0.64" SE="0.29350019690088386" STUDY_ID="STD-Halken-2003" TOTAL_1="26" TOTAL_2="21" WEIGHT="9.630267660809956"/>
<CONT_DATA CI_END="1.2157437500356962" CI_START="-0.5147579888089711" EFFECT_SIZE="0.3504928806133626" ESTIMABLE="YES" MEAN_1="-1.2" MEAN_2="-1.6" ORDER="327" SD_1="1.1" SD_2="1.1" SE="0.44146263719503115" STUDY_ID="STD-Htut-2001" TOTAL_1="15" TOTAL_2="8" WEIGHT="4.256643169111405"/>
<CONT_DATA CI_END="0.5636732322400071" CI_START="-0.8733347267606255" EFFECT_SIZE="-0.15483074726030918" ESTIMABLE="YES" MEAN_1="0.28" MEAN_2="0.33" ORDER="328" SD_1="0.29" SD_2="0.34" SE="0.36659039919497705" STUDY_ID="STD-Rijssenbeek-2002" TOTAL_1="16" TOTAL_2="14" WEIGHT="6.17295311126403"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.8038336936258523" CI_START="-1.0462082643683692" DF="0" EFFECT_SIZE="-0.1211872853712585" ESTIMABLE="YES" I2="0.0" ID="CMP-001.07.03" MODIFIED="2011-08-09 17:56:24 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.7973520925853483" STUDIES="1" TAU2="0.0" TOTAL_1="9" TOTAL_2="9" WEIGHT="3.7243301172107905" Z="0.25677548953469337">
<NAME>Physical methods - cross-over studies</NAME>
<CONT_DATA CI_END="0.8038336936258521" CI_START="-1.0462082643683692" EFFECT_SIZE="-0.1211872853712585" ESTIMABLE="YES" MEAN_1="2.04" MEAN_2="2.09" ORDER="329" SD_1="0.48" SD_2="0.28" SE="0.47195815142194353" STUDY_ID="STD-Antonicelli-1991" TOTAL_1="9" TOTAL_2="9" WEIGHT="3.7243301172107905"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="2.649772109344813" CI_END="0.42999848725160394" CI_START="-0.1336563586806452" DF="3" EFFECT_SIZE="0.14817106428547935" ESTIMABLE="YES" I2="0.0" ID="CMP-001.07.04" NO="4" P_CHI2="0.44883064436836717" P_Z="0.3027973589955697" STUDIES="4" TAU2="0.0" TOTAL_1="96" TOTAL_2="102" WEIGHT="40.12220891351751" Z="1.0304531279960492">
<NAME>Combination methods</NAME>
<CONT_DATA CI_END="0.5012782949707972" CI_START="-0.17611820809281212" EFFECT_SIZE="0.16258004343899254" ESTIMABLE="YES" MEAN_1="0.08" MEAN_2="-0.37" ORDER="330" SD_1="2.29" SD_2="3.1" SE="0.172808405768378" STUDY_ID="STD-Cloosterman-1999" TOTAL_1="63" TOTAL_2="72" WEIGHT="27.7795639544904"/>
<CONT_DATA CI_END="1.3860234359148105" CI_START="-0.4912116728447864" EFFECT_SIZE="0.44740588153501204" ESTIMABLE="YES" MEAN_1="0.36" MEAN_2="0.08" ORDER="331" SD_1="0.63" SD_2="0.56" SE="0.4788953071502813" STUDY_ID="STD-Dorward-1988" TOTAL_1="9" TOTAL_2="9" WEIGHT="3.617212219458518"/>
<CONT_DATA CI_END="2.3621131769822052" CI_START="-0.5323950928118778" EFFECT_SIZE="0.9148590420851638" ESTIMABLE="YES" MEAN_1="0.07" MEAN_2="-0.29" ORDER="332" SD_1="0.26" SD_2="0.55" SE="0.7384085352143189" STUDY_ID="STD-Ehnert-1992" TOTAL_1="7" TOTAL_2="3" WEIGHT="1.5214641926026338"/>
<CONT_DATA CI_END="0.44553927513956815" CI_START="-0.884669347260894" EFFECT_SIZE="-0.2195650360606629" ESTIMABLE="YES" MEAN_1="-0.16" MEAN_2="0.03" ORDER="333" SD_1="0.91" SD_2="0.78" SE="0.3393451698329607" STUDY_ID="STD-Marks-1994" TOTAL_1="17" TOTAL_2="18" WEIGHT="7.203968546965962"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2011-08-10 12:11:07 +0100" MODIFIED_BY="Emma J Welsh">
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2011-08-10 12:11:07 +0100" MODIFIED_BY="Emma J Welsh" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>'Risk of bias' summary: review authors' judgements about allocation concealment for each included study.</P>
</CAPTION>
<FILE>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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<APPENDIX ID="APP-01" MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh" NO="1">
<TITLE MODIFIED="2011-07-20 14:17:24 +0100" MODIFIED_BY="[Empty name]">Sources and search methods for the Cochrane Airways Group Specialised Register (CAGR)</TITLE>
<APPENDIX_BODY MODIFIED="2011-08-10 12:11:04 +0100" MODIFIED_BY="Emma J Welsh">
<SUBSECTION>
<HEADING LEVEL="3">Electronic searches: core databases</HEADING>
<TABLE COLS="2" ROWS="7">
<TR>
<TD VALIGN="TOP">
<P>
<B>Database</B>
</P>
</TD>
<TD VALIGN="TOP">
<P>
<B>Frequency of search</B>
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>MEDLINE (Ovid)</P>
</TD>
<TD VALIGN="TOP">
<P>Weekly</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>EMBASE (Ovid)</P>
</TD>
<TD VALIGN="TOP">
<P>Weekly</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>CENTRAL (<I>T</I>
<I>he Cochrane Library</I>)</P>
</TD>
<TD VALIGN="TOP">
<P>Quarterly (4 issues per year)</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>PSYCINFO (Ovid)</P>
</TD>
<TD VALIGN="TOP">
<P>Monthly</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>CINAHL (EBSCO)</P>
</TD>
<TD VALIGN="TOP">
<P>Monthly</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>AMED (EBSCO)</P>
</TD>
<TD VALIGN="TOP">
<P>Monthly</P>
</TD>
</TR>
</TABLE>
<P> </P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Handsearches: core respiratory conference abstracts</HEADING>
<TABLE COLS="2" ROWS="9">
<TR>
<TD VALIGN="TOP">
<P>
<B>Conference</B>
</P>
</TD>
<TD VALIGN="TOP">
<P>
<B>Years searched</B>
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>American Academy of Allergy, Asthma and Immunology (AAAAI)</P>
</TD>
<TD VALIGN="TOP">
<P>2001 onwards</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>American Thoracic Society (ATS)</P>
</TD>
<TD VALIGN="TOP">
<P>2001 onwards</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Asia Pacific Society of Respirology (APSR)</P>
</TD>
<TD VALIGN="TOP">
<P>2004 onwards</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>British Thoracic Society Winter Meeting (BTS)</P>
</TD>
<TD VALIGN="TOP">
<P>2000 onwards</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Chest Meeting</P>
</TD>
<TD VALIGN="TOP">
<P>2003 onwards</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>European Respiratory Society (ERS)</P>
</TD>
<TD VALIGN="TOP">
<P>1992, 1994, 2000 onwards</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>International Primary Care Respiratory Group Congress (IPCRG)</P>
</TD>
<TD VALIGN="TOP">
<P>2002 onwards</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Thoracic Society of Australia and New Zealand (TSANZ)</P>
</TD>
<TD VALIGN="TOP">
<P>1999 onwards</P>
</TD>
</TR>
</TABLE>
<P> </P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">MEDLINE search strategy used to identify trials for the CAGR</HEADING>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Condition search</HEADING>
<P>1. exp Asthma/</P>
<P>2. asthma$.mp.</P>
<P>3. (antiasthma$ or anti-asthma$).mp.</P>
<P>4. Respiratory Sounds/</P>
<P>5. wheez$.mp.</P>
<P>6. Bronchial Spasm/</P>
<P>7. bronchospas$.mp.</P>
<P>8. (bronch$ adj3 spasm$).mp.</P>
<P>9. bronchoconstrict$.mp.</P>
<P>10. exp Bronchoconstriction/</P>
<P>11. (bronch$ adj3 constrict$).mp.</P>
<P>12. Bronchial Hyperreactivity/</P>
<P>13. Respiratory Hypersensitivity/</P>
<P>14. ((bronchial$ or respiratory or airway$ or lung$) adj3 (hypersensitiv$ or hyperreactiv$ or allerg$ or insufficiency)).mp.</P>
<P>15. ((dust or mite$) adj3 (allerg$ or hypersensitiv$)).mp.</P>
<P>16. or/1-15</P>
<P>17. exp Aspergillosis, Allergic Bronchopulmonary/</P>
<P>18. lung diseases, fungal/</P>
<P>19. aspergillosis/</P>
<P>20. 18 and 19</P>
<P>21. (bronchopulmonar$ adj3 aspergillosis).mp.</P>
<P>22. 17 or 20 or 21</P>
<P>23. 16 or 22</P>
<P>24. Lung Diseases, Obstructive/</P>
<P>25. exp Pulmonary Disease, Chronic Obstructive/</P>
<P>26. emphysema$.mp.</P>
<P>27. (chronic$ adj3 bronchiti$).mp.</P>
<P>28. (obstruct$ adj3 (pulmonary or lung$ or airway$ or airflow$ or bronch$ or respirat$)).mp.</P>
<P>29. COPD.mp.</P>
<P>30. COAD.mp.</P>
<P>31. COBD.mp.</P>
<P>32. AECB.mp.</P>
<P>33. or/24-32</P>
<P>34. exp Bronchiectasis/</P>
<P>35. bronchiect$.mp.</P>
<P>36. bronchoect$.mp.</P>
<P>37. kartagener$.mp.</P>
<P>38. (ciliary adj3 dyskinesia).mp.</P>
<P>39. (bronchial$ adj3 dilat$).mp.</P>
<P>40. or/34-39</P>
<P>41. exp Sleep Apnea Syndromes/</P>
<P>42. (sleep$ adj3 (apnea$ or apnoea$)).mp.</P>
<P>43. (hypopnea$ or hypopnoea$).mp.</P>
<P>44. OSA.mp.</P>
<P>45. SHS.mp.</P>
<P>46. OSAHS.mp.</P>
<P>47. or/41-46</P>
<P>48. Lung Diseases, Interstitial/</P>
<P>49. Pulmonary Fibrosis/</P>
<P>50. Sarcoidosis, Pulmonary/</P>
<P>51. (interstitial$ adj3 (lung$ or disease$ or pneumon$)).mp.</P>
<P>52. ((pulmonary$ or lung$ or alveoli$) adj3 (fibros$ or fibrot$)).mp.</P>
<P>53. ((pulmonary$ or lung$) adj3 (sarcoid$ or granulom$)).mp.</P>
<P>54. or/48-53</P>
<P>55. 23 or 33 or 40 or 47 or 54</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Filter to identify RCTs</HEADING>
<P>1. exp "clinical trial [publication type]"/</P>
<P>2. (randomized or randomised).ab,ti.</P>
<P>3. placebo.ab,ti.</P>
<P>4. dt.fs.</P>
<P>5. randomly.ab,ti.</P>
<P>6. trial.ab,ti.</P>
<P>7. groups.ab,ti.</P>
<P>8. or/1-7</P>
<P>9. Animals/</P>
<P>10. Humans/</P>
<P>11. 9 not (9 and 10)</P>
<P>12. 8 not 11</P>
<P>The MEDLINE strategy and RCT filter are adapted to identify trials in other electronic databases</P>
</SUBSECTION>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS/>
</COCHRANE_REVIEW>